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ABSTRACT 
The toxic effects of oxygen to living organisms have been known for over a century 
and these effects are directly linked to its reactive forms or reactive oxygen species 
(ROS). ROS are known to be involved in many human physical disorders, but, the 
generation of ROS by some chemicals are exploited for medicinal purposes. An 
understanding of the toxicology of ROS and ROS-generating compounds is therefore 
very important. 
The development of modem biology has enabled the investigation of ROS-induced 
toxicity at various organisational levels. A chemical investigation was carried out to 
assess the possible interactions between DNA, ROS, ROS-generating compounds and 
modulating compounds, such as antioxidants. Various in vitro techniques, including 
the comet assay, bacterial mutation assay (the Ames test), chromosome aberration 
assay and the enhanced chemiluminescence detection of p21" oncoproteins, were 
employed to investigate ROS-induced genotoxicity by many important ROS- 
generating chemicals. Amongst these were bleomycin, doxorubicin, benzene and its 
metabolites and some less well characterised compounds in terms of ROS 
involvement such as the heterocyclic amines (food mutagens) and aromatic amines. In 
vivo investigations were also performed in rodents as well as in humans to identify 
ROS toxicity induced in vivo by chemical and biological factors including 1,3 
butadiene, bleomycin and diabetes. The effect of vitamin C supplementation on 
healthy human volunteers was also studied. Parameters for in vivo investigations were 
DNA strand breakage in the comet assay, lipid peroxidation, antioxidant capacity and 
oncoprotein p21`ß$ levels. 
The overall results showed that the effects of ROS and ROS-generating compounds to 
the genetic material were extremely detrimental in the chemical and cellular 
environment in vitro, but these effects were modulated by exogenous antioxidants. 
However, the effects of ROS-generating compounds (and other chemicals) in vivo 
varied greatly depending on the types of chemicals, and the modulating effects of 
exogenous antioxidants were ambiguous. 
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CHAPTER 1 
INTRODUCTION 
1.1 The genotoxicity of reactive oxygen species and its significance in 
the pathogenesis of human diseases 
Oxygen, which makes up 46.6% of the earth's crust and 21% by volume of dry air, is 
the most abundant element in the biosphere (The Merck Index, 1989). Since the 
discovery of oxygen by Scheele in 1771 and independently by Priestley in 1775, it has 
been recognised as essential for life on earth. However, it is also potentially toxic to 
living organisms, and the toxic effects of oxygen were not fully appreciated until 
molecular biology techniques were firmly established. It has been established that the 
toxic effects of oxygen are directly linked to its reactive forms or reactive oxygen 
species (ROS). Most significantly the pathogenesis of many human diseases, 
especially the degenerative diseases such as cancer and ageing, are probably directly 
linked to damage of the genetic material by ROS i. e. the genotoxic effects of ROS. As 
to why and how such a vital element of life is potentially dangerous, it is necessary to 
review the chemistry and biochemistry of oxygen before the effects of ROS are 
discussed. In this thesis, oxygen is referred to as both the element and molecular 
oxygen (02). 
1.2 The formation of reactive oxygen species 
A radical is defined as a chemical which has one or more unpaired electrons, and it is 
known that a radical compound is usually more reactive than a non-radical compound. 
According to the molecular orbital theory, the energy states of 02 orbitals are in rIs 
<a* is <a2s <a*2s <a2p <rr2p,, = nc2py <zt*2p,, = 7t*2py <a*2p order. Each orbital can 
1 
accommodate up to 2 electrons (Pauli principle). In the so called triplet ground state 
of the bioxygen molecule (3ZgO2), the 7t*2p,, and t*2py orbitals are half occupied 
(Hund's rule), and where each of the two unpaired electrons in parallel spin occupies a 
7c*2p antibonding orbital. In other words, ground state 02 is a bi-radical with the 
orbital configuration: ß1s2, a* 1s2, ß2s2, a*2s2, ß2p2, rc2pX2,7t2py2,7C*2pX1,7t*2py'. 
Although 02 has two unpaired electrons in its outer orbitals, usually it does not lose 
any electron to other molecules due to its very high electronegativity. Nor does it 
easily receive electrons from non-radical species because of the incompatibility of 
their bonding orbitals. Normal biomolecules usually do not have unpaired electrons 
which are easily accessible to 02. Unless their paired electrons in the exterior orbitals 
break the quantum barrier e. g. become two unpaired electrons in parallel spin which is 
rare in natural circumstances, the lowest unoccupied (or not fully occupied) molecular 
orbitals (LUMO) of 02 do not accept the electrons from biomolecules. However, 02 
is capable of receiving electrons sequentially to form 02 -, 022- [hydrogen peroxide 
(H202) in protonated form]. Homolytic fission of the 0-0 bond in H202 produces two 
hydroxyl radicals (OH'). The triplet ground state 02 also can be excited to the singlet 
form I4gO2, which has the 7t*2p,, 2,7t*2py° orbital configuration, by photons (hv) or 
chemical reactions. Because oxygen atom(s) in 02 -, H202, OH', 'AgO2 and some 
other related species are more reactive than oxygen atoms in 3 1902, these species then 
have been named as reactive oxygen species or ROS. Other active oxygen-related 
agents, e. g. the organic oxyl radicals (RO'), the organic peroxyl radicals (ROO'), 
hypochlorous acid (HOCI) and a few more, may also be called ROS, but they are 
outside the scope of this thesis. 
2 
1.3 Oxygen in living organisms 
Oxygen is one of the most important elements in living organisms. It is important in 
several aspects, and its participation in the living process is tightly regulated. It also 
can be toxic to living organisms. 
1.3.1 The evolutionary relationship between 02 and living cells 
Fossil evidence shows that 02 appeared in the earth's atmosphere 2-3 billion years 
ago and is believed to be the waste product of photosynthetic micro-organisms. The 
level of atmospheric 02 reached a steady state around 1.5 billion years ago which 
coincided with the appearance of the first eukaryotes (Tribe et al, 1981). Before the 
accumulation of 02 in the atmosphere, all the primitive single-celled living organisms 
lived in a reductive atmospheric environment. As the atmosphere evolved, many cells 
could not cope with the oxidative toxicity of oxygen (see 1.3.2). They either became 
extinct or retreated to places where 02 was rare. A few survived and have adapted to 
the new environment by developing an oxygen-detoxification mechanism. The cells 
of modern living organisms have evolved to be able to take advantage of the 
physicochemical properties of 02. Modern cells use 02 primarily for energy 
production, immune defence and xenobiotic detoxification. 
1.3.2 Oxygen toxicity 
It is well known to microbiologists that oxygen is toxic to all anaerobic bacteria, but 
oxygen can also be toxic to aerobic organisms. The consumption of 02 by living 
organisms is to some extent regulated by the partial pressure of 02 in the environment, 
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which has been very steady over the past billions of years. It is unnecessary for 
aerobes to evolve an active oxygen concentration regulator, since, the consumption of 
oxygen is regulated in a passive mode. The sudden change of 02 supply, either to the 
hypoxic or hyperoxic state, would inevitably cause stress. 02 levels higher than in 
normal air are known to be toxic to plants, animals and aerobic bacteria. Exposure of 
humans to pure 02 at 1 atmospheric pressure for 6h can cause chest soreness, give 
rise to cough and sore throat (Halliwell, 1984), but breathing pure 02 at 0.2 
atmospheres is non-toxic (Kehrer, 1993). Prolonged exposure of rodents to hyperoxia 
can be fatal for the animals (Janssen et al, 1993). High 02 pressure also is known to 
produce teratogenicity in vivo (Fantel, 1996). At the molecular level, the toxicity of 02 
has been demonstrated to arise from the direct inhibition of thiol (-SH) dependent 
enzymes and the formation of ROS, which are able to further react with essential 
biomolecules in vivo (Gilbert, 1981; Jamieson, 1986; Kehrer, 1993; Fantel, 1996). 
Many experiments have shown that by decreasing the consumption rate of 02 which 
includes dietary restriction, movement restriction or lowering body temperature, some 
animals can have a longer life span (e. g. Wachsman, 1996). Data from the experiment 
of Adelman et al (1988) showed an inverse relationship between the metabolic rate of 
some species and their lifespans. These are possibly linked to 02 toxicity. 
1.4 Biochemistry of oxygen and reactive oxygen species 
Although 02 utilisation is tightly regulated, it is unavoidable that some 02 still can 
escape the controlling mechanisms. The cells have both active and passive defence 
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mechanisms to cope with the potentially damaging effects of ROS. However, the 
defence mechanisms can be overwhelmed by the over-production of ROS in 
pathological/toxicological conditions. 
1.4.1 The existence of ROS in vivo 
Various enzymes using 02 as a substrate may `leak' electrons to 02, thus producing 
ROS in vivo, e. g. some components in the respiratory chain of mitochondria (Cadenas, 
1989) and cytochrome P450 (Goeptar et al, 1995). Many early experiments have 
demonstrated that ROS are available in vivo in measurable quantities. Using in vitro 
experimental data, it is estimated that about 1- 3% of the oxygen we breathe in is 
used to make 02*- (Halliwell, 1994a, 1994b), and this is considered to be as high as 
5% by some others (Kaul et al, 1993). The concentrations of 02' and H202 (which 
probably originate primarily from O2'7 in liver were estimated to be about 10-'0- 10"11 
and 10"7 _ 10-9 M respectively (Cadenas, 1989; Carter, 1995). The lens of the human 
eye contains pM concentrations of 13202, and perfused normal rat liver can produce 82 
nM of H202 per gram of tissue per min (Halliwell and Gutteridge, 1984). Both 02 
and H202 can be detected directly using physicochemical methods, e. g. electron 
paramagnetic resonance for detecting 02*- (Balagopalakrishna, 1996), although both 
OH' and IOgO2 are too active to be directly detected. Their existence has been 
demonstrated by using indirect methods, e. g. using ESR measurements of the spin- 
trap for OH' (Holley and Cheeseman, 1993; Partridge et al, 1994; Mao et al, 1996) 
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1.4.2 The production of ROS in vivo and the importance of the transition 
metal iron 
ROS production in vivo is actually determined by the equilibrium of many relevant 
chemical and enzymatic reactions. H202 and 02' both can be the products of normal 
enzymatic reactions, but not free OH', and under certain conditions, such as in the 
presence of transition metals, OH* can be generated by a non-enzymatic mechanism. 
In the cellular environment, all living processes involving electron transfer and 
oxygen have ROS generating potential. Mitochondrial electron transport is the energy 
source of all aerobic organisms. Many enzyme complexes in mitochondria can leak 
electrons to produce ROS (Kehrer, 1993). Reactions involving other enzyme systems, 
such as cytochrome P450, soluble and membrane-bound oxidases, peroxidases and 
reductases can all produce ROS in vivo (Goeptar et al, 1995; Halliwell and 
Gutteridge, 1984; Kehrer, 1993). For example reaction (1-2) is catalysed by amine 
oxidases (Mondovi et al, 1988) and reaction (1-3) is catalysed by some peroxidases in 
the presence of Br (Naqui and Chance, 1986): 
R-CH2-NH2 + 02 + H2O -* R-CHO + NH3 + H202 (1-1) 
H202 + H202 -+ 2 H2O +' g02 (1-2) 
In addition to the above mentioned enzyme reactions, the autooxidation of 
endogenous and exogenous chemicals, e. g. some polyphenols and ascorbic acid can 
also be a source of ROS production (Kehrer, 1993; Aruoma, 1994). 
Irrespective of which route ROS are generated, metal ions are always involved in 
ROS metabolism either in a free state form or bound with other ligands. Metals like 
iron and copper are essential for both ROS generation and disposal. Transition metals 
have very flexible outer atomic orbitals (incompletely filled d orbitals) which easily 
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become the bridge to overcome the quantum barrier of electron transfer from one 
molecule to another. It is known that all enzymes which directly participate in oxygen 
metabolism contain one or more active centres with transition metals (Malmström, 
1982). The Fenton reaction, a chemical reaction generating hydroxyl radicals from 
H202, is catalysed by iron: 
Fe 2+ + H202 --> Fe3+ + OH' + OH- (1-3) 
The subsequently proposed Haber-Weiss reaction is represented by the following 
reactions: 
Fe 3+ + 02"- t-> Fe 2+ + 02 (1-4) 
Fe 2+ + H202 -* Fe 
3+ + OH' + OH- (1-3) 
Net: 02"- + H202 --> 02 + OH' + OW (1-5) 
Further studies have revealed that more reactions are possible (Halliwell and 
Gutteridge, 1984; Badwey and Karnovsky, 1980): 
Fe 3+ + H202 --: Fe 
2+ + 02"- + H+ (1-6) 
OH' + H202 -* H2O -- 020- + H+ (1-7) 
Fe 2+ + OH' --3 Fe 
3+ + OW (1-8) 
202 -+ 2H+ --> 02 + H2O2 (1-9) 
2H202 --> 2H20 + 02 (1-10) 
H02 + 02"- + H+ -> 
1A902 + H202 (1-11) 
02"- + H202 -> 
1AgO2 + OH' + OH- (1-12) 
OC1- + H202 -> 
1A902 + H2O + Cl- (1-13) 
02 -+ OH' -+ 
10gO2 + OH- (1-14) 
202*- + RCOO-COOR --> 2'ig02 + 2R000- (1-15) 
The reactions can be very complicated if other factors such as reducing agents are 
involved. Cu and other transition metals are also able to catalyse similar reactions 
(Kawanishi et al, 1994), but the relevance of the reactions in the cellular environment 
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(Halliwell, 1994a) and that of the specific reactive intermediate(s) are still subjects of 
debate (Wink et al, 1994). All the evidence shows that ROS are easily generated when 
free transition metals are present in vivo. 
1.4.3 Iron regulation in vivo 
Its abundance in nature, versatile outer atomic orbitals, coordination-dependent redox 
potentials, ability to form chemical bonds with various ligands and other 
physicochemical properties, all make iron a natural choice for mediating many 
essential biological redox reactions. For the same reasons, iron also plays the pivotal 
role in ROS conversion and ROS toxicity. If the catalytic iron species is not limited in 
vivo, the overwhelming production of ROS and the subsequent oxidative damage to 
the cells and the tissues will make life impossible to sustain. 
An adult male is thought to have a body iron content of -4g, of which -1g belongs 
to a storage depot (Bothwell, 1995) and the rest would be incorporated into various 
tissue and cellular components. External iron exchange for humans is about 0.8 -1 
mg/day excluding female menstrual and pregnancy periods. Much of the iron exists in 
haem-containing proteins like Hb, Mb and catalase. In biological systems iron is 
usually tightly bound with proteins and does not exist in free inorganic forms in large 
quantities. It is transported in the plasma and extracellular fluids by transferrin, a 
glycoprotein with two Fe 3+ binding sites per molecule. Intracellularly, iron is stored as 
ferritin, which can store up to 4500 mole of iron per mole of protein. Low molecular 
weight chelators of iron are required to exchange iron between various iron-containing 
and utilising compounds. Such agents may include ascorbic acid, citrate, nucleoside 
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5'-diphosphates (NDPs) and nucleoside 5'-triphosphates (NTPs). Non-protein-bound 
iron has been detected in many different tissues and subcellular components and the 
free iron content of rat liver has been reported to be - 10 µM (Horton and Fairhurst, 
1987). Iron chelated by non-protein molecules is capable of catalysing ROS 
conversions (Reactions 1-4 to 1-16) in most cases. Also iron stored in ferritin and 
other iron-containing proteins may be liberated by the denaturation of these proteins 
by various factors including ROS. For example, 02*- generated by microsomal 
cytochrome P450 and b5 can free iron from ferritin and stimulate ROS production 
(Puntarulo and Cederbaum, 1996); nitric oxide, which also is regarded as a ROS, can 
remove iron from Fe-S proteins (Taniguchi, 1993); and H202 is capable of releasing 
iron from myoglobin (Prasad et al, 1989). The interactions between ROS and iron- 
containing proteins could be cyclical for both ROS production and iron release. Thus 
the ROS in vivo are normally in an equilibrium state between their generation and 
their removal (see 1.5), in which transition the metal iron plays a special role. 
1.4.4 The reaction of ROS with cellular components 
Once the ROS are formed, they will be converted to other chemically more stable 
forms through the release of energy. Because the valence of the oxygen atom(s) in 
ROS is between that of 02 and that of H2O, for thermodynamic reasons ROS 
generally tend to obtain electrons from surrounding molecules. The mechanisms of 
such reactions, however, can be very diverse. OZ' and H202 are very mild oxidants in 
aqueous solution, and are unlikely to be the main species which react with cellular 
components in the hydrophilic environment. But in the hydrophobic environment, like 
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the interior of a biomembrane, O-, '- could be extremely damaging (Halliwell and 
Gutteridge, 1984). The direct reactions between 02', H202 and biomolecules have 
not been thoroughly investigated partly because 02"- and H202 are not as active as 
their common name ROS implies, partly because they can be converted to the very 
reactive OH' which reacts with other molecules (see below). Scavengers of OH' often 
have a protective role against the damage induced by 02*-- or H202- generating 
systems, and without the presence of transition metals H202 is not very reactive with 
DNA in vitro (see chapter 3). Therefore the reactions between 02', H202 and 
biomolecules are mainly through their secondary products (i. e. OH) in vivo. In 
contrast OH' is a very powerful oxidant with a half life of - 10'9 seconds in vivo, and 
a diffusion path of approximately 1.5 atoms. It can react with any biomolecule 
immediately in situ at a diffusion-limited rate (Fantel, 1996) and the reaction is 
mainly via the electrophilic addition or H atom abstraction. 
1.4.4.1 Reactions with DNA 
Since nucleic acids contain the genetic information of living organisms, the reaction 
between ROS and nucleic acids, especially DNA is of great significance. Experiments 
have demonstrated that ROS can cause base modification, covalent binding of bases, 
abasic sites and strand breaks (Dizdaroglu, 1993). The most likely agent causing this 
damage is OH' as has been discussed above, and the consequence of OH' as a major 
cause of DNA damage is that little, if any, specificity exists along the DNA strand 
(Meneghini, 1988). When reacting with DNA, OH* can attack both the base moieties 
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and the pentose moieties. The products of these reactions will undergo further 
chemical and enzymatic reactions. 
The reactions with base moieties are mainly the addition of OH' to an unsaturated 
bond to form oxidised bases, and to a lesser extent H atom abstraction from -CH3 by 
OH' (Simic, 1994). The positions prone to OH* addition on base moieties are the C5 
and C6 on the pyrimidines and the C4, C5 and C8 on the purines where electron 
density is high. There are at least 35 different base modifications produced by ROS 
(McBride et al, 1991), 'and the well-known oxidised base 8-hydroxy-2'- 
deoxyguanosine [8-OHdG or 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG)] is 
frequently used to assess oxidative stress both in vivo and in vitro. Some OH' (up to 
20%) can abstract H atoms from any of five C atoms of the pentose moieties in DNA 
(Dizdaroglu, 1993). The following secondary reactions and/or the rearrangement of 
the pentose radicals can give rise to alkali-labile sites, abasic sites, DNA strand breaks 
and other lesions. 
It has now been recognised by many scientists that the oxidative DNA damage caused 
by ROS is extensive even under normal conditions. Ames and co-workers in the US 
estimated that there are - 4.1 x 104 8-OHdG residues present in the mitochondrial 
genome of a rat liver cell, and - 1.4 x 105 8-OHdG residues in the nuclear genome, 
while 8-OHdG residues may only account for - 5% of the total oxidative damage 
(Richter et al, 1988). The oxidative lesions of DNA have serious implications in 
human pathogenesis (see 1.6). 
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1.4.4.2 Reactions with proteins 
The reactions of ROS with protein are much less studied than those with DNA. 02 
and H202 are not very reactive, but they can oxidise the exposed -SH (Cys) and -OH 
(Tyr) groups on a protein. It has been reported that 02*- can inactivate various 
enzymes (Fridovich, 1989), but is not capable of inducing severe damage (Davies, 
1987); H202 dimerises myoglobin through its tyrosine residues (Tew and de 
Montellano, 1988). There are many proteins and enzymes containing transition 
metals, especially iron, and they are the easiest targets for ROS due to the possible 
generation of ROS in situ mediated by the metals they carry. This theory is supported 
by some experimental studies, for example, experiments with Hb (McArthur and 
Davies, 1993) and Mb (Prasad et al, 1989; Osawa and Korzekwa, 1991). The ROS- 
altered form of these proteins can easily contact other biomolecules in the cellular 
matrix and initiate the chemical modification of other compounds, e. g. initiate lipid 
peroxidation (Kanner and Harel, 1985). It is also believed that Fe(II) can bind to metal 
binding sites on some proteins to form a Fe(II)-protein complex that may react with 
H202 and produce OH' in situ (Stadtman and Oliver, 1991); the OH' has the capacity 
to cause damage to any of the amino acid residues via H atom abstraction or, other 
mechanisms on a protein, preferably at the sites with high electron density, e. g. 
tryptophan, tyrosine and methionine residues. The H atom abstraction by OH' from 
the amino acid a-C atoms can be followed by an 02 addition to the carbon-centred 
radical to form peroxyl species, and the decomposition of a-C peroxides may lead to 
changes of protein physicochemical properties, e. g., molecular weight and net 
electrical charge (Davies, 1987). It has been demonstrated that when ROS react with 
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amino acid residue side chains of a protein molecule, a protein radical can be formed, 
and further change of the protein radical- would lead to protein modification, 
denaturation, aggregation, fragmentation and greater susceptibility to proteinase. 
Although the fate of oxidised proteins has not been fully investigated, it is thought the 
reaction between ROS and proteins may regulate the turnover of proteins in vivo in all 
aerobic organisms (Davies, 1987). 
1.4.4.3 Reactions with lipids 
Because all of the biochemical activities are closely associated with biomembranes 
(e. g. DNA duplication and oxidative phosphorylation), the reactions between ROS 
and lipids are an important subject of lipid and biomembrane studies. In the study of 
lipids and ROS interaction, the simple molecular structure of lipids offers an 
advantage over proteins and DNA. It is now realised that lipid peroxidation is the 
main and most serious consequence of ROS-lipid interaction. 
Lipid molecules in biomembranes often contain polyunsaturated fatty acids (PUFA) 
for maintaining the fluidity which is essential for membrane functions. Saturated 
forms only account for a very small percentage of total fatty acids. All the PUFA have 
the common structure: -CH2-CH=CH-CH2-CH=CH-CH2-. Many PUFA have 
more than two double bonds and the number of unsaturated C can be as high as 20. 
The hydrogens attached to the saturated carbon are called `allylic' hydrogens, while 
the hydrogens attached to the unsaturated carbons are called `vinylic' hydrogens. The 
chemical bond between an allylic hydrogen and its attached C atom is weakened by 
the adjacent double bond(s), especially when the C atom has two adjacent double 
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bonds. The outcome of the weakened bond is that allylic hydrogens are easily 
abstracted by electrophilic species, including free radicals and some ROS, to form 
carbon-centred lipid radicals. The lipid radicals formed can react with 02 and give rise 
to peroxylipid radicals which can initiate radical chain reactions among PUFA 
molecules and break down the structure of PUFA, the whole process being known as 
lipid peroxidation (Horton and Fairhurst, 1987). Lipid peroxidation can be initiated 
both by cellular enzymes (Chamulitrat and Mason, 1989) and by ROS via a similar 
route. OH' and 1AgO2 certainly are able to initiate lipid peroxidation, while the ability 
of 020- is still debatable. Some believe that H02 , the protonated 
form of 020- and a 
more potent oxidant, can cause PUFA peroxidation (Fridovich, 1989). H202 cannot 
react with PUFA, but the existence of the transition metals will convert 02' and H202 
to the highly reactive OH' (see 1.4.2). Thus all ROS are potentially harmful to all 
biomolecules. 
1.4.5 The degradation of ROS in vivo 
Once ROS are formed in vivo, they are either removed by cellular detoxifying 
mechanisms or annihilated by chemical reactions. Both H202 and 02'- have enzymes, 
namely catalase and superoxide disinutase respectively, for their removal. But for OH* 
and IOg02, both are too active to be dealt with by active cellular detoxifying 
mechanisms, and therefore, can only be destroyed by `sacrifice' of some compounds 
in vivo. 
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1.4.5.1 The degradation of H202 and O2 
The degradation of H202 and 02' by chemical reactions catalysed by transition 
metals easily leads to the generation of more destructive species (Reaction 1-3 to 1- 
15), but they are dealt with by cellular enzymes. They may also directly react with 
some cellular compounds, e. g. the thiol groups of a protein (see 1.4.4) or low- 
molecular-weight antioxidants, to form stable products. 
In 1818, L. J. Thenard in France discovered that H202 was decomposed by animal 
tissues with the release of 02. The enzyme responsible for this action was named 
catalase by 0. Loew in the US in 1901 and it was later found ubiquitous in aerobic 
cells, but absent in obligate anaerobics. In animals, catalase is present in nearly all 
cells and organs, with the highest activity in liver and kidney. All these facts highlight 
the importance of catalase in aerobic metabolism. Within a typical animal cell, 
catalase is mainly concentrated in an ubiquitous organelle, the peroxisomes, which 
contain various oxidases, and catalase may constitute up to 40% of the total 
peroxisomal protein (Alberts et al, 1983). Apart from the mitochondria, which also 
contain catalase, peroxisomes are the main 02 utilising organelles in the cells, at least 
10% 02 taken up into the liver is used by peroxisomes and 5- 20% in the other cells 
(Dhaunsi et al, 1992). The oxidases inside the peroxisomes catalyse the following 
reaction: 
RH2+02-+R+H202 (1-16) 
The co-localised catalase will remove the H2O2 (also other peroxides) by catalysing 
the generalised reaction below (Vuillaume, 1987): 
R-OOH + HXOH -ý XO + ROH + H2O (1-17) 
(R = H/alkyl/acyl; X= O/NH/C=O/H(CH2)CH with n=1,2 or 3) 
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The cooperation of catalase and oxidases in the peroxisomes will ensure that most of 
the H202 generated in the organelles is destroyed before it can diffuse into the cytosol 
where it might cause oxidative damage to other important biomolecules. Another very 
important H202-removing enzyme in mammalian cells is glutathione peroxidase 
(GPX), which is located in the cytosol, nucleus and mitochondria, and it catalyses the 
following reaction (Halliwell, 1994a): 
2GSH + H202 --> GSSG +2 H2O (1-18) 
Other peroxidases catalyse similar reactions except that they use different substrates 
as electron donors to reduce H202. The significance of glutathione peroxidase lies in 
the fact that the intracellular level of GSH is in the range of 0.5-10 mM in mammalian 
cells (Meister and Anderson, 1983) and reaction (1-18) can ensure further removal of 
H202. 
The surging interests in 02*- in the late 70's and 80's led to extensive studies of 02' 
and superoxide dismutase (SOD), the enzyme which removes it. SOD was first 
isolated in 1938 by Mann and Keilin (Vuillaume, 1987). It catalyses the dismutation 
of 02*-* 
O2 -+ O2 -+ 2H+ -* 11202 + 02 (1-19) 
SOD, like catalase, is also widely distributed throughout biological systems. It has 
three distinctive forms, the manganese-containing MnSOD, its related iron-containing 
FeSOD (so far only known to exist in prokaryotes and some plants) and the 
copper/zinc-containing Cu, ZnSOD. All catalyse the same reaction (1-19) with 
comparable efficiency at different cellular locations (Fridovich, 1989). In mammalian 
cells, MnSOD is found in the matrix of mitochondria while Cu, ZnSOD is primarily 
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located in the cytosol. But Cu, ZnSOD also has been demonstrated to exist in 
peroxisomes possibly to remove locally produced 02"- (Dhaunsi et al, 1992). In 
humans, the Cu, ZnSOD in the cytosol is a dimer, but there is also a glycosylated 
homotetrameric form of Cu, ZnSOD in the extracellular spaces (McNamara and 
Fridovich, 1993). 
1.4.5.2 The degradation of OH' and IAgO2 
The degradation of OH' is achieved always through radical reaction mechanisms: 
OH' + X-H -> H2O + X' (1-20) 
OH' +Y -+ [Y-OH]' 
OH' + R" -* R-OH 
(1-21) 
(1-22) 
X-H or Y could be any compound which reacts with OH', 
R' could be any free radical 
The degradation of IA902 may involve two mechanisms: the first one is through 
reactions with other compounds in which radicals or peroxides may be formed, 
whereas the second one is a self-degradation accompanied by photon emissions. 
1.5 The equilibrium of ROS in the cells 
The biochemistry of ROS production and degradation has been generally discussed in 
Sections 1.4.1 and 1.4.2. The following discussion will concentrate on the cellular 
regulation of ROS. Mitochondria and peroxisomes use 02 most actively inside the 
cell, and they should produce more ROS than other organelles. It would be anticipated 
that these two organelles will have good mechanisms in place to dispose of ROS 
efficiently. 
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To deal with the inevitability of ROS-induced damage and to survive, cells must have 
protective mechanisms to limit the generation of ROS, to limit the concentration of 
ROS near sensitive sites and to repair the damage, particularly DNA damage. Thus all 
ROS-related biochemical processes are in a state of dynamic equilibrium for normal 
healthy cells and tissues. 
1.5.1 The regulation of ROS generation and removal in the cells 
The subject of ROS regulation is divided into its production and its removal. Further 
discussion of ROS regulation by antioxidants is given in Section 1.6.2. 
1.5.1.1 ROS generation and its regulation in the cells 
In a cellular environment, there are several chemical sources of ROS. ROS are the by- 
products of aerobic metabolism, resulting from the electron 'leakage' and/or the 
`accidental' release of partially reduced oxygen by some enzymes or enzyme 
complexes which utilise 02 as one of their substrates. ROS are the normal products of 
some enzymatic reactions, and the enzymes involved in such reactions also use 02 as 
a substrate. There are more than 200 enzymes which use 02 as one of their substrates 
(Malmström, 1982), and they are distributed throughout the cellular spaces. ROS can 
directly arise from the contact of 02 and reduced transition metals (see the reverse 
reaction of 1-4), and so are actually related to the autooxidation of reducing 
compounds. Also, large numbers of ROS may be generated by redox cycling 
compounds taken up by the cells under pathotoxicological conditions. It has been 
calculated that a typical human cell metabolises about 1012 molecules of 02 per day 
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and produces some 3x 109 molecules of H202 (mainly from 02*-) per hour (Martin et 
al, 1996). 
There are several general factors to be considered in the regulation of ROS generation. 
These include the substrate concentrations of the above mentioned enzymatic reactions 
which are possibly related to the reduced oxidative damage by caloric restriction 
(Wachsman, 1996), the pH of the place where reactions occur, and the temperature 
which is possibly related to the prolonged life span of some animals at lower 
temperatures. The concentrations of metal-binding compounds are also important, so are 
the activities of enzymes activating/ decomposing redox cycling compounds, which are 
possibly related to differences in responses to redox toxins by individuals, and many 
other factors may indirectly affect the generation of ROS due to the integrated nature of 
the cells. 
1.5.1.2 ROS removal and its regulation in the cells 
The removal of ROS generated inside a cell will be determined by various 
mechanisms: 1) the localised disposal of H202 and 02'-; 2) the ubiquitous reactions of 
any cellular component with ROS; and 3) the passive diffusion of ROS to the 
extracellular spaces. Some cells may also actively release ROS for special reasons and 
this will be discussed in Section 1.5.2. 
The first mechanism relies on the localised SODs, catalase and peroxidases in the 
cellular organelles (see Section 1.4.5.1). Various factors which affect the activities of 
these enzymes, e. g. turnover rate and inhibitors, can directly influence ROS disposal. 
The second mechanism is related to both the cytosolic `cousins' of the above 
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mentioned localised enzymes and all the molecules which may react with any type of 
ROS. The reactions which fall in this category are extremely complicated and diverse, 
and the study is mainly confined to the reactions of ROS with `antioxidants' (see 
Section 1.6.2). It is generally believed that the levels of antioxidants can directly affect 
the disposal of ROS by the cells. The third mechanism is determined by the 
permeability of the biomembranes. Both OH' and IOgO2 are too active to pass 
through, and furthermore, they are more likely to be intercepted before they can reach 
the membranes. 02 - is an ion which cannot freely cross biomembranes except 
through the anion channels (McNamara and Fridovich, 1993) and its most likely fate 
is to dismutate and become H202. H202 is the only ROS which can easily diffuse 
through the cellular membranes, and its diffusion is limited merely by the difference 
of its concentration on the two sides of the membrane it crosses. 
1.5.2 The functions of ROS other than as damaging agents 
Apart from causing damaging effects, ROS can be used by cells and tissues for 
beneficial purposes, for instance as the regulators of signal transduction. 
1.5.2.1 ROS used as signalling molecules 
Most notable is that 02*- reacts very rapidly with nitric oxide (NO), an endothelium- 
derived relaxing factor, which limits the life time of NO and decreases the net relaxing 
effect of NO on the smooth muscle of blood vessels (McNamara and Fridovich, 
1993). White et al in 1976 observed that H202 activates guanylate cyclase following 
the oxidation of -SH groups of the enzyme, resulting in the production of the second 
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messenger cGMP (Janssen et al, 1993). ROS can stimulate the phosphorylation of 
tyrosine, serine and threonine residues on the proteins, and it is proposed that ROS 
directly activate protein kinases and/or inhibit protein phosphatases, and thus is 
essentially a part of cellular signal transduction. The observations that ligand-receptor 
interactions produce ROS and that antioxidants block receptor-mediated signal 
transduction led to the proposal that ROS may be secondary messengers for several 
cellular processes (Suzuki et al, 1997). A recent finding that there is an obligatory 
requirement for intracellular ROS generation during T lymphocyte activation has 
given further evidence for ROS acting as signalling agents in the regulation of certain 
cellular processes (Goldstone and Hunt, 1997). 
1.5.2.2 ROS in immune defence 
Baldridge and Gerard in 1933 observed that the exposure of canine leukocytes to 
bacteria manifested a marked increase of 02 consumption. Sbarra and Karnovsky later 
found such 02 consumption is not related to the energy production in the 
mitochondria (Badwey and Karnovsky, 1980). Further study reveals that this 
`respiratory burst' is vital for effective killing and digestion of microbes by 
phagocytosis. During the respiratory burst, phagocytes use a NADPH oxidase system 
and 02 to produce a large amount of 02*- in the phagocytic vacuoles which contain 
bacteria, thus leading to the killing of bacteria. H202 and hypohalous acids may also 
be involved in the process (Segal and Abo, 1993). 
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1.5.3 Cellular responses to ROS-induced damage 
Under normal circumstances, a basal level of oxidative damage induced by ROS in 
the cellular components is always present. Over the millions of years of evolution, the 
cells have developed a degree of tolerance to ROS, and there is a set of `maintenance' 
enzymes which together with antioxidants deal with such ROS-mediated damage. 
Modern cells have both general and specified detoxifying mechanisms to regulate 
cellular ROS (Ames et al, 1991). The exposure of cells to elevated ROS levels would 
force them to express special gene products to counteract the ROS pressure, thus 
minimising the possible permanent damage induced by ROS. 
1.5.3.1 The importance of ROS-detoxifying enzymes 
The enzymatic detoxification of ROS by reactions catalysed by SODs, catalase and 
peroxidases is essential. Although the situation in vivo is not completely clear, data 
accumulated from in vitro studies and indirectly from in vivo studies strongly support 
this view. These enzymes are known to be necessary for sustaining aerobic 
metabolism, for resisting hyperoxic and other ROS-related toxicities, increasing the 
lifespan of experimental animals and for reducing levels of oxidised biomolecules. 
Although the regulation of such enzymes is not fully understood, there is evidence to 
suggest that some enzymes are inducible by ROS and hypoxia. 
Transgenic mice expressing increased levels of human MnSOD displayed greater 
resistance to doxorubicin whose toxicity is believed to be partly through the 
generation of ROS (Yen et al, 1996). Transgenic mice overexpressing Cu, ZnSOD 
exhibited greater resistance to hyperoxia and decreased mortality by comparison with 
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control animals (Janssen et al, 1993). The administration of 3-aminotriazole, a 
catalase inhibitor, to rabbits, guinea pigs and rats has lead to increased levels of lipid 
peroxidation in vivo (Ohta et al, 1996). Many more in vitro as well as in vivo 
experiments have emphasised the importance of detoxifying enzymes in the cells and 
tissues (e. g. see Janssen et al, 1993), but their exact roles and regulation, especially in 
vivo, need to be further investigated. 
1.5.3.2 The repair of ROS-induced damage to DNA 
In the cells, damaged lipids and proteins can simply be removed or digested by 
relevant enzymes and be replaced with newly synthesised molecules without causing 
concurring damage to other cellular components, and such a turnover of cellular 
components occurs constantly in vivo. But in some cases, they can also be repaired in 
the presence of some antioxidants, for example, some oxidised -SH groups (-S-S-) 
on proteins may be restored to their reduced form by methionine sulphoxide reductase 
(Halliwell, 1994a), GSH or other reducing agents. 
For cellular DNA, ROS-induced damage cannot be dealt with by simply regenerating 
the whole molecule. All the cells have sophisticated DNA repair mechanisms to 
remove any recognisable damage, including ROS-induced damage, usually in a short 
period of time before any irreversible damage happens. It has been identified that four 
types of DNA damage can be induced by ROS (see 1.4.4.1), and their repair processes 
are only partly understood in mammalian cells in spite of extensive study in recent 
years. 
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The major forms of repair may include direct reversal of damage, excision of damage 
and postreplication repair. Except for the direct reversal mechanism, which requires 
only a single enzyme, the other two mechanisms seem to involve a number of special 
proteins participating in damage recognition (Janssen et al, 1993), e. g. Poly(ADP- 
ribose) polymerase (PARP) recognises DNA strand breaks by its DNA-binding 
domain. 
1.5.4 The pathotoxicological conditions linked with breakdown of ROS 
regulation 
It is recognised that the cellular metabolic network can automatically respond to 
challenges by physical, chemical and biological factors and that the cells are resilient 
to any stress, but sustained overstress to a cell inevitably leads to the breakdown of 
metabolic mechanisms and eventually to cell death. The sustained stress of ROS to 
the cells has existed ever since free 02 appeared in the earth's atmosphere (see 1.3.2) 
and the cells responded by evolving the manufacture of a set of antioxidants to 
counter the constant threat of ROS. The dynamic equilibrium of ROS in a cell can be 
broken by its over-production or its inefficient removal triggered by naturally- 
occurring events (mainly pathological) and sometimes artificial events (mainly 
toxicological). The factors most likely to adversely affect the ROS regulation are 
listed below, and their actions are not mutually exclusive: 
- low energy status and malnutrition of cells, leading to an inability to 
synthesise antioxidant components; 
- mutations in structural and regulatory genes of proteins involving ROS 
generation/ removal, e. g. a thiol-dependent protector protein (Ahn et al, 1996); 
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- mutations in other related genes, e. g. genes coding repair enzymes and 
membrane channels; 
- depletion of non-protein antioxidants, e. g. vitamin E and GSH; 
- inhibitors of antioxidant enzymes, e. g. azide (an inhibitor of catalase) and 
dithiocarbamatic acid (an inhibitor of SOD); 
- signalling molecules leading to enhanced ROS production, e. g. tumour 
necrosis factor alpha (TNF a), clofibrate (a peroxisome proliferator) and 
phorbol ester (a phagocyte activator); 
- uncouplers of cellular electron transport chain, e. g. rotenone; 
- combination of xenobiotic metabolism and redox reactions involving radicals, 
e. g. heterocyclic amines; 
- hyperbaric 02 tension and ionising radiation, both are physical factors and can 
raise cellular ROS levels directly; 
- transition metals, metal-containing compounds and mineral dusts, acting as 
catalysts of redox reaction; 
- radiomimetic agents, e. g. bleomycin and quinones; and 
- biological agents able to cause inflammation and tissue injury. 
The breakdown of ROS regulation may cause temporary or permanent cellular 
damage, and in animals the appearance of tissue damage, toxicity and disease. 
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1.6 Reactive oxygen species and human health 
ROS are involved in human health in several ways: ROS have implications in many 
human diseases; drugs acting through ROS-generating mechanisms may be used in 
the treatment of diseases; and ROS have been implicated in the toxicity of many 
compounds (discussed in Section 1.6.2.4 and Chapter 7). 
1.6.1 ROS related human diseases 
So far many diseases have been identified with ROS implications, but the complicated 
in vivo situation often makes it very difficult to distinguish the causes from the 
consequences in the case of ROS involvement. The commonly used criteria for 
judging ROS involvement are the levels of oxidative products of biomolecules in 
patients' body fluids, the antioxidant levels in the tissues, the levels of ROS 
generation in the tissues and the result of antioxidant intervention. More recent 
practice is to combine all the evidence from across the whole of the biomedical 
sciences, ranging from molecular biology to epidemiological investigations. Many 
authors have cited various syndromes which might have a ROS involvement in 
previous papers (Ames, 1983; Kehrer, 1993; Janssen et al, 1993; Knight, 1997; 
Haavik et al, 1997; Jenner, 1994; Cross et al, 1994; Halliwell, 1994b; Kaul et al, 
1993; Yagi, 1987; Langseth, 1995), and the syndromes are compiled below in tissue 
and organ order: 
lung - lung cancer, respiratory distress syndrome, cystic fibrosis, immune- 
complex-mediated syndrome, emphysema, bronchial hyperreactivity, 
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bronchopulmonary dysplasia, asthma, damage caused by hyperoxia, cigarette 
smoke, environmental pollutants, industrial dusts and some other chemicals, 
ischaemia, reperfusion, infections and inflammation; 
brain and nervous system - Down's syndrome, the mitochondrial 
encephalopathies, tardive dyskinesia, Alzheimer's disease, amyotrophic lateral 
sclerosis, Parkinson's disease, multiple sclerosis, motoneuron disease, epilepsy, 
stroke, neuronal ceroid lipofuscinosis, traumas, superficial haemosiderosis, neuronal 
necrosis, degeneration of dopaminergic neurones, and damage caused by ischaemia, 
reperfusion, vitamin E deficiency and some neurotoxins e. g. endrin and 
methamphetamine; 
heart and cardiovascular system - atherosclerosis, hyperlipidaemia hypertension, 
congestive heart failure, apoplexy, damage caused by ischaemia, reperfusion, 
Keshan disease (selenium deficiency) and some chemicals e. g. doxorubicin and 
hydroperoxides; 
kidney - autoimmune nephrosis, glomerular sclerosis, neutrophil-mediated 
glomerular injury, diabetic nephropathy, damage caused by ischaemia, reperfusion 
and some chemicals e. g. aminonucleoside; 
liver - hepatitis, liver cirrhosis, fatty liver, Reye syndrome, endotoxin-induced 
liver injury, damage caused by ischaemia, reperfusion and some chemicals e. g. 
ethanol, quinones, metals; 
blood - favism, sepsis, haemodialysis, malaria, various anaemias, poisoning 
induced by some chemicals e. g. phenylhydrazine, lipid peroxides; 
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skin - radiation, thermal injury, contact dermatitis, porphyria, damage caused by 
some chemicals e. g. photosensitisers; 
muscle - muscular dystrophy, physical exercise, muscle fatigue; 
eye - cataracts, retinopathy of prematurity, retinal ischaemia, age-related macular 
degeneration, ocular haemorrhage, photic retinopathy; 
miscellaneous - ageing, mutations, cancer, organ transplantation, diabetes, 
arthritis, pancreatitis, sperm abnormalities, ulcerative colitis, inflammation, metal 
poisoning. 
Although the pan-ROS-involvernent in the pathology of many diseases is very 
convenient for explaining phenomena associated with those diseases, it must not be 
assumed that ROS is the definite cause (Kehrer, 1993). Also care must be taken 
when relating the in vitro experimental results to the relevant pathogenesis in vivo 
for very obvious reasons. 
1.6.2 ROS related medicines 
"For some time it has been possible to buy superoxide dismutase tablets (sometimes 
with added catalase) in health food stores to protect oneself against ageing (with total 
disregard for the action of digestive enzymes on dietary proteins)" (Halliwell and 
Gutteridge, 1989, Chapter 6). It does seem important to address the potentially 
damaging effect of ROS on human health, but there should be a more balanced 
approach. ROS-related medicines can be basically divided into two categories: 
namely those that have an inhibitory effect on ROS generation, and those that have an 
activating effect on ROS generation. The first category is often related to medicines 
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which could improve human health, and the second category to medicines used to 
cure malignant conditions. 
1.6.2.1 Antioxidants and prooxidants 
An antioxidant or a prooxidant are difficult to define, because neither word has a strict 
scientific definition. In chemical terminology, an antioxidant can be described as a 
substance that inhibits the chemical reactions of other substances with oxygen, while a 
prooxidant is a substance that accelerates the chemical reaction of other substances 
with oxygen. In biomedical science, an antioxidant is referred to as a substance that 
can protect a cell or tissue from ROS-related damage, whether directly or indirectly, 
while a prooxidant does the reverse. For example catalase, the enzyme which 
decomposes H202, does not relate to other chemical reactions, is not an antioxidant in 
chemical terms but is a good antioxidant in biology. In the in vivo situation, whether a 
substance is chemically an antioxidant or a prooxidant is irrelevant, its function 
largely depends on its surrounding environment. An antioxidant may easily be turned 
to a prooxidant, especially in the case of non-protein antioxidants. Antioxidants can be 
defined as `endogenous' or `exogenous' based on their origins, and what is an 
exogenous antioxidant for one species may be endogenous for another. 
1.6.2.2 Endogenous antioxidants 
Endogenous antioxidants are those synthesised by cells or tissues in vivo. A large 
array of biomolecules belong to this category, and for most mammalian cells they 
include catalase, SOD, GPX, GSH, -SH groups on proteins, metal chelators (e. g. apo- 
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transferrin), urate, bilirubin, ubiquinol and many other unidentified elements. Many 
do not have the distinctive characters of an antioxidant, e. g. albumin (Halliwell, 
1994b), but are as a whole an indispensable pool of supplements for those well- 
defined antioxidants. How enzyme antioxidants work has already been discussed in 
the previous sections. The mechanisms of action of non-enzyme antioxidants are not 
totally understood, but in a cellular environment they commonly work as: the positive 
regulators of enzyme antioxidants, e. g. some growth factors; auxiliary agents of 
enzyme antioxidants, e. g. GSH and NADH; `sacrificial' targets of ROS, e. g. plasma 
proteins and vitamin E; and metal chelators. A few human disorders may be directly 
linked to the deficiency of some endogenous antioxidants, especially antioxidant 
enzymes, for example amyotrophic lateral sclerosis patients have decreased levels of 
Cu, ZnSOD activity (McNamara and Fridovich, 1993). 
1.6.2.3 Exogenous antioxidants 
Exogenous antioxidants are the antioxidants which are not synthesised by cells or 
tissue in vivo. Cells need partially or totally to acquire a number of antioxidants from 
their nutrients, and those antioxidants are usually small or medium sized molecules. 
Two important antioxidants are vitamin C (ascorbic acid) and vitamin E (a-, ß-, y- 
and a few other tocopherols). Both cannot be synthesised by human cells and must be 
taken from the diet. 
Vitamin C is widely distributed in the plant and animal kingdom, and although 
primates (including humans) are unable to synthesis vitamin C, most other mammals 
do (Levine, 1986). The biochemical importance of vitamin C is still not completely 
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understood. One of its known functions is acting as the cofactor of enzymes to 
accelerate hydroxylation in a number of biosynthetic pathways, of which the most 
important is the hydroxylation of proline in the synthesis of collagen. Amongst others, 
the enzymes which require vitamin C for their optimal function include proline 
hydroxylase, procollagen-proline 2-oxoglutarate 3-dioxygenase, lysine hydroxylase 
and dopamine ß-monooxygenase. Another known function of vitamin C is to regulate 
the metabolism of some ions, in particular that of iron. Vitamin C is also possibly 
important for the regeneration of oxidised vitamin E; many experiments have 
demonstrated the synergism of the two antioxidants (Liebler, 1993). 
Vitamin E is a group of closely related chemicals called tocopherols, its most 
abundant forms include a-, ß-, and y-tocopherols, among which, a-tocopherol is 
biologically the most active form. Different from the water-soluble vitamin C, vitamin 
E is lipophilic and mainly found in the lipid fraction of biological materials, especially 
plants. Good sources of vitamin E are wheat germ, corn, sunflower seed, rapeseed, 
soybean oils, lettuce and some other plants. Its has been used in the prevention of 
neuromuscular degeneration and for promoting fertility. Both in vivo and in vitro 
experiments have indicated that vitamin E prevents lipid peroxidation which may be a 
causative factor in a number of pathogenic conditions. The functions of vitamin E in 
vivo are not certain, but as an antioxidant it can react with ROS directly (Mukai et al, 
1993) and quench the radical chain reactions in lipid rich structures (Liebler, 1993). 
The current research interests are mainly focused on its reactions with free radicals 
(including ROS), its deficiency in some diseases, and its prevention of ROS-related 
cellular and tissue damage/diseases by exogenous fortification. 
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There are also a number of other compounds which show promising antioxidant 
characteristics. These include bioflavonoids, polyphenols, carotenoids and some of 
their derivatives. The reasons for these compounds as possible important exogenous 
antioxidants are that: they have nucleophilic sites in their chemical structures, e. g. 
conjugated double bonds or hydroxyl groups on aromatic rings which may be reactive 
with ROS; they are consumed by humans in large quantities daily; in vitro 
experiments often show their ability to inhibit ROS-involved reactions; some are able 
to chelate transition metals; some may directly stabilise the structure of biomolecules, 
and some epidemiological data imply their importance in preventing some ROS- 
related diseases. The above points have been compiled from the known chemical 
structures of these compounds, recent research papers and reviews (Payä et al, 1992; 
Pryor et al, 1993; Chimi et al, 1995; Formica and Regelson, 1995; Manach et al, 
1996). However, their role as antioxidants needs to be further investigated. 
1.6.2.4 Medicines involving ROS in their mechanism of action 
The devastating effects of ROS to cells and tissues also can be useful, especially for 
destroying malignant tissues. Some antibiotics exert their effects at least partially 
through ROS mechanisms, for example, the naturally occurring antibiotics bleomycin, 
mitomycin C, doxorubicin and a few others. The function of phenol, one of the 
earliest artificial disinfectants and antiseptic agents, also involves ROS. 
Many chemicals which contain a quinone structure are known to be capable of redox 
cycling, and the radical intermediates of these compounds may initiate the sequential 
electron transfer to 02 and the production of ROS. The rate-limiting step for radical 
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formation during the redox cycling of simple quinones is their reduction by 
flavoenzymes, and not the transfer of electrons to 02 (Powis et al, 1981). However, 
the in vivo generation of free radicals is far from simple. It is determined by both the 
drug kinetics and the drug thermodynamics, and only a few quinones have extensive 
in vivo pharmacology/toxicology data. More than 1500 quinone compounds have been 
tested for their antitumour activities, and today this class of drugs represents the 
second largest group of clinical agents (Kehrer, 1993). It needs to be stressed that 
mechanisms other than ROS may play a significant role in the therapeutic function of 
these drugs, e. g. the alkylating activity of mitomycin C. 
Other medicines involving ROS in their mechanism of action, either themselves or 
their metabolites are able to partially reduce 02 although the precise mechanisms are 
always not very clear, e. g. in the case of bleomycin (see 3.3.2). Another widely used 
medication involving ROS is phototherapy, the principle of which is incorporating 
photosensitisers into malignant tissue, which are then activated by certain 
wavelengths of light and followed by transfer of energy/electrons to 02 to form ROS, 
which kill the cells in the malignant tissue by causing various types of damage 
including that to DNA (Paillous and Vicendo, 1993). 
1.7 Reactive oxygen species in genetic toxicology 
Humans are at increased risk from exposing themselves to environmental pollutants 
and chemicals whose toxicity may be mediated through or partially through ROS 
mechanisms. An understanding of the toxicology of ROS and their related chemicals 
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can provide safety guidance for individuals exposed to them, and the study of ROS 
toxicity to the genetic material and its modulation is pivotal in understanding the long 
term effect of ROS. 
The biggest threat of ROS to living organisms is that their ability to cause irreversible 
damage to cellular components, especially DNA, and such damage is often manifest at 
different levels of biological structure, from the subcellular level to the population 
level. One classic example of this is the industrial toxin benzene, a radiomimetic 
chemical. The ROS mechanism is ultimately involved in benzene toxicity (Yardley- 
Jones et al, 1991; Parke, 1996) and benzene has caused damage from the subcellular 
level through to humans (Dean, 1985). Genetic toxicology of ROS is a subject which 
crosses all the other branches of biomedical science. Therefore, the present study of 
ROS-induced genotoxicity was a multidisciplinary approach involving experiments 
carried out at various organisational levels. 
1.8 The objectives of the present research work 
The literature review has shown that ROS can react with tissues and organs and are 
thought to be involved in some of the major chronic ailments of man such as heart 
disease and cancer. There is still however, a paucity of data relating to the genotoxic 
effects of ROS. Thus the present research work has concentrated on these aspects and 
my contribution has been to explore such effects. 
The overall objectives of the present study are as follows: 
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" To evaluate and compare the potential of a variety of assays to determine 
chemically mediated ROS-induced genetic damage. The chosen assays are 
characterised by different genetic endpoints, and employ both cellular and 
non-cellular systems. 
" To evaluate the potential of antioxidants, both endogenous and exogenous, to 
modulate chemically mediated ROS-induced DNA damage. 
" To investigate the genotoxic effects of various toxins possibly involving ROS 
generation in vivo in rodents. 
" To determine whether vitamin C supplementation modulates plasma 
antioxidant status and ROS-induced toxicity in persons with low and high 
plasma cholesterol levels; also to investigate whether insulin-dependent 
diabetes in humans is associated with alterations in plasma antioxidant status 
and susceptibility to ROS-induced DNA damage. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Sources of major chemicals, principal reagents, media and cell lines 
The suppliers of major chemicals and equipment are shown in Tables 2-1 and 2-2. 
Table 2-1: General chemicals and reagents * 
Chemical or reagent Supplier/Distributor 
acrylamide Sigma 
agarose (low melting point-LMP) BRL 
agarose (normal melting point-NMP) BRL 
albumin (fraction V form bovine serum, 96-99 %) Sigma 
2-aminofluorene Sigma 
2-amino-3-methylimidazo-(4,5-f)quinoline Toronto Research 
2-amino-l-methyl-6-phenylimadazo(4,5-b)pyridine Toronto Research 
3-amino-I-methyl-5H-pyrido(4,3-b)indole Toronto Research 
apo-transferrin Sigma 
2,2'-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) Aldrich 
bacteriophage lambda deoxyribonucleic acid Fluka 
benzene Aldrich 
1,2,4-benzenetriol Aldrich 
1,4-benzoquinone Aldrich 
bleomycin Lundbeck 
bromophenol blue Fisons 
1,3-butadiene ICI 
ß-carotene Sigma 
catalase Sigma 
catechol Aldrich 
ChromoprobeTM-M kits for FISH Cytocell 
collagenase Boehringer Mannheim 
cyclophosphamide Sigma 
cytosine-ß-D-arabine furanoside hydrochloride Sigma 
demecolcine Sigma 
deoxycholic acid, sodium salt Sigma 
desferoxamine mesylate (deferoxamine) Sigma 
continued ... 
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diepoxybutane Aldrich 
dimethyl sulphoxide Sigma 
doxorubicin hydrochloride Aldrich 
1,2-epoxybutene Aldrich 
enhanced chemiluminescence detection solution Amersham 
ethidium bromide Sigma 
ethylenediaminetetracetic acid disodium salt dihydrate Fisons 
ethylene glycol monomethyl ether Sigma 
ethyl methane sulphonate Sigma 
N-ethyl-N-nitrosourea Sigma 
foetal calf serum Harlan Sera 
Folin and Ciocalteu's phenol reagent BDH (Merck Ltd) 
formamide Sigma 
Giemsa stain-Gurr's improved R66 BDH 
glucose-6-phosphate Sigma 
Gurr's buffer tablets for Giemsa staining BDH 
heparin, lithium salt Sigma 
horseradish peroxidase-labelled anti-mouse Ig from sheep Amersham 
hydrogen peroxide Sigma 
hydroquinone Aldrich 
iodoacetamide Sigma 
N-lauryl sarcosinate Sigma 
lymphocyte separation medium Gibco 
ß-mercaptoethanol Sigma 
N, N'-methylene-bis -acrylamide Sigma 
methyl methane sulphonate Sigma 
monoepoxybutane Aldrich 
muconic acid Aldrich 
myoglobin (95-100%, from horse skeletal muscle) Sigma 
myricetin (97%) Fluka 
13-nicotinamide adenine dinucleotide (oxidised form) Sigma 
13-nicotinamide adenine dinucleotide phosphate (oxidised form) Boehringer Mannheim 
pan-ras antibody (Ab-3), 100 µg/ml in 50 mM sodium Oncogene 
phosphate containing 0.1 % azide and 0.2% gelatin 
penicillin/streptgmycin solution, (10000 U+ 10000 µg)/m1 Gibco 
m-pheneylenediamine Sigma 
phenylmethylsulphonyl fluoride Sigma 
continued ... 
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phosphate buffered saline tablets (Dulbecco 'A') Oxoid 
phytohaemagglutinin Murex 
protein molecular marker (rainbow coloured) Amersham 
proteinase K Boehringer Mannheim 
reduced glutathione Sigma 
RMPI 1640 medium Gibco 
S9 (Aroclor 1254-induced rat liver 9000 xg supernatant) Robens institute 
silymarin Aldrich 
sodium ascorbate Sigma 
sodium lauryl sulphate Sigma 
sodium persulphate Sigma 
superoxide dismutase (5800 U/mg) Sigma 
N, N, N', N'-tetramethyl-ethylenediamine Sigma 
tocopherol acid sarcosinate Sigma 
tris[hydroxymethyl]aminomethane Sigma 
Triton X- 100 Sigma 
trolox C (trolox) Aldrich 
trypsin DIFCO 
tween-20 Sigma 
* The addresses of the suppliers are listed in Table 2-3 
Table 2-2: Equipment and other materials * 
Equipment and other materials Supplier/Distributor 
Acrodisc, 0.2 p Gelman Sciences 
Automatic bacterial colony counter Seescan 
Blue-light sensitive autoradiography film (Hyperfilm) Amersham 
Centrifuge: Centaur 2 MSE 
Centrifuge: micro model 112 Sigma 
Centrifuge: refrigerated model 3K 10 Sigma 
Comet analysis software (COMET 2.4 and 3.0) Kinetic Imaging 
Coverslips, 20 x 60 mm Surgipath 
Electrophoresis Power Supply: EPS-600 Pharmacia 
Electrophoresis power supply: Power Pac 300 Bio-Rad 
Fully frosted microscope slides Surgipath 
I Iotplate (Techne Dri-Block R. DB-3) FSA 
continued ... 
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Kodak GBX developer and replenisher Eastman Kodak 
LPO-586 kits for lipoperoxidation Bioxytech S. A. 
Microscope: Photomicroscope II Carl Zeiss 
Nitrocellulose membrane for Western blotting (0.45 t) Bio-Rad 
Spectrophotometer: MPS-2000 Shimadzu 
Tissure culture flask, various sizes, Nunclon® Gibco 
Vogel Bonner 'E' plates DIFCO 
* The addresses of the suppliers are listed in Table 2-3 
Two cell lines were used in the present study: Hela S3 cell (human cervix carcinoma) 
and HT29 cell (human colon adenocarcinoma). The former was from a cotinunous 
culture in BIBRA, the latter was provided by Dr I. Subirade at Groupe Danone in Paris, 
France. 
Table 2-3: The addresses of the suppliers of chemicals and other materials 
Aldrich, Gillingham, Dorset, UK Gibco Ltd, Paisley, Scotland, UK 
Amersham Life Sciences, Buckinghamshire, UK Harlan Sera-Lab Ltd., Crawley Down, UK 
BDH (Merck Ltd), Lutterworth, Leics, UK ICI Chemical & Polymers Ltd, Wilton, UK 
Bio-Rad Labs, Richmond, CA, USA Kinetic Imaging Ltd, Liverpool, UK 
Bioxytech S. A., Bonneuil Sur Marne, France Lundbeck Ltd., Milton Keynes, UK 
Boehringer Mannheim, Lewes, East Sussex, UK MSE Scientific Instruments, Crawley, UK 
BRL, Life Technologies, Gaithersburg, MD, USA Murex diagnostics, Dartford, Essex, UK 
Carl Zeiss Ltd., Oberkochen, Germany Oncogene Research Products, Cambridge, UK 
Cytocell Ltd, Banbury, Oxon, UK Oxoid Ltd, Basingstoke, Kent, UK 
DIFCO Laboratories, Surrey, UK Pharmacia Biotech, Uppsala, Sweden 
Eastman Kodak, Rochester, NY, USA Robens institute, University of Surrey, UK 
Fisher, Loughborough, UK Seescan plc., Cambridge, UK 
Fisons, Loughborough, UK Shimadzu Co., Kyoto, Japan 
Fluka, Gillingham, Dorset, UK Sigma, Poole, Dorset, UK 
FSA Laboratory Supplies, Loughborough, UK Surgipath, Winnipeg, Manitoba, Canada 
Gelman Sciences, Ann Arbor, MI, USA Toronto Research, Ontario, Canada 
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2.2 Methods 
2.2.1 Electrophoresis of DNA treated with ROS-generating compounds 
When a group of uniform DNA molecules are incubated in a medium containing ROS- 
generating agents, the attack on DNA strands by ROS may break down the DNA 
molecules and form heterogeneous fragments of DNA. The severity of the treatment can 
be evaluated by applying the treated DNA to agarose gel electrophoresis. 
2.2.1.1 Principal reagents and media 
The principal reagents and media are given in Tables 2-4 below. 
Table 2-4: Principal media used in the DNA electrophoresis studies 
Media or reagents Constituent reagents and/or chemicals 
DNA storage buffer (SB) 10 mM Tris 
10 mM NaCI 
1 mM Na, EDTA 
adjust pH to 7.8 with HCI, in H, O (sterile) 
ý. -DNA solution 
Electrophoresis buffer 
(TAE buffer, 10 x concentrated) 
Sample buffer (5 x concentrated) 
100 µg/m1 bacterial phage ?, DNA in SB 
400 mM Tris 
20 mM Na2EDTA 
200 mM NaAc 
296 mM HAc 
in H, O, pH 7.8 
25% glycerol 
50 mM Na2EDTA 
0.5% SDS 
0.05% bromophenol blue 
in H2O 
Agarose 0.5% normal melting point agarose in DNA SB 
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2.2.1.2 Basic procedures 
Storage and treatment of DNA 
%-DNA (1 mg) was dissolved in 10 ml of storage buffer (SB), the solution was aliquoted 
and stored at -20°C. When required, DNA (4 µ1 equivalent to 0.4 µg) was added to an 
eppendorf tube containing 12 µ1 of various agents in SB and incubated at 37°C for 2 
hours. Sample buffer (4 µl) was added to each tube before electrophoresis. 
Electrophoresis and photography 
X-DNA sample (15 µl containing 0.3 µg) from each eppendorf tube was added into a 
sample well in the 0.5% agarose gel bed immersed in electrophoresis buffer in a 
horizontal tank (HorizonTM 20.25, BRL). Electrophoresis was run at 20 mA for the first 
30 min, then the current was increased to 120 mA for a further 60-90 min. 
After electrophoresis, the gel was stained in EtBr (0.5 µg/ml) for 30 min, and, if 
necessary, destained in deionised H2O for 30 min. It was placed on a UV 
transilluminator and the DNA bands were photographed with a Polaroid camera. 
Processing of photographic images and categorising DNA damage 
Polaroid pictures were scanned using a Hewlett-Packard DeskScan II, and the enhanced 
digital images were printed using Kodak Digital Science 1Dm. The distance of DNA 
migration and the pattern of fragment distribution (determined by the intensity of DNA- 
EtBr fluorescence) were compared and graded. A system of categorisation was used for - 
comparison (see Figure 3-1). The further the extent of DNA migration during 
electrophoresis, the greater the extent of damage by the treatment. 
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2.2.2 The Salmonella typhimurium mutation assay (Ames test) 
The Ames test is a bacterial mutation assay, the principle of which is to expose 
histidine-dependent Salmonella typhimurium strains to a chemical to be examined in a 
histidine (His) deficient medium (only a trace amount of His is present to allow initial 
growth). His-independent bacterial colonies may rise from spontaneous reversions 
(backwards mutations) or chemically-induced mutations. The mutagenicity of a 
chemical can be assessed by comparing the control with the treated bacterial culture. 
2.2.2.1 Principal reagents, media and Salmonella strain 
The principal reagents and media used in the Ames test are given in Tables 2-5 below. 
Table 2-5: Principal media used in the Ames studies (all sterile) 
Media or reagents Constituent reagents and/or chemicals 
Bacterial culture media 2.5% Oxoid Nutrient Broth No. 2, in H, O 
Vogel Bonner salt for minimal agar 1% MgSO4.7H2O 
(VB salt, 50 x concentrated) 10% citric acid monohydrate 
50% K, HPO4 
17.5% NaNH4HPO4 
in H2O 
Vogel Bonner `E' plate 1.5% agar with VB salt (x 1) and 2% D-glucose, in H, O 
Top agar (soft agar) 0.6% agar with 0.5%NaC1, in H2O 
S-9 mix (with cofactors) 10% S-9 fraction (v/v) 
4 mM NADP 
6 mM of G-6-P 
33 mM of KC1 
8 mM of MgCl, 
in 0.1 M PBS(A) buffer (pH 7.4) 
Salmonella strain TA98 cultured in BIBRA was used in all the Ames test experiments. 
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2.2.2.2 Basic procedures 
The basic technique was described by Ames et al (1975) and Maron and Ames (1983), 
and the procedures employed in the current studies is that of Blowers (1992): 2 ml 
molten top agar (50°C) containing trace amounts of histidine/biotin (50 µM/50 µM) 
were mixed with 0.1 ml Salmonella typhimurium (- 108 cells), varying amounts of 
compound or combination of compounds to be examined with each in a volume of 0.1 
ml DMSO solution, and 0.5 ml S-9 mix. The mixture was then quickly mixed by 
shaking and was poured onto a Vogel Bonner `E' plate. The plate was tilted and rolled 
to distribute the mixture evenly over its surface. The plate was placed horizontally to 
allow the agar to solidify for 5 -10 min before it was inverted and placed in a 37°C 
incubator. The bacteria in the plate were incubated at 37°C for at least 48 hr. The 
bacterial colonies were scored using an automatic colony counter (Seescan). 
2.2.3 Comet assay 
The comet assay or single cell gel electrophoresis assay performed in neutral solution 
was first introduced by Östling and Johnson in 1984, and it primarily detected DNA 
DSBs (Fairbaim et al, 1995). A modified and more widely used alkaline version (Singh 
et al, 1988,1989) has a higher sensitivity to DNA DSBs and DNA SSBs as well as to 
alkaline labile lesions. All the experiments involving the comet assay in this thesis have 
used the alkaline version and the method of Singh et al (1989) was followed. 
2.2.3.1 Principal reagents and media 
The principal reagents and media used in the comet assay are given in Tables 2-6. 
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Table 2-6: Principal media used in the comet assays 
Media or reagents Constituent reagents and/or chemicals 
PBS(A) Dulbecco `A' phosphate buffered saline, p11 7.4 
Lysing solution 2.5 M NaCl 
100 mM Na2EDTA 
10mMTris 
(adjust pH to 10 with solid NaOH) 
I% sodium lauryl sarcosinate 
1% Triton X-100 and 10% DMSO were added just 
before cooling and use 
Electrophoresis solution 
Neutralising solution 
Staining solution 
LMP agarose 
1 mM Na, EDTA 
300 mM NaOH 
0.4 M Tris, pH 7.5 
20 µg/ml EtBr 
0.5% low melting point agarose in PBS(A) 
NMP agarose 0.5% normal melting point agarose in PBS(A) 
2.2.3.2 Separation of lymphocytes from peripheral blood 
For each experiment 5 ml of whole blood were collected by venepuncture from each 
donor and sodium heparin was added to a final concentration of 50 units/ml. The blood 
sample was diluted with 5 ml of PBS(A), and 5 ml of diluted blood was carefully loaded 
onto the top of 3 ml of lymphocytes separation medium (Gibco), which has a density of 
1.077 g/ml and composed of an aqueous solution of Ficoll (57 g/1) and sodium 
diotrizeate (90 g/1), in a 16 mm screw-capped and siliconised test tube. The test tube was 
placed in a bench centrifuge (MSE Centaur 2) and centrifuged at 1200 g (mid-range 
distance, - 3000 rpm) for 15 min (Boyum, 1976). The lymphocytes in the layer which 
appeared in the middle of the separation medium and the blood plasma were transferred 
using a siliconised Pasteur pipette into another test tube containing 10 ml of fresh 
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PBS(A) or RPMI 1640 medium. The cells were washed by repeated Pasteur pipetting a 
few times and spun down at 520 g (mid-range distance, - 2000 rpm) for 10 min, and 
were subsequently suspended in the medium at approximately 2x 105 cells/ml until 
further use. 
2.2.3.3 In vitro treatment and preparation of cells 
An aliquot of the cell suspension (50 µl, - 104 cells) was added to an eppendorf tube 
containing medium and treatment agent, in a total volume of 950 µl, with or without S9 
activation. Usually each treatment was examined in triplicate, two for slide preparation 
and the other one for viability check. The cells were incubated at 37°C for various 
periods of time (e. g. 30,60,120 min). After treatment, the cells were harvested by 
centrifugation at 800 xg for 3 min at 4°C. 
2.2.3.4 Preparation of cells from the tissues of animals treated with genotoxins 
Animals and husbandry 
Animals (rats or mice, described in Chapter 5) were housed in cages with solid plastic 
sides and stainless steel grid tops and floors in a room designed for control of 
temperature (approximately 22°C), humidity 45 - 75% and light cycle (12 hr light, 12 hr 
dark). Rat and mouse No.! expanded diet (Special Diet Services Ltd, Witham, Essex) 
was supplied ad libitum to each cage by hopper. Tap water was also available 
ad libitum. The animals were assigned randomly to either the control or treatment 
groups and were housed singly. All animals received a minimum of 8 days' 
45 
acclimatisation before the start of experimental procedures. (The animal husbandry was 
carried out by the staff members in the Animal Unit in BIBRA). 
Animal treatments and cell removal 
Animals were treated with chemicals, or physiological saline in the case of controls, by 
gastric gavage with volumes not exceeding 5 mI/kg. Animals were killed by cervical 
dislocation and bone marrow cells and germ cells removed. 
Bone marrow cell preparation 
Cells were removed from the femur after cutting the epiphyses and cells removed by 
aspiration with PBS(A) at 4°C. The resulting single cell suspension was then used for 
slide preparation. 
Germ cell preparation I 
The testes were carefully decapsulated with a fine forceps avoiding damage to the 
seminiferous tubules. The testicular tubules from each animal were pooled and kept in 
cold PBSG buffer [0.1% w/v, D-glucose in autoclaved PBS(A)] before enzymatic 
digestion. The tubules from each animal were placed in a 30 ml Universal tube 
containing 20 ml collagenase solution (1 mg/ml in PBSG). This was shaken in a 
waterbath at 32°C until the testes were dispersed into individual tubules, which were 
then washed twice with PBSG, allowing the tubules to settle between the washings. 
Twenty ml of a 0.25% (w/v) solution of trypsin in saline was added and the suspension 
was incubated under the same conditions as described above. Approximately 5-7 min 
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were required for the tubules to be broken into small fragments. The fragments were 
dispersed with a5 ml pipette for 8 min and the undigested tissue was removed. The cells 
were then used for viability check and slide preparation. 
Germ cell preparation II 
The testes were removed from the animals as described in preparation I, and the tubules 
were washed and kept in PBS(A) at - 4°C before they were minced into small pieces in 
7 ml bijou tubes in cold PBS(A) using a pair of fine scissors. The cells were released by 
the physical force of the mincing action. Before using the cells, the bijou tubes were 
gently swirled so that heavy debris sank to the bottom of the tube and the single cells 
remained in the top of the suspension. Small volumes of the top suspension were 
withdrawn for viability check and slide preparation. 
2.2.3.5 Cell viability check 
The cells from one of the triplicate samples were checked for viability by trypan blue 
exclusion (25 µl of 0.05% trypan blue was added to 25 µl of cell suspension, and the 
percentage of cells excluding dye was estimated using a haemacytometer under a 
microscope). Only preparations with > 85% viability after a treatment were suitable for 
use in the comet assay. The cells in the remaining two eppendorf tubes were used for 
slide preparation. 
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2.2.3.6 Slide preparation 
The basic alkaline technique of Singh et al (1988) was followed. Fully frosted 
microscope slides (Surgipath, Winnipeg, Manitoba) were each covered with NMP 
agarose (110 µl) at about 50°C. They were immediately covered with a No. 1 coverslip 
(24 x 60 mm) and kept at room temperature for about 5 minutes to allow the agarose to 
solidify. This layer was used to promote the attachment of the second and third layers. 
Approximately 104 treated or control cells were mixed with 75 µl of LMP agarose to 
form a cell suspension. After gently removing the coverslip, the cell suspension was 
rapidly pipetted onto the first agarose layer, spread using a coverslip, and maintained on 
an ice-cold flat tray for -5 minutes to solidify. After removal of the coverslip, the third 
layer of LMA (80 µl) at 37°C was added, spread using a coverslip and again allowed to 
solidify on ice for -5 minutes. Duplicate slides were used for each observation. 
2.2.3.7 Lysis of the cells 
After removal of the coverslip, the slides were immersed in cold lysing solution for a 
minimum of 1 hour or up to several days at 4°C. 
2.2.3.8 Electrophoresis 
The slides were removed from the lysing solution, drained and placed in a horizontal gel 
electrophoresis tank side by side, avoiding spaces in between the slides, nearest the 
anode. The tank was filled with fresh electrophoresis solution to a level approximately 
0.25 cm above the slides. The slides were left in the solution for 20 minutes to allow the 
unwinding of the DNA and expression of alkali labile damage. Electrophoresis was 
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conducted at a low temperature (initially 4°C) for 20 minutes using 26 volts and 
adjusting the current to - 300 milliamperes by raising or lowering the buffer level and 
using a compact power supply (POWER PAC 300, BioRad). All of these steps were 
conducted under dimmed light (apparatus covered with a black cloth) to prevent the 
occurrence of additional DNA damage. After electrophoresis, the slides were taken out 
of the tank, Tris buffer (0.4 M Tris, pH 7.5) was added dropwise and gently to neutralise 
the excess alkali, and the slides were allowed to stand for 5 minutes. The neutralising 
procedure was repeated 3 times. 
2.2.3.9 Staining 
EtBr (60 µl of a 20 µg/ml solution) was added to each slide and covered with a 
coverslip. The slides were placed in a humidified air-tight container to prevent drying of 
the gel, and analysed within 3.4 hr. 
2.2.3.10 Slide scoring 
Microscopy 
Slides were examined at a x725 magnification resulting from a X40 objective, a A. 25 
magnifying lens and a 42.5 eye piece on a fluorescence microscope (Zeiss 
photomicroscope II, equipped with an excitation filter of BP 546/10 nm and a barrier 
filter of 590 nm). 
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Scoring by eye 
Images of 200 randomly selected cells (100 cells from each of 2 replicate slides) were 
analysed from each sample. It has been suggested (McKelvey Martin et al, 1993; Olive 
et al, 1992) that if tail length does not clearly discriminate between different doses, then 
the quantification of the percentage of DNA in the tail may represent the most accurate 
evaluation of the damage. An image analysis system (Seescan) was used for calibration 
of visual scores, but it was not used for the evaluation. Cells were graded by eye into 5 
categories corresponding to the following amounts of DNA in the tail: no damage (or 
none) - <5%; low level damage -5- 20%; medium level damage - 20 - 40%; high level 
damage - 40 - 95%; complete damage - >95% (Figure 2-1). 
Figure 2-1: The various typical comets in the eye-scoring comet assays 
a: No damage; b: Low level damage; c: Medium level damage; cl: 1 ligh level damage; e: Complete damage 
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Scoring by computer 
A Charge Coupled Device (CCD) camera was attached to the microscope and computer, 
and the set-up was calibrated by using a micron gauge. Usually 25 cells were scored 
from'each replicate slide (i. e. 50 cells in total). The COMET software (Version 2.4 or 
3.0 lately) was used to measure comet parameters. The parameter chosen for 
presentation is the tail moment. The tail moment is equivalent to the integrated value of 
density multiplied by migration distance, and is considered to be the most appropriate 
measurement; it was automatically generated by the computer. The system set-up for 
this equipment was as follows: head threshold - 8%, tail threshold - 0.5%, smoothing 
value - 1, background height - 20, and tail break length - 5. 
2.2.4 Chromosome aberration assay (using human lymphocytes and the 
Giemsa staining technique) 
The morphological changes of cellular chromosomes or chromosome aberrations (CAs) 
indicate the structural defects of cellular genetic organelles, which may have a harmful 
consequence to the survival and reproduction of the cells. Thus, a study of the potential 
for induction of CAs (clastogenicity) may determine the genotoxicity of a chemical. 
PHA-stimulated lymphocytes from human peripheral blood are frequently used for such 
studies, and cells can be treated by the chemical before or after the PHA-stimulation. 
2.2.4.1 Principal reagents and media 
The principal reagents and media used in the chromosome aberration assay (Giemsa 
staining) are given in Tables 2-7, however, the commercial media are not included and 
they are described elsewhere. 
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Table 2-7: Principal media used in the chromosome aberration assays, Giemsa staining 
method (all sterile) 
Media or reagents Constituent reagents and/or chemicals 
PIS(A) Dulbecco 'A' phosphate bntiered saline, pl 17.4 
Anticoagulant 2000 U/ml heparin in HO 
Reconsituted PHA phytohaemagglutinin, in HO (according to manufacturer's 
instructions) 
Cell treatment/wash medium RPMI 1640 medium supplemented with: 
penicillin (50 U/ml) 
streptomycin (50 pg/m1) 
L-glutamine (2 mM) 
Cell culture medium 9.5 ml RPMI 1640 medium supplemented with: 
penicillin (50 U/ml) 
streptomycin (50 pg/ml) 
L-glutamine (2 mM) 
foetal calf serum (10°/x, v/v) 
100 pl heparin (2000 U/ml) 
100 pl reconstituted PHA 
Mitosis inhibitor 10 µg/ml demecolcine in HO 
Fixative methanol : glacial acetic acid, 3: 1 
Giemsa staining solution 15 ml Gurr's improved R66 with 285 nil Gurr's buffer, p11 6.8 
2.2.4.2 Basic procedures 
Handling of blood samples 
For each experiment blood (10 ml) was collected by venepuncture in a tube containing 
50 units/ml sodium heparin. Freshly remixed blood (I ml) was added to a 30 ml plastic 
universal tube containing 10 ml of RPMI 1640 without FCS. Cells were washed and 
sedimented by centrifugation (170 xg for 5 min), and the supernatant withdrawn and 
discarded. 
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Culturing of the cells 
The cell pellet was disrupted and resuspended in 9.5 ml RPMI 1640 containing 
penicillin/streptomycin, L-glutamine and FCS. Heparin (100 µl of a 2000 U/ml 
solution) and 100 µl of reconstituted PHA were added per culture prior to a 44 - 48 hr 
period of incubation at 37 ± 0.5°C in humidified air with 5.0 ± 0.1% CO2. Demecolcine 
in a volume of 50 µl (0.05 pg/ml in final solution) was added to each culture 2 hr prior 
to slide preparation. 
Hypotonic treatment and fixation of cells 
Cells were transferred from the universal tube to a 16 mm screw-capped conical tube 
and harvested by centrifugation (170 xg for 5 min). The cell pellet was dispersed and 
swelled in 10 ml of KCl (0.075 M) at 37°C for 5 min. The mixture was centrifuged (170 
Xg for 5 min) and the haemoglobin released by the burst red cells was removed by 
withdrawing the supernatant, only leaving a volume approximately equal to that of the 
cell pellet. The cells were resuspended by Pasteur pipetting, and the suspension was 
withdrawn into the Pasteur pipette. The suspension was then mixed with 2.5 ml fresh 
cold fixative which was gradually released from another pipette by drawing up and 
down the content in the conical tube using the Pasteur pipette. The cells again were 
pelleted by centrifugation and the supernatant was removed. The fixation step was 
repeated several times until the cell suspension was colourless. The fixed cells in the 
suspension were stored at -20°C if they were not used immediately for making slides. 
The fixative was changed 3 times more before the making of slides. 
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Preparing a slide with metaphase cells 
Drops (6 - 7) of the cell suspension were evenly dropped on a labelled clean and water- 
wet slide from - 0.5 metres above. The slide was placed on a bench, covered with a 
single layer of soft tissue and left to dry. The slide was checked under a phase contrast 
microscope to confirm that sufficient metaphase cells were spread satisfactorily. 
Staining chromosomes on a slide and making a permanent slide 
The dried slide was immersed in Giemsa staining solution for 5 min and rinsed 
thoroughly in flow tap water, before briefly being rinsed in deionised water. The slide 
was left to dry and then 3 drops of DPX microscope mountant were dropped and a 22 X 
50 mm coverslip was placed on the top. The slide was left on a horizontal bench surface 
until the mountant dried up. 
Scoring the chromosome aberrations 
The criteria for the scoring of aberrations were those recommended by UKEMS (Scott 
et al, 1983). The aberrations were categorised as chromatid and chromosome gaps, 
chromatid and chromosome breaks, chromatid and chromosome fragments, 
interchanges, dicentrics and rings. 
2.2.5 Chromosome aberration assay (using human lymphocytes and 
fluorescence in situ hybridisation technique) 
The fluorescence in situ hybridisation (FISH) of a whole chromosome or `chromosome 
painting' assay is a novel cytogenetic technique that detects the structural defects of the 
chromosomes. A recent development in molecular biology is the availability of specific 
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DNA probes [flourescein (FITC) labelled probe for human chromosome I in this case] 
in substantial quantities that can be used in genetic toxicological studies. Compared with 
conventional CA studies, FISH can provide highly specific information on metaphase 
chromosomes, and can be also performed on interphase cells. However, the lower 
definition of fluorescence leads to less discriminative power toward minute structural 
defects (e. g. chromatid gaps). In the current study, the FISH probe for metaphasic 
human chromosome 1 (ChromoprobeTM-M, Cytocell) was used to detect CAs on human 
chromosome 1, which is one of the largest chromosomes and comprises 8.56% of the 
genome. 
2.2.5.1 Principal reagents and media 
The principal reagents and media used in the chromosome aberration assay (FISH) are 
given in Tables 2-8, however, the commercial media are not included and they are 
described elsewhere. 
Table 2-8: Principal media used in the chromosome aberration assays FISH (all sterile) 
Media or reagents Constituent reagents and/or chemicals 
PIS(A) Dulbecco 'A' phosphate buffered saline, pl1 7.4 
Anticoagulant 2000 U/ml heparin in 11,0 
Reconsituted PHA phytohaemagglutinin, in 11.0 (according to manufacturer's 
instructions) 
Cell treatment/wash medium RPMI 1640 medium supplemented with: 
penicillin (50 U/ml) 
streptomycin (50 pg/ml) 
L-glutamine (2 mM) 
contiiuiccl ... 
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Cell culture medium 9.5 ml RPMI 1640 medium supplemented with: 
penicillin (50 U/ml) 
streptomycin (50 µg/ml) 
L-glutamine (2 mM) 
foetal calf serum (10%, v/v) 
100 pl heparin (2000 U/ml) 
100 gl reconstituted PHA 
Mitosis inhibitor 10 µg/m1 demecolcine in H2O 
Fixative methanol : glacial acetic acid, 3: 1 
SSC stock solution 3M NaCI and 0.3 M sodium citrate, pH 7.0 
(20 x concentrated) 
Washing solution 50% formamide in SSC [formamide : SSC (2 x strength), 1: 1] 
ST buffer SSC (4 x strength) containing 0.05% Tween 20 (v/v)) 
2.2.5.2 Basic procedures 
Cell cultures and slide preparation 
The same procedures as those performed in conventional CA studies were followed 
(Section 2.2.4). 
Fluorescence in situ hybridisation 
FISH was performed according to the manufacturer's instructions. Freshly prepared 
slides were dehydrated through an ethanol series (70%, 85% and 100% each for 2 min) 
and dried at 37°C. Hybridisation solution (15 µl), which contained DNA painting probe 
for chromosome 1, at 37°C was added to a marked area of the dehydrated pre-warned 
slide to which was added the pre-warmed chromoprobe coverslip. The edges were 
sealed with a rubber solution, and dried at 37°C for 5 min. The probe and target DNA 
were denatured by placing slides on an accurately controlled hotplate at 75 - 78°C for 5 
min. Slides were hybridised in the dark overnight at 37°C. The coverslip was removed 
with a forceps, slides were washed 3x5 min in 50% formamide/1 x SSC at 45°C, 1x5 
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min in SSC at 45°C, 1x5 min in ST buffer at 45°C and then 1x5 min at room 
temperature. Excess fluid was removed, and DAPI-antifade solution (10 µl) was added 
to the marked area and a standard coverslip added. 
Scoring of chromosome aberrations on painted chromosomes 
A Photomicroscope II fitted with a 63 x oil-immersion objective for fluorescence, 15 x 
eye-pieces and a triple bandpass filter was used, which allows simultaneously 
visualisation of both the bright FITC-painted chromosomes (chromosome 1) and the 
weak DAPI-stained background chromosomes. Only intact painted chromosomes were 
scored as `normal' while others were classified as `abnormal'. The maximum number of 
metaphase cells possible was scored on each slide. Some `normal' and `abnormal' 
painted chromosomes can be seen in Figure 4-5. 
2.2.6 p2l r"S detection 
Using Western blotting to detect and quantify specific proteins has advantages over 
traditional biochemical methods. With a highly specific monoclonal antibody and a 
sensitive detective system (Enhanced Chemiluminescence Detection or ECL), a small 
quantity of a designated protein in a coarsely treated biological sample can be rapidly 
determined. 
2.2.6.1 Principal reagents and media 
The principal reagents and media used in the Ames test are given in Table 2-9. 
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Table 2-9: Principal media and their constituents used in the p21' °` detection 
Media or reagents Constituent reagents and/or chemicals 
Erythrocyte lysis buffer 160 mM NH4C1 
10 mM KHCO3 
1 mM EDTA 
Cell culture medium RPMI 1640 medium supplemented with: 
penicillin (50 U/m]) 
streptomycin (50 pg/ml) 
L-glutamine (2 mM) 
foetal calf serum (10%, v/v) 
PBS (10 x concentrated) for cell lysate 8% NaCl 
0.2% KC1 
1.44% Na, HPO4 
0.24% KH, P04 
in H20, pH 7.4 adjusted with HCI 
Lysing/sample storage solution 1% Triton X- 100 
(PBSTDS) 0.5% sodium deoxycholate 
0.1% SDS 
1 mM EDTA 
0.2 mM PMSF 
0.2 mM lodoacetamide 
in PBS (1 x strength) 
Lowry agent C I% CuSO4.5H, O : 2% tartrate (Na+, K+, 4H, O) : 2%, Na7CO3, 
1: 1: 100 
Gel stock solution 30% acrylamide 
8.6% N, N-methylene-bis-acrylimide 
in H, O 
Main gel buffer (4 x concentrated) 1.5 M Tris 
10% SDS 
pH 8.8 
Stacking gel buffer (4 x concentrated) 0.5 M Tris 
10% SDS 
pl1 6.8 
Sample loading buffer 2`% SDS (w/v) 
30`%O glycerol (v/v) 
50 mM Tris-HCI, pFl 6.8 
0.025% bromophenol blue (w/v) 
10% mercaptoethanol (v/v) 
in ILO 
continued 
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Main gel (12.5%) 29.92 ml gel stock solution 
25.78 ml HZO 
18.76 ml main gel buffer 
300 µl 15% (NH4)2S203 
38 µl TEMED 
Stacking gel (3%) 
Running buffer (10 x concentrated) 
Transfer buffer 
PBS-Tween for washing 
Membrane blocking solution 
Incubation solution for primary 
antibody attachment 
2 ml gel stock solution 
13 ml H2O 
5 ml stacking gel buffer 
130 µl 15% (NH4)2S208 
20 µl TEMED 
1.92 M Glycine 
1% SDS 
250 mM Tris 
in H2O, pH8.3- 8.5 
192 mM Glycine 
25 mM Tris 
in MeOHJH2O solution (MeOH : H20,1 : 4) 
80 mM Na2HPO4 
20 mM NaH2PO4 
100 mM NaC1, 
pH adjusted to 7.5 
1% Tween 20 
PBS-Tween with 5% BSA 
PBS-Tween with 5% BSA 
1%o (v/v) pan-ras Ab-3 
Incubation solution for secondary PBS-Tween with 0.25% BSA 
antibody attachment 1%o (v/v) HRP-labelled anti-mouse Ig from sheep 
2.2.6.2 Basic procedures 
Preparing samples from human blood plasma 
Heparinised blood was centrifuged at 170 xg for 5 min and 1.5 ml of plasma transferred 
to a7 ml bijou tube containing protein inhibitors (65 µl of 0.5 M iodoacetamide and 26 
µ1 of 0.1 M PMSF). Five millilitres of 20% SDS was added and the mixture dispensed 
into 1.5 ml aliquots and stored frozen at -70°C until required (Brinkworth et al, 1992). 
Samples were thawed at 37°C and chilled on ice to precipitate SDS, which was 
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removed by centrifugation (-' 500 x g) in a micro bench centrifuge (Sigma 112) for 3 
min. 
Preparation of samples from lymphocyte cultures 
Human peripheral blood cells were cultured as has been already described in culturing 
cells in Section 2.2.4, for 48 hr. The cells were then treated with various chemicals or 
combination of chemicals in the same medium for 24 hr. -The culture was centrifuged at 
170 xg for 5 min and the supernatant was withdrawn. Erythrocyte lysis buffer (10 ml) 
was added to the tube and the lymphocytes were pelleted by the further centrifugation; 
the supernatant was discarded. Cell lysing solution (1 ml) was added to the lymphocyte 
pellet and sonicated for 20 sec. The cellular debris was removed by centrifugation (700 
x g, 15 min) and the supernatant of the cell lysate was stored frozen at -20°C for until 
use. 
Preparation of samples from Held cell cultures 
One vial containing cryopreserved Hela cells (S3 cell line) was left on the bench for 1 
min and transferred to a 37°C for 1-2 min until fully thawed. The contents were 
carefully pipetted into a universal tube containing 10 ml of pre-warmed 10% FCS- 
supplemented RPMI 1640 and centrifuged at 100 xg for 5 min. The cells were then 
transferred to a small tissue culture flask containing culture medium to restore growth. 
When cell growth covered over 80% of the flask bottom wall, the cells were shaken off 
and the culture was divided to several flasks to continue growth until sufficient cells 
were present in the flasks. The cultures were checked on a daily basis for medium 
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change and contamination. After adequate cells were collected, they were pooled and 
divided for various treatments in the culture medium for 24 hr. The cells were then 
lysed in 1 ml of the cell lysing solution and processed as the lymphocytes from whole 
blood mentioned above. 
Protein determination 
Before electrophoresis, protein levels in the samples was measured by using Lowry's 
method. Briefly, 50 µ1 of sample were added to a test tube containing 950 µl of 0.5 M 
NaOH, followed by 5.0 ml freshly prepared Lowry agent C. After 15 min, 0.5 ml of 
freshly diluted Folin and Ciocalteu's phenol reagent (commercial stock : H2O =1: 2) 
was added to the test tube. The absorbance was measured at 720 nm after 30 min and 
recorded by using a spectrophotometer. The difference of the mean absorbance for 
duplicate samples and for triplicate blanks (AA720) was compared with that of albumin 
standards (0 - 200 µg/ml). 
Sample preparation for electrophoresis 
A known amount of a plasma preparation or a cell lysate (e. g. 100 pg of total protein for 
a sample) was pippetted into an eppendorf tube and mixed with 50 µl of sample loading 
buffer or an equal volume of loading buffer if larger than 50 µl. Rainbow protein 
molecular marker (20 µl) and 8 µl of a positive cell lysate (T15 cell line, from Dr 
Paterson, Chester Beatty Labs, ICR, London), which contains excess amounts of 
recombinant p21'ß, were also each mixed with 50 µl of sample loading buffer in an 
eppendorf tube. The eppendorf tubes were then heated at 100°C for 3-5 min to 
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denature proteins and unfold peptide chains. The tubes were placed on ice to cool before 
electrophoresis. 
Electrophoresis of the proteins using SDS-polyacrylamide gel 
The gel electrophoresis system of Laemmli (1970) was followed and the gel size was 
1.5 mm x 16 cm x 16 cm. After the samples, molecular marker and p21`ß-positive cell 
lysate were carefully loaded, the electrophoresis was first run at 20 mA/gel until the 
bromophenol blue line crossed the interface of the stacking gel and the main gel. The 
electrophoresis current was then raised to 30 mA/gel and run to the finish. 
Transferring separated proteins from gel to nitrocellulose (blotting) 
The gel was soaked in 50 mM Tris-HC1 buffer (pH 7.5) for 1 hr to allow proteins to 
renature (Dunn, 1986), and the proteins in the gel were electrically transferred to a 
nitrocellulose membrane. The transfer was performed under constant voltage at 30 V for 
20 hr in the transfer buffer. 
Development of the blot 
The nitrocellulose membrane blot was incubated in the blocking solution for 1 hr at 
room temperature, followed by incubation with the primary antibody (pan-ras Ab3) for 
2 hr and washed in PBST for 3x5 min. It was then incubated with the secondary 
antibody (HRP-conjugated anti-1g) for 1 hr followed by 3x5 min and 1x 15 min 
washes in PBST. 
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ECL detection of p21'°s 
The antibody-attached blot was incubated in the ECL detection solution [solution 1 and 
2 of the ECL kit (Amersham) mixed in equal volumes, - 0.125 ml/cm2 blot membrane] 
for precisely 1 min. The excess fluid on the blot was drained and the blot was carefully 
wrapped in transparent cling film. In a dark room, a sheet of autoradiography film 
(Hyperfilm) was exposed to the wrapped blot for a suitable period of time (e. g. 90 sec), 
and the film was developed in Kodak film developer following the manufacturer's 
instructions. 
Densitometric determination of p21'°s levels 
The p21`ß protein bands on the Hyperfilm were scanned by a light densitometer (Bio- 
Rad 620 Video Densitometer) and the data were analysed by using software 1D Analyst 
(version 3.10, Bio-Rad). 
2.2.7 Lipid peroxidation assay (LPO-586) 
The in vivo lipid peroxidation level is an important indication of oxidative stress. The 
classical method for measuring malondialdehyde and 4-hydroxyalkenals, which are the 
breakdown products of lipid peroxidation, is the thiobarbituric-acid assay, and this 
method is prone to interference and is characterised by unsatisfactory reproducibility 
(Janero, 1990). The LPO-568 is an improved method for measuring malondialdehyde 
and 4-hydroxyalkenals according to the manufacturer (BIOXYTECH S. A. ). 
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2.2.7.1 Principal reagents 
The principal reagents were commercially bought from BIOXYTECH S. A., France in 
kits. 
2.2.7.2 Basic procedures 
The experimental procedure was followed as in the User's Guide for LPO-586 to 
measure 4-hydroxyallcenals: 650 µl of freshly prepared RI solution (chromogenic 
agent, 10.3 mM in acetonitrile) and 200 pl of plasma sample were added to a test tube 
and the reaction was started by adding 150 pl of R2 solution (methanesulphonic acid, 
10.4 M) to the mixture. The tube was closed with a tight stopper and the contents 
were thoroughly mixed. The reaction was carried at 45°C in a water bath for 40 min. 
The tube was then cooled on ice and the insoluble materials were removed by 
centrifugation when necessary. The absorbance of the mixture at ?= 586 nm was 
measured and recorded using a spectrophotometer (Shimadzu MPS 2000). A standard 
curve, which was drawn from a series of Si (standard solution for hydroxyalkenals) 
concentrations assayed simultaneously with the sample, was used to determine the 
concentration of the hydroxyalkenals in the sample. 
2.2.8 Antioxidant capacity assay (myoglobin-ABTS-H202 system) 
There are several methods currently used for determining the antioxidant capacity of a 
compound or a mixture of compounds (e. g. Wayner et al, 1987; Duthie et al, 1990; 
Pryor, 1993; Miller et al, 1993; Cao et al, 1993; Barnett and King, 1995; Abella et al, 
1996). Considering the complex nature of the biological specimen, a non-specific 
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biochemical assay system, which was devised by Miller et al (1993,1995) and uses 
MetMb as a peroxidase and ABTS as a chromogen, was chosen and adapted to 
measure the total antioxidant capacity of a biochemical sample. 
2.2.8.1 Principal reagents and media 
The principal reagents and media used in the assay are given in Table 2-10 below. 
Table 2-10: Principal reagents used in the antioxidant capacity assays 
PBS 5 mM phosphate saline with 1.35 mM KCl and 
68.5 mM NaCl, pH7.4 
ABTS solution 500 µM ABTS in PBS 
MetMb [oxidised myoglobin in which 10 µM myoglobin in PBS [commercially available Mb usually 
iron is in Fe (III) state] solution is in MetMb form (Mehlhorn and Gomez, 1993)] 
H202 solution 1.5 mM H202 in PBS (made up freshly) 
2.2.8.2 Basic procedures 
MetMb [iron in Fe(III) state] has peroxidase-like properties which can react with 
H202 and ABTS and give rise to a chromogen having an absorbance peak at X= 734 
nm (Osawa and Korzekwa, 1991; Szutowicz et al, 1984; Wolfenden and Wilson, 
1982). The presence of an antioxidant can suppress or delay the production of the 
chromogen and it has been established that the delay (lag time) is linearly correlated 
with the concentration of the antioxidant (see Section 2.8.8.4). 
2.2.8.3 Measuring the lag time of the chromogen production 
The spectrophotometer (Shimadzu MPS 2000) was set in the rate mode with the 
following settings: lag time-5 seconds; interval time-30 seconds; absorbance-[0-0.5]; 
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paper running-slow; slit-2 nm; and wavelength-734 nm. To measure the antioxidant 
capacity (lag time of the chromogen production) of a sample, reagents were added 
into a cuvette in the quantities and in the order shown in the Table 2-11 below. 
Table 2-11: The antioxidant capacity assay set-up for controls and samples 
Reagents Blank System Control Standard Sample 
10 µM MetMb 400 µ1 400 µl 400 pl 400 µl 
sample/antioxidant 20 pl - X PI 20 pI 
500 µM ABTS 300 µ1 300 µl 300 pI 300 µ1 
PBS 280 1l 250 pl (250-x) µl 230 µ1 
to init iate reaction, quickly add H202 and pipette mixture 
1.5 mM H202 - 50 µl 50 pl 50 µl 
Two straight tangent lines were drawn, one was tangent to the lag phase of the curve 
and the other was tangent to the linear increase phase of the curve. The intersection 
point of the two tangent lines was defined as the starting point of the chromogenic 
reaction. The time period between the point where the reaction was initiated and the 
point where the chromogenic reaction started was the lag time of the reaction. 
2.2.8.4 The modification of the antioxidant capacity assay 
Miller et al (1993) developed a simple method for measuring the antioxidant capacity 
in a biological sample, which is based on a chromogenic MetMb-ABTS-H202 system. 
Two modifications were made: firstly, the pre-treatment of Mb was disregarded 
because commercially bought Mb was usually in its oxidised form [(i. e. MetMb 
(Mehlhorn and Gomez, 1993)] and more over, it was observed that Mb did not yield 
different results whether treated or not (data not shown); and secondly, the time-point 
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measurement of absorbance was replaced by the measurement of the delay of the 
appearance of chromogen, i. e. lag time. which proved to be more suitable for this 
study (see below). 
The disadvantages of the unmodified antioxidant capacity assay: using trolox C as 
a model agent 
This was determined using the method of Miller et al (1993). The reaction set-up has 
been detailed in Table 2-11. The absorbance of the reaction mixture was measured at 
wavelength 734 nm at 6,12,18,24 minute after the reaction was initiated by H202, 
and the results from one of the experiments are shown below in Figure 2-2. A simple 
comparison of values in Figure 2-2 is given in Table 2-12 and Figure 2-3. The 
absorbance values at 6 min, which were used by Miller et al, do not show a straight 
trolox C-concentration dependent relationship. 
Figure 2-2: The absorbance curves of the reaction mixture at different time 
points after the commencement of the reaction' 
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.X" . _, x___ x 
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-Ar - - ý -"t--6min 0.6 ...... A ....... . """... . 
- 
-0--12 min c 
--º- 18 min 
0.4 .. ........................... 
-"X-24 min 
0.2 ............ 
ý.. ý":.... -. ý ßt1 ::......... 
0 
0 5 10 15 20 25 
Trolox C concentration (NM) 
Trolox C used as a standard reagent 
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Table 2-12: Inhibition index In at different time points after the commencement of the reaction a 
In* 6 min 12 min 18 min 24 min 
I, 0.00%, 0.00%> 0.00%, 0.00%, 
I5 16.56%, 11.32%, 7.74%, 5.79%, 
I10 24.25%> 14.18% 9.43% 6.88% 
I155 32.44% 17.89%, 11.26%, 7.97% 
120 41.47% 22.55%> 14.07%, 10.43%, 
125 52.01% 27.40%, 17.80% 13.18%, 
Trolox C used as a standard reagent; *h= (A -A)/A,,, A= absorbance, ,= trolox concentration 
in pM 
% values are calculated as a mean percentage reduction by comparing with time zero 
Figure 2-3: Difference between the theoretical and the experimental relative inhibitions in 
antioxidant capacity assay at different time points after the commencement of the reaction a, b 
5 
x 
D4 
0 
c 
10 2 d 
I 
---6 min 
p 12 min 
A 18 min 
f- -24 min 
0 expected 
Using unmodified method by Miller ei a1,1993; h Trolox C used as a standard reagent 
Using the modified method to determine the antioxidant capacity 
The reaction set-up has been detailed in Table 2-1 1. After the reaction was initiated by 
H202, the absorbance of the reaction mixture at wavelength 734 nnl (A7 4) was 
continuously and automatically registered. A typical A7 4-time curve is given in 
Figure 2-4, in which the lag time is also shown. The lag time data from one of the 
experiments is given below in Table 2-13. A simple comparison of data in "fable 2-13 
is given in Table 2-14. 
68 
5 10 15 20 25 
Trolox concentration in IN 
Figure 2-4: A typical Absorbance-Tinte curve in the antioxidant capacity assay 
and the illustration of lag time measurement * 
au 
ci 
A 
0 
0i 
ý_ Lag time Time 
* The lag time period starts at the time point where the reaction is initiated and ends at the time 
point where two lines tangential to the Absorbance-Time curve intersect. 
Table 2-13: The antioxidant capacity of trolox and vitamin C measured in lag time 
(seconds): typical data 
]Trolox], µM Lag time ]Vitamin Cl, µM Lag time 
o 0 0 0 
o 0 0 0 
5 158 5 116 
5 140 5 111 
10 253 10 211 
10 255 10 21S 
15 398 15 120 
15 376 15 345 
20 512 20 427 
20 521 20 433 
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Table 2-14. The relative values of antioxidant capacity of various concentrations of 
trolox and vitamin C measured in lag time (seconds) 
ITrolox], Relative lag time a (Vitamin C1, Relative lag time h 
µM Expected Observed µM Expected Observed 
0 0 0 0 00 
5 1 1.16 5 1 1.06 
10 2 1.97 10 2 1.99 
15 3 3.00 15 3 3.09 
20 4 4.00 20 4 4.00 
Means of values in Table 14 and assuming the value of 20 µM of trolox is 4 
b Means of values in Table 14 and assuming the value of 20 µM of vitamin C is 4 
From the comparison of relative values of the inhibition index and the antioxidant 
capacity in Figures 2-3, Tables 2-12 to 2-14, it can be concluded that using lag time 
as the measurement of antioxidant capacity reflects better the antioxidant capacity 
than using the absorbance value at a particular time-point. However, the modified lag 
time method also has it limitations, e. g. when measuring the antioxidant capacity of 
silymarin, the inhibitory effect on the chromogen formation was underestimated (I 
mM of silymarin was equivalent to 0.26 mM of trolox in one of the experiments) 
because the inhibitory effect was extended beyond the lag phase of the A7; 4-time 
curve. Overall, however, it appears to be a better method. 
2.2.9 Statistical analysis 
Various statistical methods were used for the experimental data analysis. A flow chart 
(Figure 2-5) is shown to illustrate the common strategy approach for the general data 
analysis. However, several other methods also were used to analyse data for the CA 
studies (x-square heterogeneity test, Fisher's exact test) and for the eye-scored comet 
assays (Wilcoxon rank - sum test). 
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Figure 2-5: Flow chart for statistical analysis of experimental data 
Commencement of Analysis 
Normality Test of Data Groups 
Normal Not Normal 
Equal Variance? 
Homogeneity Test 
Yes or No 
t 
t-Test 
Y 
Equal Variance? 
Homogeneity Test 
Yes 
ANOVA 
1 
Kruskal-Wallis Test 
Significant Significant 
FLSD Test Not Significant I Mann-Whitney Test 
Completion of Data Analysis 
0 
Cannot Proceed, 
Discuss Why 
Generally continuous data from various treatment groups and the controls were tested 
for their normality and homogeneity of the variances. If they were normally 
distributed, a parametric statistical method (i. e. t-test or ANOVA) would be used; if 
they were not normally distributed, a non-parametric statistical method (i. e. Kruskal- 
Wallis test) would be used. The least significant difference (LSD) test or the Mann- 
Whitney test was used for pair-wise comparisons after obtaining the significant results 
of the ANOVA or the Kruskal-Wallis test. 
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CHAPTER 3 
ROS-INDUCED DNA DAMAGE IN VITRO: 
MODULATION BY ANTIOXIDANTS 
3.1 Introduction 
As it has been discussed in Section 1.4.4.1, the interaction between ROS and DNA can 
lead to the following events: 1) base modifications, 2) covalent binding of bases, 3) 
formation of abasic sites and 4) DNA strand breakage (Dizdaroglu, 1993). So far there is 
no single method capable of measuring all types of DNA damage. However, 
investigating any of the above events individually would provide similar information 
about comparative ROS-induced toxicity. Practically, measurement of ROS-induced 
damage at the DNA level can be investigated by examining any of the above events, and 
how the results can be interpreted is only limited by the sensitivity and specificity of the 
assay used. Measuring the extent of base oxidation (e. g. 8-OHdG, 5-OHdC) is a well- 
established method that has been widely used for estimating oxidative DNA damage 
both under in vivo and in vitro situations, and much of our knowledge of ROS-DNA 
interaction has been derived using this procedure. It has, however, a number of 
drawbacks: 1) it requires expensive analytic equipment, usually high performance liquid 
chromatography (HPLC, e. g. Frenkel et al, 1991) or gas chromatography-mass 
spectrometry (Marnett and Burcham, 1993); and 2) the way the sample is prepared can 
influence the results greatly (Halliwell, 1993). The measurement of covalent binding of 
bases, i. e. DNA-DNA or DNA-protein cross-links, can use the same techniques as used 
for oxidised bases, but it is a much less well-studied method. Determining abasic site 
damage is complex and only a biological system with a high specificity is able to 
discriminate such events. The most frequently used method involves repair-deficient 
mutant or abasic-site-specific enzymes to detect such damage. Measurement of abasic 
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sites is especially important for studying mutations and repair at the molecular level. 
There are many assays, however, that can measure DNA strand breaks, either single- 
stranded or double-stranded and more than a dozen assays for detecting DNA strand 
breaks have been listed (Whitaker et al, 1991), each having its advantages and 
disadvantages. 
Accumulated evidence suggests that DNA double strand breaks (DSBs) play a significant 
role in geno- and cyto-toxicity (see Section 3.4). In order to increase our understanding of 
how ROS cause DNA damage and how the interaction between ROS and DNA is 
modulated by antioxidants, a study of the chemical interactions between these molecules 
in a simple chemical environment is necessary. A rapid and easy method that can measure 
the most significant DNA lesions (i. e. DNA DSBs) would be suitable for this type of 
investigation. 
Naked DNA molecules have been used for studying ROS-DNA interaction since 1968 
(Rhaese and Freese, 1968). In the current investigation, bacteriophage %-DNA was 
incubated with ROS-generating compounds and modulating chemicals in an artificial 
system, without metabolic activation, followed by a DO-specific neutral 
electrophoresis technique to study ROS-caused damage and its modulation by various 
factors, including antioxidants. 
3.2 Materials and methods 
The technique used in this study is neutral DNA agarose gel electrophoresis for 
detecting DNA DSBs. General materials and methods have been detailed in Chapter 2. 
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Various methods were evaluated for the analysis of the DNA migration patterns in this 
study, including using a light densitometer to scan the negative films. It was found that 
making a relative comparison by calliper and eye was the most practical and sensible 
method. Comparisons were made between individual treatments on enhanced digital 
images, using maximum DNA migration distance, taking into account DNA distribution 
and then assigning the images with arbitrary units. The purpose of this study was to 
determine whether well-known ROS-generating agents can induce DNA damage in a 
simple chemical system, with or without Fenton reaction components (iron and reducing 
agents), and to explore whether antioxidants, which normally exist in the cellular 
environment, can modify such damage, i. e. to determine chemical reactions of relevance 
to biological systems. The qualitative approach to representing the data did not 
compromise the power of discrimination of this assay. 
3.3 Results 
, %-DNA was incubated with various chemicals or combination of chemicals in DNA 
storage solution at 37°C for 2 hrs, before assessing the degree of damage by 
electrophoresis (see Section 2.2.1). The results of this assay reflect DNA DSBs 
induced by ROS. 
Figure 3-1 shows the criteria used for categorising DNA damage in this study. 
Damage is graded, scored on an arbitrary scale from 0-13. The images of Figure 3-1 
were taken from 2 gels from one experiment. The category of DNA damage depended 
on both the maximum DNA migration distance and the distribution of DNA mass. 
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Figure 3-2 shows how a high concentration of doxoruhicin (Dox, I mM) obscured the 
DNA band whereas other agents induced extensive DNA damage. Figures 3-3a, 3-3b 
and 3-3c show the DNA electrophoresis patterns after treatment with ROS-generating 
agents [Hydrogen peroxided (H202), bleomycin (BLM) and sodium ascorbate (Vit C)] 
and modulating agents. The extent of DNA damage for each individual treatment is 
shown in Table 3-2. Taking Figure 3-3b as an example, the electrophoresis pattern is 
shown of DNA treated with BLM and various modulating agents. Trolox-modulated 
DNA has the same maximum migration as myricetin-modulated DNA, but the DNA 
distribution for the former is obviously closer to the point of electrophoresis origin 
(i. e. DNA fragments are larger). Taking into account both the maximum DNA 
migration distance and fragment distribution, they have been assigned different 
extents of damage (11 for trolox-modulated, 12 for myricetin-modulated). It should be 
pointed out that the numbers assigned are not necessarily proportionally related as 
they are in mathematics. 
Figure 3-2: Abolition of ethidium bromide-stained I)NA 
0.3 tg DNA as loaded to each lane alter IIca Iinent \ý ith \ ari , us agents in 
a medium containing 1 mM of reduced glutathione and 25 pM of FeUI,. 
Lane 1: with 1 mM sodium ascorhate; Lane 2: with 0.25 U/nil hleonrycin; 
Lane 3: with 1 mM doxoruhicin; Lane 4: with I mM hydrogen peroxide. 
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Figure 3-3: DNA damage induced by ROS-generating compounds and 
its modulation by various chemicals 
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() 54 () 
Chemical concentrations in DNA storage buffer (SB): BSA -- bovine serum albumin: 0.9 mg/nil; X- 
DNA: 25 µg/ml; GSH - reduced glutathione: I mM; FeCI2 ferrous chloride: 25 µM; SOD 
superoxide dismutase: 1000 U/ml; CAT - catalase: 500 U/ml; Trolox: 2 mM; IWO deferoxamine: 2 
mM; Silymarin: half saturated solution in SB; Myricetin: half saturated solution in S13 
Numbers below figures represent the arbitrary grade of DNA damage for relevant lanes 
The results from the different experiments involving the various ROS-generating 
chemicals and modulating agents are summarised in Tables 3-1,3-2 and 3-3. 
Table 3-1: DNA damage in the absence of iron and its modification by 
treatment with various agents' 
A B C D E F G 
Treatment factors SB HQ BQ BT H202 BLM Vit C 
Final concentrations 1 mM 1 mM 1 mM 1 mM 0.25 U/ml 1 mM 
x 0 1 2 0 0 7 2 
2 X+BSA 3 3 4 5 5 4 n. d. 
3 X+SOD 3 3 4 4 4 0 n. d. 
4 X+Fe2+ 0 6 3 13 2 9 13 
5 X+GSH 3 3 3 7 0 6 6 
6 X+GSH+BSA 4 4 4 7 0 0 7 
7 ?. +GSH+SOD 3 3 0 13 4 4 4 
8 X+GSH+Fe2+ 2 11 7 13 13 10 12 
9 ? +GSH+trolox 8 4 4 4 0 4 5 
10 X+GSH+DFO 4 5 5 5 3 0 3 
` Primarily in the absence of Fenton components (iron + reducing agents) except for rows 4 and 8 
SB-DNA storage buffer; HQ-hydroquinone; BQ-benzoquinone; BT-benzenetriol; BLM-bleomycin; 
Vit C-sodium ascorbate 
Concentrations: X: X-DNA-25 µg/ml; BSA: bovine serum albumin-0.9 mg/ml; SOD: superoxide 
dismutase-1000 U/ml; Fee+: FeC12-25 µM; GSH: reduced glutathione-1 mM; trolox-2 mM; DFO: 
deferoxamine-2 mM 
Increasing damage scored on an arbitrary scale from 0-13; n. d.: not determined 
All the treatments have been repeated at least twice. Comparisons were made only 
within each experiment to determine the effects of relevant compounds. There were 
inter-experimental differences for some of the compounds possibly because reagent 
volumes involved in the experiments were very small (less than 20 µl) and 
consequently relative errors were large. Overall, however, the results were consistent. 
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Table 3-2: ROS-induced DNA damage in the presence of iron and its modification by antioxidants " 
H I J K L M N 0 
Treatment factors SB HQ BQ BT H202 Dox BLM Vit C 
Final concentrations 1 mM 1 mM 1 mM 1 mM 5 µM 025U/mI 1 mM 
11 x 0 1 3 0 1 0 9 3 
12 ? +Fe2+ 1 5 3 13 2 1 5 12 
13 X+Fe2++GSH 5 10 8 13 9 2 8 13 
14 ?, +Fe2++GSH+BSA 6 11 10 13 11 6 6 13 
15 X+Fe2++GSH+S0D 4 13 13 13 5 5 7 13 
16 X+Fe2++GSH+CAT 5 8 5 10 4 3 7 10 
17 X+Fe2++GSH+troloa 3 9 4 11 6 6 11 11 
18 X+Fe2++G5H+DFO 4 9 6 11 5 4 7 11 
19 ? +Fe2++GSH+silymarin 3 9 5 12 6 2 9 11 
20 %+Fe2++GSH+myricetin 9 11 9 13 12 9 12 13 
In the presence of Fenton components (iron + glutathione and other reducing agents) 
SB-DNA storage buffer; HQ-hydroquinone; BQ-benzoquinone; BT-benzenetriol; Dox-doxorubicin; BLM- 
bleomycin; Vit C-sodium ascorbate 
Concentrations: A,: X-DNA-25 pg/ml; Fee+: FeC12-25 µM; GSH: reduced glutathione-1 mM; BSA: bovine 
serum albumin-0.9 mg/ml; SOD: superoxide dismutase-1000 U/nil; CAT: catalase-500 U/ml; trolox-2 mM; 
DFO: deferoxamine-2 mM; silymarin-half-saturated solution in SB; myricetin-half-saturated solution in SB. 
Increasing damage scored on an arbitrary scale from 0-13. 
The DNA-damaging effect of individual chemicals 
In the various experiments (comparisons between Al and B1-G1, between Al and 
A2-A5 in Table 3-1; between H11 and I11-011 in Table 3-2), H202, hydroquinone 
(HQ), benzoquinone (BQ), benzenetriol (BT), Dox, BLM, Vit C, reduced glutathione 
(GSH) and Fe2+ (FeC12) have been individually examined in DNA storage buffer. 
Individual chemicals (except BLM-F1, N11) did not induce a large number of DSBs 
in the absence of iron, even at quite high concentrations (1 mM). The damage caused 
by Dox could not be determined in the mM concentration range because Dox almost 
abolished the fluorescence of the DNA-EtBr complex (Figure 3-2). 1 mM of BT (D1, 
K11) and 5 µM of Dox (M11) did not produce DSBs. 
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Table 3-3: ROS-induced DNA damage in the presence of iron and its 
modification by flavonoids 
P Q R S T U 
Treatment factors SB HQ BQ H202 BLM Vit C 
Final concentrations 1 mm 1 mm 1 mM 025Uhnl 1 mm 
21 X, +Fe2++GSH 1 11 6 7 7 9 
22 X+Fe2++GSH+DMSO n. d. 0 0 8 8 7 
23 X, +Fe2++GSH+silymarin+DMSO n. d. 3 0 8 7 n. d. 
24 , %+Fe2++GSH+myricetin+DMSO n. d. 0 0 8 8 n. d. 
Concentrations: %- %-DNA: 25 µg/ml; Fee+- FeC12: 25 µM; GSH - reduced glutathione: 1 mM; 
DMSO: 50%; silymarin: 2 mM; myricetin: 2 mM 
SB - DNA storage buffer; HQ - hydroquinone; BQ - benzoquinone; H202 - hydrogen peroxide; 
BLM - bleomycin; Vit C- sodium ascorbate; DMSO - dimethyl sulphoxide 
Increasing damage scored on an arbitrary scale from 0- 13; n. d.: not determined 
The modulating effects of iron and DMSO 
In the absence of the reducing agent GSH (A4, Table 3-1; H12, Table 3-2), Fe(II) 
would readily be oxidised to become Fe(III) in aqueous solution and it did not 
produce distinguishable DSBs. The concentration of FeC12 used was 25 µM. In the 
presence of GSH, the valence of Fe(II) would not change, and DNA breaks were 
induced (A8 vs Al, Table 3-1; H13 vs H1 I, Table 3-2). Fe(II) increased the DNA 
DSBs production caused by HQ, BQ, BT, H202 and Vit C (row 8 vs rows 1 and 5, 
Table 3-1; row 13 vs row 11, Table 3-2). Fe(III) increased the DNA DSBs production 
induced by the reducing compounds HQ, BT and Vit C, to a lesser extent the DNA 
DSBs production induced by H202 or Dox (Table 3-2), and did not or slightly altered 
the DNA DSBs production in the presence of BQ (row 4 vs row 1, Table 3-1; row 12 
vs row 11, Table 3-2). The effect of iron on BLM-induced damage was uncertain 
probably due to the fact that BLM contains copper ions. In the presence of iron and 
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GSH, dimethyl sulphoxide (DMSO, 1: 1 ratio to DNA SB) attenuated the damaging 
effect of HQ, BQ, and Vit C, and had no effect on H202 and BLM (Table 3-3, row 22 
vs row 21); its effect on other compounds was not examined. 
The modulating effect of GSH 
In the absence of iron, GSH enhanced the damaging effect of HQ, BT and Vit C, with 
little or no effect on BQ and H202 respectively, but had possibly a small protective 
effect on BLM (row 5 vs row 1, Table 3-1). In the presence of iron, GSH enhanced the 
damaging effect of all compounds studied except BT, probably due to the acceleration 
of ROS production (row 8 vs row 4, Table 3-1; row 13 vs row 12, Table 3-2). 
The modulating effects of SOD and CAT 
Both superoxide dismutase (SOD) and catalase (CAT) are essential antioxidant 
enzymes in vivo. When compared with the non-enzyme protein bovine serum albumin 
(BSA), SOD abolished the effect of BLM, slightly ameliorated the effects of BT and 
H202, and did not alter the effects of HQ and BQ (row 3 vs row 2, Table 3-1). In the 
presence of GSH without iron, SOD diminished the effects of HQ, BQ, and Vit C but 
enhanced the effects of BT, H202 and BLM (row 7 vs row 6, Table 3-1). In the 
presence of both GSH and iron, SOD enhanced the effects of HQ, BQ and BLM, 
ameliorated the effects of H202 and Dox, and did not alter the effects of BT and Vit C 
(row 15 vs row 14, Table 3-2). In the presence of iron and GSH, CAT (compared with 
BSA) showed a protective effect for all compounds examined, except BLM (row 16 
vs row 14, Table 3-2). 
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The modulating effects of DFO and trolox 
In the presence of GSH alone, deferoxamine (DFO) enhanced the effects of HQ, BQ 
and H202, ameliorated the effects of BT, BLM and Vit C, whilst it induced damage on 
its own (row 10 vs row 5, Table 3-1). With iron and GSH, DFO was protective for all 
compounds except Dox (row 18 vs row 13, Table 3-2). Trolox induced some damage 
with GSH alone, but showed a protective effect with BT, H202, BLM and Vit C (row 
9 vs row 5, Table 3-1). Trolox, in the presence of iron and GSH, was protective for all 
compounds except Dox and BLM (row 17 vs row 13, Table 3-2). 
The modulating effects of silymarin and myricetin 
In various experiments with iron and GSH, silymarin was protective for all 
compounds except for Dox and BLM (row 19 vs row 13, Table 3-2). With iron and 
GSH, myricetin induced a large number of DSBs. Moreover, it synergistically 
enhanced the effects of H202, Dox and BLM, possibly enhanced the effects of BQ and 
HQ, whilst it had no effect on BT and Vit C (row 20 vs row 13, Table 3-2). In the 
presence of iron, GSH and DMSO (1: 1 ratio to DNA SB), however, silymarin and 
myricetin had little effect on HQ, BQ, H202 and BLM and the damage was generally 
diminished by DMSO (rows 23 and 24 vs row 22, Table 3-3). 
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3.4 Discussion 
The uncertain role of antioxidants in ROS-induced DNA damage 
The importance of ROS in inducing genotoxicity is widely accepted and has been 
extensively studied during the last decade. ROS can induce virtually all types of DNA 
damage, the most significant and readily detectable being DSBs (Whittaker et al, 
1991). Due to the elusive nature of ROS and the complexity of the situation in vivo 
(Holley and Cheeseman, 1993), there are many questions that need to be answered 
(Simic, 1994). It is particularly, unclear how ROS production and removal is 
modulated in vivo by exogenous antioxidants, including vitamins, carotenoids and 
plant polyphenols. The increasing concern of the significance of ROS toxicity to 
human health has led to many large-scale clinical and epidemiological, as well as 
laboratory, investigations (Langseth, 1995). It is generally believed that exogenous 
antioxidants are beneficial (Halliwell, 1996), but this view has been questioned 
(Diplock, 1996). The investigations with exogenous antioxidants have not drawn 
conclusive results, e. g. with carotenoids (Gaziano, 1996; Davison et al, 1993), ß- 
carotene and Vit E (Kardinaal et al, 1993), Vit E (Hense et al, 1993), Vit C (Rimm et 
al, 1993; Shklar et al, 1993), Vit E and C (Aalto and Raivio, 1993). It is recognised 
that some antioxidants can turn into prooxidants under certain conditions, e. g. Vit E 
(Bowry and Stocker, 1993; Aruoma, 1993b), Trolox (Ko et al, 1994; Kontush et al, 
1996) and flavonoids (Sahu and Gray, 1996). The relevance of these observation to 
the in vivo situation remains unclear (Halliwell, 1996). It has been suggested that a 
full-spectrum approach with evidence drawn from cell biology, animal studies, 
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clinical trials and epidemiological surveys is needed to clarify the situation 
(Blumberg, 1995). In the present investigation, many possible reactions were explored 
in a simple chemical system. 
The non-specific nature of ROS-induced DNA damage 
All DNA bases and the sugar ring of the DNA backbone can be targeted by OHS 
(Spencer et al, 1996). At the chromosomal and sub-chromosomal levels, however, 
there are reports that ROS cause site-preferential mutation at some specific DNA sites. 
For example, it was reported that mutagenic hotspots for base substitutions were 
found at positions 133,160 and 168 for supF gene in an E. coif vector plasmid, 
pZ189, following treatment of the bacteria with H202 (Akasaka and Yamamoto, 
1994). This can probably be explained by the fact that some sites on DNA are more 
nucleophilic than others. An alternative possibility is that transition metals 
preferentially bind to specific sites of DNA (Samuni et al, 1983; Imlay and Linn, 
1988) and the localised generation of ROS leads to site-specific mutation. 
DNA DSBs versus other DNA lesions 
Compared with base modifications, DNA strand breaks are more damaging. Many 
base modifications can be repaired via the `base excision mechanism' or `one step 
repair' while other DNA lesions are repaired by `nucleotide excision repair' 
(Wassermann, 1994). The last scheme involves 20-100 bases obviously requiring 
substantially more resources and energy. It is well established that DNA strand breaks 
may lead to mutagenesis or clastogenesis (Bryant, 1984; Phillips and Morgan, 1993; 
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Columna et al, 1993; Povirk, 1996). Because strand breaks can be repaired, it is 
difficult to measure them accurately in vivo. In a cellular environment, if the extent of 
damage does not lead to cell killing, most of the lesions (including breaks) will be 
repaired within several hours. For example, human SCC61 (radiosensitive) and 
SQ20B (radioresistant) cell lines both repaired 75-85% of DSBs induced by radiation 
within 1h at 37 °C (Smeets et al, 1993). 
There is also ample evidence that DNA DSBs are more toxic and more persistent in 
the cell than single strand breaks (SSBs). For example, only DSBs correlated with cell 
killing (Whitaker et al, 1991). In addition, in cultured rabbit lens epithelial cells, 80% 
of the DNA SSBs were repaired within 4 hrs after the termination of UVexposure 
(Sidjanin et al, 1993), and in another study, using Chinese hamster cells, many DSBs 
remained unrejoined after 17 hrs post-ionizing-radiation incubation (Kysela et al, 
1993). Although cells are able to rejoin the broken DNA ends regardless of the 
structure, the incorrect repair of DNA DSBs may lead to deletions, translocations, 
inversions and insertions of nucleotide sequences, and hence lead to mutagenesis 
(Phillips and Morgan, 1993; Povirk, 1996). Thus DNA DSBs play a more significant 
role in geno- and cyto-toxicity. In the current investigation, a DSB-specific 
electrophoresis technique was used to examine ROS-caused damage and its 
modulation (see Chapter 2). 
Measuring DNA DSBs using the neutral electrophoresis technique 
Unwinding of the DNA double helix requires substantial energy to break down the 
forces welding the two DNA strands together, i. e. hydrogen bonds and the 
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hydrophobic interactions between successive stacked bases. Both base modification 
and spontaneous SSBs do not lead to DNA denaturation (otherwise large numbers of 
DNA lesions cannot be repaired properly in vivo because accurate repair requires the 
complementary strand of the damaged one, and the denaturation can easily undermine 
the integrity of DNA structure). To discriminate DNA SSBs, alkaline conditions must 
be applied to electrophoresis solution (Whitaker et al, 1991). In a near neutral aqueous 
environment (pH 7-8), DNA molecules with SSBs would have the same size and 
mobility in agarose gel during electrophoresis, and are not distinguishable. Only DNA 
molecules with DSBs, i. e. fragmented DNA, will change their size and mobility in the 
electrophoresis process. Conventional agarose gel electrophoresis has enough 
discrimination power to achieve separation between randomly broken %-DNA and 
intact molecules. The DNA electrophoresis pattern is directly linked to the severity of 
the damage, i. e. the further the DNA fragments migrate, the smaller the size of the 
fragments and the greater the extent of DNA damage. 
In the present study, double-stranded bacteriophage ), -DNA, having a size of 48,502 
bp and molecular weight of -. 3.3 x 107 Dalton, was used. If the DNA molecules are 
not broken by physicochemical factors, the DNA should appear as a narrow single 
band after electrophoresis in agarose gel. If the DNA molecules have been partially 
broken by physicochemical factors (e. g. ROS), the narrow DNA band in agarose gel 
would become more widely spread, and the extent would depend on the degree of 
damage. It is not expected that distinct bands would appear after electrophoresis due 
to the above discussed non-site-specific nature of ROS-DNA reaction. By comparing 
the extent of DNA damage by different treatments, the factors which affect ROS 
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generation can be identified, hence providing guidance for studying ROS genotoxicity 
and its modulation at higher biological organisation levels, e. g. at the chromosomal, 
cellular and individual animal levels. Similar techniques have been used by a number 
of other investigators studying ROS-induced DNA damage (Liu and Dixon, 1996; Li 
et al, 1995; Sarker et al, 1995; Toyokuni and Sagripanti, 1993; Sakurai et al, 1992; 
Lewis et al, 1988). 
The ROS-generating compounds and modulating agents used in this study 
There are large numbers of ROS-related agents (Horton and Fairhurst, 1987, Kehrer, 
1993), the most common being quinones, phenolic compounds, transition metals and 
their compounds, many reducing compounds and some cellular enzymes involving 
electron transfer, etc. The compounds chosen for this study are those believed to be 
very important and representative. Hydrogen peroxide, BLM and Dox, Vit C, the 
benzene metabolites HQ, BQ, and BT were chosen as potential ROS-generators, while 
SOD, CAT, trolox, DFO, silymarin, and myricetin were used as modulating agents. 
GSH was used for providing a reducing environment. Finally, ferrous ion 
(FeC12.4H20) was used as the catalyst for the Fenton or Haber-Weiss reactions (see 
Chapter 1, reactions 1-3 and 1-5). The modulating agents were chosen as they are 
naturally occurring and a number of them have been used for theraputical purposes, 
e. g. DFO. The chemical structures of BLM, Dox, BQ, HQ and BT are shown in 
Figure 3-4, trolox, and those of ascobic acid, trolox, silymarin, myricetin and DFO in 
Figure 3-5. 
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Figure 3-4: Chemical structures of bleomycin, doxorubicin, benzoquinone, 
hydroquinone and benzenetriol 
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Figure 3-5: Chemical structures of ascorbic acid, trolox, silymarin, 
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ROS-generating compounds used in the present study 
Hydrogen peroxide is the natural by-product of aerobic metabolism of the cells. It is 
recognised as a primary source ROS (Sections 1.4 and 1.5) and used as a standard 
agent for ROS genotoxicity studies. 
Bleomycin (BLM) is a generic name for a group of related soluble glycopeptide 
antibiotics isolated from Streptomyces verticillus, first discovered in 1965 in Japan 
and frequently used in the treatment of cancer. Its `radiomimetic' property involving a 
ROS mechanism provides primary anticancer function. Under aerobic conditions, the 
`activated' form of BLM can react with DNA strands thus inducing DNA abasic sites, 
DSBs and SSBs (Povirk, 1996). DSBs cannot be induced in the absence of 02 
(Absalon et al, 1995). It has been suggested that DNA DSBs induced by BLM are 
formed by rapid `reactivation' of BLM in situ at primary break sites and the attack of 
a secondary site in the opposite strand., BLM is reactivated via the reduction of 
[Fe(III)-BLM] (Povirk, 1996), but the possibility that some DSBs can be produced 
from a single radical attack cannot be totally excluded (Butler and Hoey, 1993). 
Doxorubicin (Dox, formerly called adriamycin) is a soluble anthracycline antibiotic 
isolated from Streptomyces peucetius var caesius. It was first discovered in 1968, and 
is one of the most effective antitumour drugs (Ling et al, 1993). Its effectiveness has 
been ascribed to its ability to intercalate with DNA, interact with biomembranes, 
inhibit enzymes and participate in oxidation-reduction reactions (Tritton and Yee, 
1982; Butler and Hoey, 1993). Many studies indicate that ROS production is directly 
involved in the cytotoxic and genotoxic activities of Dox (Doroshow, 1986; Sinha et 
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al, 1987; Akman et al, 1992; Malisza and Hasinoff, 1995). It is currently believed by 
many researchers, however, that the genotoxic effect of Dox in vivo is primarily 
linked to the activity of nuclear topoisomerase II (Wassermann, 1994; Anderson et al, 
1997b). This study could help determine to what extent ROS generated by Dox 
directly induce DNA breaks since there is no enzyme involvement in this study. 
HQ, BQ and BT are directly linked to one of the most important industrial materials- 
benzene, which has a total global cycle of more than 30 million tonnes per annum. 
Although benzene has been studied since the early 19th century (Frederick Kekule 
proposed the ring structure of benzene in 1865), its toxicity was not notified by 
scientists until 50 - 70 years ago (Yardley-Jones et al, 1991; Parke, 1996). The 
consequences of benzene exposure are well documented (Dean, 1978,1985), but how 
benzene and its metabolites cause various abnormalities and modulate many 
biomarkers is still the subject of extensive studies. To understand benzene toxicity 
further, it is essential to investigate benzene metabolism and the interactions between 
its metabolites and cellular macromolecules, especially DNA. It has been 
demonstrated that all active benzene metabolites are able to act through ROS 
mechanisms in vivo (Yardley-Jones et al, 1991; Kolachana et al, 1993; Snyder and 
Hedli, 1996). HQ, BQ and BT are three typical benzene metabolites which also are 
able to generate ROS in vitro to react with DNA (Kawanishi et al, 1989; Singh et al, 
1994; Li et al, 1995; Shen et al, 1996). 
Sodium ascorbate or vitamin C (Vit C) was first isolated by A. Szent-Györgyi in 
1928. Its free acid form contains four hydroxyl groups which makes it a good 
reducing agent. It is easily oxidised by air in aqueous solution, the reaction being 
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accelerated by iron. It is regarded as one of the most important antioxidants. As a 
result of its reducing potential, however, it can act in a totally opposite way as a 
prooxidant in the presence of transition metals (Shamberger, 1984; Halliwell, 1994a). 
DNA damage induced by individual chemical: influence of other agents 
In the absence of the transition metal iron and the redox intermediate GSH, most of 
the compounds examined caused only a small number of DNA DSBs, possibly due to 
the small amounts of DNA-bound transition metals. With the addition of iron and/or 
GSH in the system, usually larger numbers of DNA DSBs were induced. Therefore 
the presence of transition metals and the conditions which make the redox cycle 
possible (i. e. the regeneration of an oxidised molecule to its reduced form by another 
reducing agent) are necessary for ROS-generating compounds to exert their DNA- 
damaging capacities. The fact that the OH' scavenger DMSO reduced the effect of 
some of the compounds examined suggests that OH' was largely responsible for 
causing DNA damage. In fact, among H202,02*- and OH', only OH' can directly 
cause DNA breaks (Aruoma, 1994; Pogozelski, 1995). Both H202 and 02*- generated 
by redox agents can be converted to OH* under favourable conditions and thus also 
induce DNA breaks (Halliwell and Gutteridge, 1984). It has also been suggested that 
singlet oxygen (1eg02) may be involved in metal-related DNA damage (Mao et al, 
1996; Li and Trush, 1994). It is worth noting that none of the antioxidants or other 
modulating factors can totally abolish ROS-induced DNA damage. This reflects the 
complicated interactions between DNA, ROS-generating compounds, transition metal 
ions and modulating agents in a specific physicochemical environment. 
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All potential ROS-generators investigated in this study induced the anticipated DNA 
damage with the exception of Dox. Dox failed to induce large numbers of DNA DSBs 
in the treatment combinations (column M vs column L). There are two possible 
explanations: 1) Dox is a poor ROS generator under the experimental conditions 
employed in the present study; and 2) the intercalation of Dox with DNA prevents 
DNA with DSBs from breaking down. The latter, however, is unlikely since 
treatments with BSA, SOD, trolox and myricetin (column M) still caused a substantial 
number of DNA DSBs. The first explanation is more feasible. A previous study 
(Akman et al, 1992) showed that OH' produced by Dox cannot be detected in the 
presence of NADH dehydrogenase. Catalase and OH' scavengers had no clear effects 
on the production of modified bases by Dox/Fe(III)/NADH/NADH dehydrogenase 
system. The effect of GSH varied depending on the nature of the monitored bases. 
SOD enhanced the oxidised base production but the precise role Dox played seems 
uncertain due to the many factors involved in the system. It can be concluded that at 
least OH* seems not to be largely involved in the Dox/Fe(II)/GSH system which is 
essential for inducing DNA strand breakage. 
The modulation of DNA damage by iron and reduced glutathione 
As a catalyst of the Fenton reaction and the Haber-Weiss reaction, iron plays a 
prominent role in the production of ROS and its possible role in carcinogenesis has 
been discussed (Ryan and Aust, 1992; Toyokuni and Sagripanti, 1996). Without the 
modulation of reducing agents, such as GSH, its catalytic ability is limited. For 
instance, DNA damage induced by the combination of iron and H202 is only 
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marginally increased by comparison with the damage induced by H202 alone (E1 vs 
E4; L12 vs L11). It was reported that DNA strand breaks were increased in a dose- 
dependent manner depending both on the concentration of iron and of H202 (Sarker et 
al, 1995). In contrast, strong reducing agents (e. g. Vit C, BT) greatly increased the 
DNA damage in the presence of iron, without the modulation of GSH. The results 
confirm that a reducing environment is more favourable for iron and ROS-generating 
agents to produce DNA damage. Similar observations have been made by others 
(Jonas et al, 1989; Stoyanovsky et al, 1995; Peskin, 1996). 
Glutathione is one of the most important compounds for maintaining the cellular 
integrity in vivo due to its reducing property (its standard oxidation-reduction 
potential E°j = -0.23 V) and its wide involvement in cellular metabolism. The 
intracellular level of GSH is in the range of 0.5 - 10 mM in mammalian cells (Meister 
and Anderson, 1983). At lower concentrations, it exacerbated the effect of H202 on E. 
coli, but at higher concentrations it afforded protection (Müller and Janz, 1993). Its 
role as an antioxidant has been well studied and discussed (Meister, 1994; Spear and 
Aust, 1995). GSH, when in combination with iron and the redox cycling agents, can 
modulate the redox status of iron and other agents, and hence, affect the mode and the 
rate of ROS generation (Imlay and Linn, 1988; Sakurai et al, 1992; Shi et al, 1993). 
GSH induced a very small number of DNA DSBs on its own. A previous study 
(Rowley and Halliwell, 1982) has demonstrated the prooxidant properties of GSH. 
Some other thiols (N-acetylcysteine, captopril and nacystelyn) have also shown to 
display prooxidant properties at low concentrations (Vanderbist et al, 1996). 
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The modulation of DNA damage by SOD and CAT 
The protective role of SOD and CAT is very clear, although the mode and the pattern 
of protection depend on the prevailing conditions, e. g. the presence of GSH and iron. 
The different protection patterns also reflect how the environment can affect the 
generation of ROS by redox compounds. For example, in the presence of GSH, BQ 
exerts its damaging effect through 02*- (SOD is protective), while in the presence of 
both GSH and iron, 02 - seems not to be involved in the DNA damaging effect of BQ 
(SOD is non-protective). Quinone compounds not only can generate ROS, but also are 
able to react with GSH to form glutathionyl addition products which are very 
significant in producing cytotoxic effects. SOD can mediate the reduction of 
semiquinone compounds by 02 - (QO- + 02 =Q+ 02*- ) where the equilibrium of the 
reaction depends on the characteristics of the semiquinone (Cadenas, 1989). In a 
cellular environment, it is very difficult to totally exclude one type of reaction in 
favour of another because of the non-homogeneous and compartmentalised nature of 
the cells. Without carefully investigating the possible interactions amongst various 
related agents, it is very difficult to harmonise conflicting results from the many 
experimental studies, e. g. in the case of BQ (Lewis et al, 1988). 
The modulation of DNA damage by DFO and trolox 
DFO, which has chemically active hydroxyamino and amino groups (see Figure 3-5), 
is a naturally occurring iron chelator. In the absence of iron, DFO is not necessarily 
protective which demonstrates the diverse mechanisms of ROS-generation. However, 
it reduced the DNA damage induced by all compounds (except Dox) in the presence 
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of iron. Although the protection given by DFO is not marked, the hypothesis of the 
mediation of ROS toxicity through iron is still supported by this study. DFO is not 
able to totally suppress the DNA damage induced by the treatments (row 18, Table 3- 
2). The possible explanations could be: 1) the Fe(II)/Fe(III) ratio is extremely high 
and the chelating power of DFO is compromised; 2) the [DFO-Fe(III)] complex can 
be, to a lesser extent, a prooxidant as has been demonstrated by others (Ryan and 
Aust, 1992); and 3) EDTA in the SB competes for iron with DFO, and [EDTA- 
Fe(III)] can be a Fenton agent (Sakurai et al, 1992). In fact, it was demonstrated that 
DFO can undergo autoreduction to form Fe(II) which is capable of catalysing the 
Fenton reaction, thus showing a prooxidant effect (Gutteridge et al, 1994). Trolox is a 
soluble form of vitamin E which acts as a `chain-breaking' antioxidant (Liebler, 1993) 
in a `self-sacrificial' manner. It also has the ability to repair some of the reversible 
oxidative damage (Giulivi and Cadenas, 1993). In previously conducted antioxidant 
capacity assays, trolox exhibited a strong ability to inhibit free radical formation 
(Section 2.2.8). The data imply that if the rate of ROS formation is high in the system, 
the presence of trolox could diminish the rate and partly inhibit the formation. If no 
other reactive species was available, trolox itself might be a source of damage. 
The modulation of DNA damage by silymarin and myricetin 
Silymarin and myricetin both belong to a chemical group called flavonoids which 
exist widely in nature. Most flavonoids have strong antioxidant properties due to their 
polyphenolic structure. They are consumed daily by humans in substantial quantities 
and are believed to be beneficial (Formica and Regelson, 1995; Manach et al, 1996). 
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However, they can also act as prooxidants in vitro depending on the environment 
(Formica and Regelson, 1995; Cao et al, 1997). In the present studies the protective 
role of silymarin is in accordance with the results of the comet assay (Anderson et al, 
1994) and the antioxidant capacity assay (Section 2.2.8). Similarly, the prooxidant 
effect of myricetin is in agreement with previous studies (e. g. Sahu and Gray, 1996). 
In summary, the modulation of ROS-induced DNA damage by the various agents 
clearly demonstrate the potentially harmful effect of ROS-generating compounds 
towards the genetic material, and the dual role of some antioxidants in the cellular 
system. The results also provide some indications of how to minimise ROS 
generation, and perhaps reduce the toxicity of ROS in vivo. 
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CHAPTER 4 
ROS-INDUCED DAMAGE AND ITS MODULATION 
BY VARIOUS AGENTS IN THE CELLULAR 
ENVIRONMENT 
4.1 Introduction 
Studies carried out in simple chemical systems may provide important information 
concerning the reactions which may occur in a biological system. However they are 
unable to explain the modulation of such reactions by the numerous factors existing in 
the biological environment. The study of ROS-induced genetic damage at the cellular 
level is the key to establishing the link between the mechanisms of ROS-DNA 
interactions and the pathology of various related diseases. 
Various chemicals can generate ROS through their chemical and/or biochemical 
reactions, e. g. HQ, BQ, BT, Dox and BLM (see Section 4.3). The genotoxicity of 
these compounds has been widely studied under the in vitro situation. However, there 
is a paucity of data concerning the modulation of their genotoxicity by antioxidants 
and some other modulating agents. 
Many compounds (including both antioxidants and non-antioxidants) have the 
potential to modulate, either directly or indirectly, the genotoxic effects of ROS 
generating compounds. Antioxidants are usually directly involved in the removal of 
ROS, whereas non-antioxidant compounds modulate ROS-induced responses 
indirectly, e. g., DFO acts through the decrease of ROS generation by chelating free 
iron ions (see Section 3.4). 
The comet assay is a straightforward and visual method which is able to determine the 
extent of DNA breaks and alkaline labile sites induced by physicochemical factors, 
including ROS, in eukaryotic cells (Singh et al, 1988; McKelvey-Martin et al, 1993; 
Fairbaim et al, 1995). Many experimental studies have demonstrated that the assay is 
sensitive and comparable to other biochemical, genetic and cytotoxic endpoints 
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(Slamenovä et al, 1997; Plewa et al, 1997; Siim, 1996). The Ames test and 
chromosomal aberration assays are the traditional methods for determining genetic 
damage caused by physicochemical factors in prokaryotic and eukaryotic cells 
respectively. They also have been employed to determine ROS-related DNA damage 
and its modulation by antioxidants and some other agents (Urios et al, 1995; Phillips et 
al, 1984). Genetic damage including that induced by ROS may lead to change of gene 
expression (Section 1.5.3.3). The expression of oncogenes are of special interest in 
toxicology due to the critical role of oncogenes in carcinogenesis. p21"a' is a group of 
closely-related oncoproteins which have a molecular weight of about 21 KDa (Grand 
and Owen, 1991). It is established that p21`m is an inhibitor of cyclin-dependent kinase 
that prevents cellular entrance into S-phase (Jacks and Weinberg, 1996). The level of 
p21'ß is not a direct index of DNA damage, but some studies have shown elevated 
p21'ß levels in subjects (tissue cultures, animals) exposed to DNA-damaging agents 
(Tanaka et al, 1996; Waga et al, 1994). A recent study (Qiu et al, 1996) suggested that 
elevated p21 expression in some human chronic myelogenous leukaemia cell lines was 
mediated by an increase in the cellular steady-state concentration of oxygen radicals in a 
p53-independent manner. Such studies suggested that ROS-generating agents would 
cause an increase in ras oncogene expressions and p21`ß levels. 
The objective of the studies in this chapter was to use the above mentioned methods to 
investigate ROS-induced genotoxicity in the cellular environment. All the methods 
used, with the exception of the p21 assay, were able to directly measure genetic damage 
caused by chemicals. The present p21 assay was a preliminary exploration to determine 
whether there was an increase in p21 levels in cells in culture after treatment with ROS- 
generating chemicals. 
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4.2 Materials and methods 
4.2.1 Materials 
Materials used in each assay have been detailed in Section 2.1.2. 
4.2.2 Methods 
4.2.2.1 Comet assay 
In the comet assays, PBS or RPMI 1640 were usually used as incubation media, and if 
necessary, rat liver S9 fraction was employed as the metabolic activation system. In 
the assays with arylamines, TX1MX, a cell free plant activating mixture, was used to 
determine the effect of plant activation (Plewa et al, 1995). 
Treatment regimen: The standard treatment regimen for the comet assay involved 30 
60 min incubation at 37°C. H202 in many cases was used as the positive control, 
while PBS or culture medium, in the presence or absence of S9 were always used as 
negative controls. Other regimens will be detailed at the appropriate sections. 
Scoring: The methods used are detailed in Section 2.2.3. 
Responses: The responses presented in the Figures and the Tables are usually the 
percentage values of the various categories of comets, which were scored by 
microscopic examination, usually from duplicate slides; and the median values of the 
tail-moments of 50 damaged cellular nuclei (or comets), which were scored by 
computer, for each concentration level. 
4.2.2.2 Other methods 
All the other methods have been detailed in Section 2.2. 
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4.3 Results 
4.3.1 Comet assays with human peripheral lymphocytes and HT29 cells 
The comet assays were mostly performed on separated human lymphocytes but, in 
addition, human leucocytes from whole blood/whole blood culture and cultivated 
HT29 cells were also used. 
4.3.1.1 DNA damage in human lymphocytes induced by ROS-generators and its 
modulation by various agents 
DNA damage induced by the ROS generators such as H202, BLM and sodium ascorbate 
has already been discussed in Chapters 1 and 3 (see 1.4.4.1 and 3.4.1.2). 
DNA damage induced by H202, BLM and sodium ascorbate 
Many experiments showed that DNA damage could be induced in a concentration- 
dependent manner by incubating separated human lymphocytes with H202, and the 
results from a typical experiment are shown in Figure 4-1. Statistically significant 
responses were seen at all concentration levels and concentration-response relationship 
was evident. 
DNA damage was also induced by ROS generated by chemicals in human 
lymphocytes. Figures 4-2 and 4-3 show the effects of BLM and sodium ascorbate (Vit 
C) on human lymphocytes over different concentrations, and the extent and grade of 
damage using the comet assay. Statistically significant responses were seen at all 
concentration levels with a significant concentration-response relationship. 
101 
Figure 4-1. DNA damage induced by hydrogen peroxide (H, O2) in human lvmphocvtes " 
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Figure 4-2: DNA damage induced by bleomycin(BLM) in human lymphocytes a 
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Figure 4-3: DNA damage induced by sodium ascorhate in lnnnun Ivmphocvtes a 
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The modulation of H202- or BLM-induced DNA damage by some endogenous 
antioxidants 
Catalase (250 U/ml) completely abolished the genotoxic effects of H102, at 
concentrations ranging from 5-80 µM, in separated lymphocytes (only data at 
concentration of 40 µM are shown in Table 4-1), whilst SOD at concentration of 
290 U/ml showed a small protective effect (Table 4-1). Catalasc (250 U/ml) and SOD 
(150 U/ml) slightly reduced (P = 0.05) the effect of BLM (0.15 units/ml) (Table 4-2). 
When whole blood, which contains catalase in erythrocytes, rather than separated 
lymphocytes was used, H202 at concentrations up to 480 pM was without effect (Table 
4-1). Apo-transferrin was seen to have statistically significant protective effect (Tables 
4-1 and 4-2). The supplementation of the culture medium with foetal calf serum also can 
diminish the effect of oxidative damage induced by H-, O-, (Table 4-1). 
103 
Table 4-1: The protective effects of catalase, apo-transferrin and serum against lymphocyte 
DNA damage induced by hydrogen peroxide (H202) in the comet assay a 
Comets in each grade of damage (average per 100 cells) 
Treatment none 
(55%) 
low 
(>5-20%) 
medium 
(>20-40%) 
high 
(>40-95%) 
complete 
(>95%) 
negative control 90 6.5 2 1.5 0 
4011M H202 14.5 8 2 6 69.5 
40 µM H202 + 250 U/ml catalase° 98 0 0.5 1 0.5 
40 pM H202 + 1.25 pM apo-transferrin° 39.5 12 2.5 5 41 
40 pM H202 + 2.5 pM apo-transferrin° 26.5 13.5 2 4.5 53.5 
negative control 93.5 31 2 0.5 
480 µM H202 + whole bloodb 98 1 0.5 0 0.5 
20 µM HZO2 in PBS(A) 4 31 0 92 
20 gM H202 in RPMI 1640b 5 34 5 83 
20 µM HZO2 in RPMI 1640 + 15% FCS`' b 30 25 10 11 34 
negative control 97.5 2 0 0 0.5 
80 µM H2O2 3 21.5 2 4.5 69 
80 µM H202 + 290 U/ml SODb' d 15.5 1.5 2.5 13 67.5 
' Scored by microscopic examination; b Significant protective effect (p < 0.05); ` Foetal calf serum; d Superoxide dismutase 
Table 4-2: The protective effects of catalase, superoxide dismutase (SOD) and apo-transferrin 
against lymphocyte DNA damage induced by bleomycin (BLM) in the comet assay' 
Comets in each grade of damage (average per 100 cells) 
Treatment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
negative control 94 2.5 1.5 1.5 0.5 
0.15 units/ml BLM 0 0 0 91 9 
0.15 U/ml BLM + 150 U/ml SODb 0 0 10.5 77 12.5 
0.15 U/ml BLM + 250 U/ml catalaseb 0 0 6 90.5 3.5 
0.15 U/ml DIM +5 pM apo-transferrin` 65 18 0.5 3.5 13 
' Scored by microscopic examination; b Weakly reduced effect (p = 0.05); ` Significant protective 
effect (p < 0.05) 
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The modulation of H201- or BLM-induced DNA damage by some exogenous 
antioxidants 
Sodium ascorbate alone produced a clear concentration-related increase in DNA 
damage (Figure 4-3). In combination with H202 there was a small protective effects at 
low concentrations of vitamin C and an exacerbating effect at concentrations above 5 
mM (Table 4-3). With BLM there was only an exacerbating effect of vitamin C at the 
concentrations studied (Table 4-4). 
Table 4-3: The modulating effects of sodium ascorbate (Vit C) on lymphocyte DNA 
damage induced by hydrogen peroxide (H202) in the comet assay a 
Comets in each grade of damage (average per 100 cells) 
Treatment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
negative control 89 7.5 2 0 0 
8011M HZO2 0.5 22.5 12 19 46 
80 µM H2O2 + 40 pM Vit C 5 25 6 14 50 
80 µM H202 + 200 µM Vit Cb 14.5 25 5 21.5 34 
80 µM H202 +1 mM Vit Cb 23.5 17.5 4 14.5 40.5 
80 µM H202 +5 mM Vit C` 0 8.5 14.5 22 54.5 
80jMH2O2+25mMVitC° <1 <1 <1 <1 >95 
' Scored by microscopic examination; b Significant protective effect (p < 0.05); ` Significant 
exacerbating effect (p < 0.05) 
Table 4-4: The modulating effects of sodium ascorbate (Vit C) on lymphocyte DNA 
damage induced by bleomycin (BLM) in the comet assay' 
Comets in each grade of damage (average per 100 cells) 
Treatment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
negative control 91 2 0.5 5 1.5 
0.15 U/ml BLM 0 12 24 43 21 
0.15 U/ml BLM + 250 µM Vit C° 0 0 4 66.5 29.5 
0.15 U/m1 BLM + 500 µM Vit Cb 0 0 0 67.5 32.5 
0.15 U/mI BLM +I mM Vit Cb 0 0 0.5 33.5 66 
Scored by microscopic examination; b Significant exacerbating effect (p < 0.05) 
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Trolox, a more water soluble vitamin E analogue, had no significant effects with 
either H202 or BLM over the concentration range 100 - 400 µM (Table 4-5) or on its 
own (data not shown). 
Table 4-5: The modulating effects of trolox on lymphocyte DNA damage induced by 
hydrogen peroxide (H202) and by bleomycin (BLM) in the comet assay' 
Comets in each grade of damage, average per 100 cells 
Treatment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
40 µM H202 12.5 2.5 2 5 77 
40 µM H202 +100 µM trolox 20.5 2 0.5 2.5 74.5 
40 µM H202 +200 µM trolox 16.5 13 3.5 5.5 61.5 
40 µM H202 + 400 µM trolox 21 8 2 3 66 
0.15 U/ml BLM 17.5 25.5 43 9 5 
0.15 U/m1 BLM + 100 µM trolox 17 26 41 10.5 5.5 
0.15 U/m1 BLM + 200 µM trolox 18 25 42.5 12.5 2 
0.15 U/m1 BLM + 400 µM trolox 18 26.5 41 10 4.5 
' Scored by microscopic examination 
Silymarin significantly lowered the numbers of cells completely damaged by H202 
(Table 4-6) and shifted the spectrum of damage to a lower degree. Silymarin, on its own, 
produced no effect (data not shown). 
Table 4-6: The modulating effect ofsilymarin on lymphocyte DNA damage induced by 
hydrogen peroxide (H2°2) in the comet assay' 
Comets in each grade of damage (average per 100 cells) 
Treatment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
negative control 91 4.5 0.5 3 1 
40 µM H202 4.5 5.5 0.5 1.5 88 
40 pM H202 + 100 pg/ml silymarin ° 6 6.5 3 27 57.5 
' Scored by microscopic examination; b Significant protective effect (p < 0.05) 
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The modulation of H202- or BLM-induced DNA damage by various other agents 
In combination with H202 or BLM, deferoxamine mesylate elicited statistically 
significant protective effects (Table 4-7). Ferrous chloride in combination with BLM 
exacerbated responses (Figure 4-2). Deferoxamine mesylate and ferrous chloride 
produced no significant effect on their own (Table 4-7). Mannitol, and ß-carotene did 
not affect the damage induced by 80 µM of H202 (Table 4-8); similarly mannitol did 
not affect responses induced by BLM (data not shown). Reduced glutathione 
(concentration range 0- 80 µM) and reduced coenzyme II (concentration range 0 
200 µM) did not influence lymphocyte responses to 40 µM H202 (data not shown). 
Table 4-7: The modulating effects of deferoxamine (DFO) on lymphocyte DNA damage 
induced by hydrogen peroxide (H202) and by bleomycin (BLM) in the comet assay' 
Comets in each grade of damage (average per 100 cells) 
Treatment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
negative control 87.5 9.5 2.5 0.5 0 
80µM H202 0 6.5 3.5 5.5 84.5 
80 gM H202 + 200 gM DFO b 13 529 71 
80 µM HZO2 + 400 µM DFO b 15 12 2 12 59 
1.25 mM DFO 96.5 2.5 0 0.5 0.5 
0.15 U/m1 BLM 0 0 0 68.5 31.5 
0.15 U/m1 BLM + 156 µM DFO b 28 33 4 12.5 22.5 
0.15 U/m1 BLM + 312 µM DFO b 52 12.5 3 14.5 18 
0.15 U/m1 BLM + 625 µM DFO b 54 12 3.5 21.5 9 
0.15U/m1BLM+1.25mMDFOb 71 8 2.5 15.5 3 
negative control 94.5 2.5 0.5 2.5 0 
250 µM DFO 92 2.5 1 4 0.5 
10 µg/ml ferrous chloride 92.5 2 1 2.5 1.5 
' Scored by microscopic examination; b Significant protective effect (p < 0.05) 
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Table 4-8: The modulating effect of some agents on lymphocyte DNA damage induced 
by hydrogen peroxide (H202) in the comet assay " 
Comets in each grade of damage (average per 100 cells) 
Treatment none low medium high complete 
(S5%) (>5-20%) (>20-40%) (>40-95%) ' (>95%) 
negative control 97.5 2.0 0 0 0.5 
80 µM H202 3.0 21.5 2.0 4.5 69.0 
80 pM H202 +100 gg/ml mannitol 2.5 14.5 6.5 8.0 68.5 
80 pM H202 +100 pg/ml 0-carotene 3.0 15.5 7.0 7.0 67.5 
" Scored by microscopic examination 
DNA damage induced by doxorubicin 
Dox was able to increase the comet tail moments of cycling human lymphocytes 
significantly whereas it was unable to affect that of Ga lymphocytes (Table 4-9). 
Table 4-9: The effects of doxorubicin on cycling and non-cycling human lymphocytes' 
Doxorubicin level Mean tail moment t SE Median tail moment 
On non-cycling cells b 
negative control 7.83 ± 1.99 1.70 
0.2 µM 6.99 ± 1.98 1.22"' 
0.4 µM 7.46: h 2.04 2.04"' 
0.8 µM 7.32 ± 2.49 2.49" 
On cycling cells 
negative control 5.36 ± 1.82 0.99 
1.25 µM 9.17±2.01 2.04* 
2.5 µM 10.85 f 2.21 2.55*** 
5.0µM 18.17±3.20 2.89*** 
' 100 comets scored for each treatment; b3 hr treatment before initiating cycling - 68 hr 
incubation; ` 20 hr treatment after 48 hr initiating cycling - 68 hr incubation; 
°` = not significant; *=p<0.05; *** =p<0.001 (Mann-Whitney test on median values) 
108 
The reproducibility of the microscopic examination and the interindividual 
differences in cellular response to H202 and to BLM 
In Table 4-10, negative and positive control data for two donors used in the studies are 
presented. The negative control data showed consistency between the two donors 
[Donor A is a female (43 yrs) smoker, Donor B is a male (23 yrs) non-smoker], high 
reproducibility between experiments and good quality of the lymphocytes with a low 
level of background damaged cells. After H202 treatment, there was also consistency 
between the donors showing about 70% of cells being completely damaged. After BLM 
treatment, however, some differences between the donors were evident. For example, 
the number of highly susceptible lymphocytes (the complete category) in donor A varies 
greatly while it is relatively stable in donor B. 
Table 4-10: The reproducibility of the microscopic examination and the interindividual differences 
of donor in cellular response to hydrogen peroxide (H202) and to bleomycin (BLM) 
Comets in each grade of damage, average per 100 cells 
Donorb Compound- none low medium high complete No. of 
concentration level (>5%) (>5-20%) (>20-40%) (>40-95%) (>95%) expts 
A negative control 89.414.3 6.2±3.3 2.0± 1.3 1.8±1.6 0.64±0.96 5 
B negative control 93.213.1 3.4 f 1.9 0.87 ± 0.96 1.9 ± 1.7 0.63 f 0.89 8 
A H202-40µM 11.1± 8.5 6.7±4.6 2.0±1.1 5.8±5.1 74.3±13.2 11 
B H202-40µM 13.9±6.6 7.7±4.0 2.4±2.4 8.616.0 67.4±132 5 
A BLM-0.15 U/ml 4.7±7.4 9.1±11.2 17A 120.3 24.4±27.5 44.3 ± 45.8 5 
B BLM-0.15 U/ml 0 3.0±5.6 6.3±11.1 71.5± 19.7 19.3±9.0 4 
' Presented as mean ± standard deviation; b Donor A-43 yrs old female smoker, donor B-23 yrs old male non- 
smoker; ` Two or more slides examined in each experiment, all experiments carried out at different times 
independently 
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4.3.1.2 DNA damage induced by aromatic amines and food mutagens and its 
modulation by various agents 
In the cellular environment, as the substrates of cytochrome P-450, oxidases and 
peroxidases, aromatic amines and food mutagens can be involved in 
oxidative/reductive metabolic processes leading to ROS production (Aeschbacher and 
Turesky, 1991; Goeptar et al, 1995; Mondovi et al, 1988; O'Brien, 1984; Sato et al, 
1992). Two classic aromatic amines m-phenylenediamine (m-PDA) and 2- 
aminofluorene (2-AF) were investigated in this study. 
The effects of m PDA and 2 -AF on human lymphocytes 
Tables 4-11 to 4-13 and Figure 4-4 show that both m-PDA and 2-AF induced 
significant DNA damage in separated human lymphocytes, either at high concentrations 
or following prolonged incubation, with or without metabolic activation by mammalian 
(S9) or plant activating mixtures (TX1MX). 
At lower concentrations (Tables 4-11 and 4-13, Figure 4-4) and shorter incubation times 
(Table 4-11), however, the effects of both 2-AF and m-PDA were insignificant. The 
presence of S9 reduced the toxicity of 2-AF (1 mM) towards lymphocytes, while 
showed no effects on the toxicity of m-PDA over the concentration range of 0.1 - 10 
mM (Table 4-11). The plant activating mixture TX1MX alone did not cause any 
damaging effect (data not shown), and it reduced the DNA-damaging effects of both m- 
PDA and 2-AF in separated human lymphocytes (Figure 4-4, a and b). The 
simultaneously conducted trypan blue exclusion test also showed that TX1MX reduced 
the cytotoxicity of 2-AF (the cell viability of the culture of the 5 mM concentration with 
TX1MX was the same as the control culture at - 95% after 4 hr incubation while that 
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without TX1MX was only 30%). m-PDA was largely non-toxic with or without 
TX1MX (the cell viability of the culture of the 5 mM concentration with/without 
TX1MX was the same as the control culture at - 95% after 4 hr incubation). 
Table 4-11: DNA damage induced in human lymphocytes by m-phenylenediamine 
(m-PDA) and 2-aminofluorene (2 AF) A 
_S9 +S9 
Median tail moment Significance Median tail moment Significance 
Treatment values for 25 comets level b values for 25 comets level b 
negative control 0.32 0.79 
1 µM 2-AF 0.44 ns 0.83 ns 
10 µM2-AF 0.97 ns 0.45 ns 
100 gM 2-AF 0.50 ns 0.96 ns 
1 mM 2-AF 5.91 *** 2.18 ns 
100 gM m-PDA 0.52 ns 0.74 ns 
500 µM m-PDA 0.73 ns 1.43 ns 
1 mM m-PDA 0.52 ns 0.88 ns 
10 mM m-PDA 0.90 ns 1.17 ns 
' Cells treated for ihr at 37° C, with or without S9 activation; 
b Compared with respective negative 
control; ns = not significant; *** =p<0.001 
Table 4-12: DNA damage induced by 2-aminofluorene (2 AF) in 
human leucocytes in peripheral blood' 
Median tail moment Significance level b 
Treatment values for 50 comets 
negative control 2.51 
200 µM 2-AF 3.30 ns 
400 µM 2-AF 4.80 
800 µM 2-AF 5.94 
' After 1 hr incubation at 37°C; b Compared the negative control; 
ns = not significant; ***=p<0.001 
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Table 4-13: DNA damage induced by 2-aminofluorene (2 AF) in human lymphocytes' 
-TX1MX +TX1MX 
Median tail moment significance Median tail moment significance 
Treatment values for 25 comets level b values for 25 comets level b 
negative control 0.86 0.67 
10 µM 2-AF 0.81 ns 0.70 ns 
20 µM 2-AF 0.93 ns 0.81 ns 
40 µM 2-AF 0.74 ns 0.87 ns 
80 µM 2-AF 2.63 *** 1.18 
160 µM 2-AF 13.55 *** 12.35 *** 
' After 2 hr incubation at 37°C with or without 50% TX1MX; b Compared with respective negative 
control; ns = not significant; * =p < 0.05; *** =p < 0.001 
Figure 4-4: DNA damage induced in human lymphocytes by m-phenylenediamine 
(m-PDA) and 2-aminofluorene (2-AF)' 
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The effects of PUP, IQ and Trp-P-2 on human lymphocytes and HT29 cells 
The food mutagens used in the study were 2-amino-l-methyl-6-phenylimadazo(4,5- 
b)pyridine (PhIP), 2-amino-3-methylimidazo-(4,5-f)quinoline (IQ) and 3-amino-l- 
methyl-5H-pyrido(4,3-b)indole (Trp-P-2). 
The experiments showed that PhIP was able to induce significant DNA damage in both 
human lymphocytes (Tables 4-14 to 4-16) and in cultured HT29 cells (Table 4-17) at 
various concentrations (6 - 2000 µg/m1) with or without S9 activation. The DNA 
damage induced by IQ was also significant but much smaller compared with that 
induced by PUP (Table 4-14). Trp-P-2 also induced significant DNA damage at 200 
pg/ml (Experiment N, Table 4-17). 
The effects of S9, catalase, silymarin and DFO on the genotoxic activity of PhIP 
The damage induced by PUP on human lymphocytes was significantly reduced by the 
presence of catalase (Tables 4-15) and by the presence of S9 or silymarin, but not by 
deferoxamine in HT29 cells (Table 4-17). It was shown that the presence of proteinase 
K in the lysing solution was able to enhance the expression of DNA damage in the 
comet assay system (Tables 4-15). In Experiment II in Table 4-17, PhIP induced much 
higher level of damage on HT29 cells when compared with data derived from similar 
treatments in other experiments (Table 4-17). 
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Table 4-14: DNA damage induced by PhIP in human lymphocytes 2 
Experiment 1 Experiment 2 
Treatment Median tail moment Significance Median tail moment Significance 
values for 50 comets level b values for 50 comets level 
b 
S9 control 0.78 0.87 
2 µg/ml PhIP + S9 0.48 ns 1.18 ns 
10 pg/ml PhIP + S9 4.21 *** 3.04 *** 
50 gg/ml PhIP + S9 11.47 *** 8.71 *** 
5 gg/ml IQ + S9 0.68 ns 0.86 ns 
25 µg/ml IQ + S9 1.12 ns 1.68 
125 gg/ml IQ + S9 1.62 1.53 
' After 2 hr incubation at 37°C; b Compared with the S9 control; 
ns = not significant; *=p<0.05; ** =p<0.01; *** =p<0.001 
Table 4-15: DNA damage induced by PhIP in human lymphocytes: Influence of 
catalase and proteinase K' 
Median tail moment 
Treatment and lysing conditions values for 50 comets b 
negative control in normal lysing solution 13.35 
negative control with proteinase K in lysing solution 36.19(***l 
125 pg/ml PhIP in normal lysing solution 49.92*** 
125 µg/ml PhIP with proteinase K in lysing solution 81.74***(***l 
125 pg/ml PhIP + 1250 U/ml catalase in normal lysing solution 13.09(***) 
125 pg/ml PhIP + 1250 U/ml catalase with proteinase K in lysing solution 21.53(***) 
(*1 
' After 0.5 hr incubation with or without catalase and with or without the presence of proteinase K in 
the lysing solution; b Compared with respective negative control or corresponding treatment; *=p< 
0.05; *** =p<0.001; no parenthesis = the effect of PhIP; (*) = the effect of catalase; *ý = the post- 
treatment effect of proteinase K in the lysing solution 
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Table 4-16: DNA damage induced by food mutagen PhIP in human lymphocytes 
Experiment I Experiment 2 
Median tail moment Significance Median tail moment Significance 
Treatment values for 50 comets level b values for 50 comets level b 
S9 control 0.6 1.0 
6.25 µg/mlPhIP+S9 3.3 *** 6.5 *** 
12.5 µg/mlPhIP+S9 6.4 *** 8.2 *** 
25 µg/ml PhIP + S9 9.8 *** 10.0 
50 pg/mlPUP+S9 9.2 *** 9.4 *** 
100 gg/mlPhIP+S9 9.1 *** 10.9 *** 
' After 1 hr incubation at 37°C; b Compared with the S9 control; ***=p<0.001 
Table 4-17: DNA damage induced by food mutagens and the modulation of damage 
by deferoxamine and silymarin in HT29 cells 
Median tail Median tail 
Treatment moments b Treatment moments b 
Experiment I Experiment II 
negative control 5.23 S9 control 2.00 
125 jig/nil PhIP 6.49 6.25 µg/ml PhIP + S9 12.27*** 
500 µg/ml PhIP 14.25** 12.5 gg/ml PhIP + S9 15.46*** 
2000 µg/ml PhIP 20.51*** 25 gg/ml PhIP + S9 26.26*** 
S9 control 1.67(*) 50 µg/ml PhIP + S9 34.18*** 
125 µg/ml PhIP + S9 8.23("')*** 100 gg/ml PhIP + S9 36.97*** 
500 µg/ml PhIP + S9 3.43(***)* 
2000 gg/ml PhIP + S9 8.08(***)*** 
Experiment III Experiment IV 
S9 control 1.51 S9 control 0.92 
0.8 mM DFO `+ S9 0.63 25 µg/ml PhIP + S9 6.89* 
0.8 mM SIL d+ S9 1.07 50 pg/ml PhIP + S9 6.69*** 
PhIP' + S9 7.16*** 100 pg/ml PhIP + S9 11.65*** 
PhIP' + 0.2 mM DFO + S9 4.2l'n" 200 pg/ml PhIP + S9 5.59*** 
PhIP' + 0.4 mM DFO + S9 10.351"'1 25 pg/ml Trp-P-2 + S9 1.98"" 
PhIP' + 0.8 mM DFO + S9 5.611"' 50 pg/ml Trp-P-2 + S9 1.191's 
PhIP e+0.2 mM SIL + S9 4.82 100 µg/ml Trp-P-2 + S9 0.95"' 
PhIP' + 0.4 mM SIL + S9 2.41 ***1 200 pg/ml Trp-P-2 + S9 4.57*** 
PhIP`+0.8mMSIL+S9 1.44(***1 
' After 1 hr incubation at 37°C; b Compared with res ective control; ' DFO - deferoxamine; L 
" SIL = silymarin; ' 50 pg/ml; (*) = the effect of S 9; *1= the effect of DFO/SIL; not significant; 
*=p<0.05; **=p<0.01; ***=p<0.001 
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4.3.1.3 DNA damage in human lymphocytes induced by benzene and its 
metabolites determined using the comet assay 
There were various treatment regimens for this study of benzene and its metabolites, 
and their effect on lymphocytes was very dependent upon the experimental 
conditions. Also two slide-scoring methods were used since a computer was not 
available at the commencement of these studies. 
Genotoxic effects of benzene and its metabolites in the absence of metabolic 
activation: analysis by microscopic examination 
Table 4-18: The DNA-damaging effects of benzene and some of its metabolites in 
human lymphocytes in the comet assay' 
Treatment 
Comets in 
Experiment none 
(55%) 
each grade of damage (averaged per 100 cells) 
low medium high complete 
(>5-20%) (>20-40%) (>40-95%) (>95%) 
Control (PBS) I 95 3 1 1 0 
II 95.5 3.5 1 0 0 
III 92.5 3.5 1.5 2.5 0 
H2O2 40µM Ib 9.5 2.5 5.5 27.5 56.5 
II b 4 6 6.5 39 44.5 
Benzene 100 µM II 96.5 1.5 0 1.5 0.5 
III 94.5 3.5 1 1 0 
Muconic acid 100 pM II 95.5 1.5 2 1 0 
Hydroquinone 100 µM I 96 4 0 0 0 
IIIb 76 24 0 0 0 
Catechol 100 µM Ib 61 26.5 6 4 2.5 
IIIb 7.5 72 15.5 5 0 
Benzoquinone 100 µM I 100 0 0 0 0 
III 98.5 0.5 0.5 0.5 0 
Benzenetriol 100 µM II" 3.5 11 6 25.5 54 
III b 0 5.5 3 25 66.5 
' After 0.5 hr incubation at 37°C, values are scored by microscopic examination from duplicate slides, 
b I, II and III are independent studies; Significantly different from corresponding controls (p < 0.001) 
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Table 4-18 shows the effects of benzene and its metabolites, namely muconic acid, 
hydroquinone, catechol, benzoquinone and benzenetriol on human lymphocytes without 
metabolic activation. Hydrogen peroxide was used as a positive control. Benzene and its 
metabolites were all tested at 100 µM, at which concentration catechol had a moderate 
effect and benzenetriol a strong effect. In only one of the two experiments hydroquinone 
showed a significant increase in the number of comets in low damage category. These 
responses were significantly different (p < 0.001) by comparison with the corresponding 
controls. p-Benzoquinone was also tested at 1 mM but appeared inactive (data not 
shown). However, it induced morphological changes, producing condensed round nuclei 
of a smaller size with a brighter central area but with no migration of DNA (see also tail 
moment values in Table 4-23). 
Genotoxic effects of benzene and its metabolites in the presence of metabolic 
activation: analysis by microscopic examination 
Table 4-19 shows the effects of benzene (at 100 µM and at 2.4 mM) and its 
metabolites (BQ and BT, at 100 µM) in the presence and absence of S9 mix following 
exposure of human lymphocytes for 0.5 hr. S9 mix alone acted as the control and had 
no effect. Benzene was inactive in the presence of S9 mix even when tested at 
2.4 mM. In the absence of S9 mix there was a weak, but statistically significant, 
response (p < 0.05). (However, in Table 4-18 there was no response of benzene at 
100 µM in the absence of S9 mix when compared with its corresponding control). The 
damage due to benzenetriol was statistically significant (p < 0.001) by comparison 
with the corresponding control. This was greatly reduced in the presence of S9 mix. In 
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contrast, p-benzoquinone became active in the presence of S9 mix. This difference 
was also statistically significant (p < 0.001) by comparison with the control slides. 
Table 4-19: The genotoxic effects of benzene and some of its metabolites in human 
lymphocytes in the comet assay with and without metabolic activation (S9 mix) 
Comets in each grade of damage (average per 100 cells) 
Treatment Experiment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
S9 control I 98.5 0 0.5 0.5 0.5 
II 99.5 0.5 0 0 0 
Benzene 100 µM + S9 b 100 0 0 0 0 
Benzene 100 µM - S9 ° 94.5 3.5 1 1 0 
Benzene 2.4 mM + S9 II °' 98.5 0.5 0 1 0 
Benzene 2.4 mM- S9 d 97 2.5 0 0.5 0 
Benzenetriol 100 µM + S9 I°d 95 2.5 0.5 2 0 
II'" 79 16 3 2 0 
Benzenetriol 100 µM - S9 I` 0 5.5 3 25 66.5 
II ` 0 2.5 5.5 14.5 77 
Benzoquinone 100 µM + S9 IN C 22 75 2.5 0.5 0 
IIb'` 31.5 36 7 25 0.5 
Benzoquinone 100 µM - S9 I "` 98.5 0.5 0.5 0.5 0 
II°' 99 0.5 0.5 00 
I and II are independent experiments, treatment was carried out at 37°C for 0.5 hr 
' Values are scored by microscopic examination from duplicate slides; b Significantly different from 
each other with or without S9 mix (p < 0.001); ` Significantly different from corresponding controls 
(p < 0.001); d Significantly different from corresponding controls (p < 0.05); " Not significantly 
different from each other with and without S9 mix (p z 0.05) 
Genotoxic effects of benzenetriol and H202 in cycling and non-cycling lymphocytes: 
analysis by microscopic examination 
Table 4-20 shows the genotoxic effects of benzenetriol and H202 in cycling and non- 
cycling cells. Whilst damage was produced by each agent in both cycling and non- 
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cycling cells, there was a shift (p < 0.001) in the response towards less damage in 
cycling cells by comparison with non-cycling cells for H202 and BT with the exception 
of experiment II for H202 at 40 µM, in which the shift was not statistically significant. 
Table 4-20: Influence of catalase and cell cycling on the genotoxic effects of hydrogen 
peroxide (H2O2) and benzenetriol (BT) towards human lymphocytes in the comet assay 
Comets in each grade of damage (average per 100 cells) 
Treatment Experiment none low medium high complete 
(55%) (>5-20%) (>20-40%) (>40-95%) (>95%) 
Non-cycling cell control I 97.5 2.5 0 0 0 
H 95.5 3 2.5 0.5 0.5 
Cycling cell control I 91 8.5 0 0.5 0 
Non-cycling cell + 20 . tM H202 1b, ` 4.5 1.5 1 5 88 
Cycling cell + 20 µM H202 I" 0 5 7.5 34.5 53 
Non-cycling cell + 40 µM H202 I b, ` 1.5 1 5 15.5 77 
IIb, (ns) 1.5 2 2 11 92.5 
Cycling cells + 40 µM H202 I° 0 1 3 42.5 53.5 
II" 0 0.5 0.5 18.5 80.5 
Non-cycling cells + 100 µM BT II "' ` 0 0.5 3 27 69.5 
Cycling cells + 100 µM BT II b 0 2.5 6.5 62 29 
Non-cycling cells + 100 µM BT 1I °' 97.5 2.5 000 
+ catalase (250 U/ml) 
Cycling cells + 100 µM BT + II °' 95.5 3 1.5 0.5 0.5 
catalase (250 U/nil) 
I and II are independent experiments, treatment was carried out at 37°C for 0.5 hr 
' Values are scored by microscopic examination on duplicate slides; b Significantly different from 
corresponding controls (p < 0.001); ` Significantly different from each other - cycling and non-cycling 
cells (p < 0.001); " Not significantly different from corresponding controls; (") Not significantly different 
from each other - cycling and non-cycling cells 
Effects of catalase on the genotoxic activity of benzenetriol: analysis by microscopic 
examination 
In the presence of catalase (250 units/ml), the effects of benzenetriol in cycling and non- 
cycling lymphocyte cells was abolished (Table 4-20). 
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Genotoxic effects of H202, benzenetriol and catechol: analysis by computer 
A 0.5 hr treatment on human lymphocytes with H202, benzenetriol and catechol without 
metabolic activation (Table 4-21), after scoring using a computer, confirmed positive 
results observed by microscopic examination. However, metabolic activation was also 
used and S9 mix reduced markedly the genotoxic responses induced by all three 
compounds. 
Table 4-21: Effects of hydrogen peroxide, benzenetriol and catechol on human lymphocytes' 
Experiment 1 Experiment 2 
Treatment Median tail moment Significance Median tail moment Significance 
values for 50 comets level b values for 50 comets level b 
Hydrogen peroxide 
S9 control 0.29 
20 µM - S9 57.87 *** 
10µM+S9 0.19 ns 
20µM+S9 0.24 ns ***ý 
Catechol 
S9 control 0.41 0.24 
100 µM - S9 0.65 ns 1.77 
200 tM - S9 2.33 *** 4.00 *** 
100 µM + S9 0.45 ns (*) 0.39 ns** 200. tM+S9 0.19 ns(***) 0.55 ns ***ý 
Benzenetriol 
S9 control 0.41 0.24 
100 Jim - S9 44.20 *** 48.50 *** 
200 µM - S9 51.80 *** 57.70 *** 
100. tM+ S9 0.78 ns ***ý 1.40 *** ***ý 200 µM + S9 1.30 ******ý 1.65 ******ý 
' Comet assay - 0.5 hr treatment at 37°C, scored by co mputer; 
b Compared with respective control; 
ns = not significant; *=p < 0.05; ***=p<0.001; () = difference with and without metabolic activation. 
Genotoxic effects of benzene and its metabolites on human lymphocytes after 
prolonged treatment: analysis by computer 
Not only were experiments conducted with longer treatment times but also at higher 
concentrations because some of the benzene metabolites failed to show a positive effect. 
Table 4-22 shows the effects of a1 hr treatment of benzene and various metabolites. In 
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both the presence and absence of S9 mix, benzene produced a statistically significant 
response at 12 mM (p < 0.001). The presence of S9 mix increased the genotoxic effect 
of benzene (12 mM) significantly (p < 0.001). In contrast, muconic acid, hydroquinone 
and benzoquinone did not elicit a positive effect, except at the top concentration of 
hydroquinone in the absence of S9 mix (p < 0.05), but this was not of toxicological 
importance due to lack of damaged cellular nuclei on the slides by visual examination 
under microscope. 
Table 4-22: The effects of benzene and some of its metabolites on human lymphocytes 
Experiment 1 Experiment 2 
Median tail moment Significance Median tail moment Significance 
Treatment values for 50 comets level b values for 50 comets level b 
Benzene 
Control 0.48 0.75 
2.4 mM - S9 0.49 ns 0.85 ns 
12 mM - S9 16.00 *** 5.41 *** 
2.4 mM + S9 0.37 ns 0.53 ns 
12mM+S9 
i 
64.20 ***(`) 68.65 ***(`) 
Mucon c acid 
Control 0.54 0.99 
100 µM - S9 0.51 ns 0.82 ns 
400 µM - S9 0.44 ns NA NA 
880 µM - S9 0.14 ns 1.11 ns 
100 µM + S9 0.44 ns 0.59 ns 
200 µM + S9 0.30 ns NA NA 880 µM + S9 
d i 
0.71 ns 1.06 ns 
ro u none Hy 
S9 control 0.10 0.06 
100µM-S9 0.11 ns 0.15 ns 
200 µM - S9 0.29 ns 0.18 
100 µM + S9 0.17 ns 0.09 ns 
200 µM + S9 
B i 
0.23 ns 0.19 ns 
enzogu none n- 
S9 control 0.10 0.06 
100 µM - S9 0.30 ns 0.22 ns 
200 pM - S9 0.12 ns 0.13 ns 
100 pM + S9 0.08 ns 0.11 ns 
200 pM + S9 0.07 ns 0.07 ns 
' Comet assay after a1 hr treatment with or without metabolic activation, scored by computer; b Compared 
with respective control; (c) Significantly different from without S9 (p < 0.001) 
*=p<0.05; ***=p<0.001 significantly different from corresponding controls; NA = not available 
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When treatment times were increased from 0.5 and 1 hr to 2 and 4 hr (Table 4-23), in 
the presence of S9, muconic acid, hydroquinone, catechol and benzoquinone, showed 
effects at high concentrations and, in general, greater effects at 4 hr than 2 hr. There 
were some differences in the degree of response between the repeat experiments, with in 
some cases no effect being seen (e. g. benzoquinone 2 hr Experiment 2). Experiments for 
2 and 4 hr treatments were not conducted without S9 mix. At the highest concentration 
(4 mM) in the case of benzoquinone, the morphology of the cellular nuclei was affected 
showing a small compact core physically reduced in area (by average 26%) with no 
comets. 
Table 4-23: The genotoxic effects of some benzene metabolites on human lymphocytes °b 
2 hr incubation 4 hr incubation 
Treatment Experiment 1 Experiment 2 Experiment I Experiment 2 
S9 control 0.20 0.07 0.41 0.25 
0.14 mM + S9 0.23 0.19 0.51 0.05 
0.28mM+S9 0.38 0.11 1.15*** 0.32*** 
0.56mM+S9 2.20*** 0.05 12.91*** 1.18*** 
1.12 mM + S9 NA 49.6*** NA NA 
Hydroquinone 
S9 control 0.16 0.15 0.16 0.16 
0.5 mM + S9 0.25 0.37* 0.37* 25.85*** 
1.00 mm + S9 0.80* 0.54*** 0.54*** 55.65*** 
2.00 mM+ S9 5.85*** NA NA 58.99*** 
Catechol 
S9 control 0.34 0.26 0.13 0.15 
0.5 mM + S9 0.33 0.39* 15.10*** 29.75*** 
1.00mM+S9 2.46*** 14.76*** 36.67*** 45.61*** 
2.00mM+S9 27.78*** 50.10*** 38.34*** 44.91*** 
Benzoguinone 
S9 control 0.11 0.11 0.49 0.17 
0.5mM+S9 0.82*** 0.12 3.48*** 7.82*** 
1.00 mm + S9 0.78*** 0.10 4.63*** 0.13 
2.00mM+S9 0.73*** 0.20 7.93*** 0.00 
4.00mM+S9 0.18 0.14 0.19 0.00 
' Comet assay - after a2 hr or 4 hr treatment at 37°C with or without metabolic activation, scored by 
computer; b Showing median tail moment values, each represents 50 comets 
NA = not available; *=p<0.05; ***=p<0.001 significantly different from corresponding controls 
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The consistency of S9 control in the computer-analysed experiments 
Table 4-24 shows the extent of variability, when computer analysis was utilised, for 
controls with S9 mix only. Among all the S9 controls, there is some statistically 
significant variability (Kruskal-Wallis test on all S9 control data, p<0.001) arisen from 
the treatment regimen (i. e. time). In contrast, within treatment times no significant 
variability was seen. Responses in the different experiments (Tables 4-21 to 4-23) are 
relatively consistent. A t-test on the median tail moment values from 2 and 4 hr also 
showed no significant difference between the two treatment times for S9 controls. 
Table 4-24: The consistency of computer-scored comet assays' 
Treatment times Median tail moment values 
(result of significant test on tail moment values) for 50 comets in the S9 controls 
0.5 hr 0.29 
(no significant difference between 3 experiments) 0.24 
0.41 
I hr 0.06 
(no significant difference between 2 experiments) 0.10 
2 hr 0.11 
(no significant difference between 8 experiments) 0.11 
0.34 
0.26 
0.15 
0.16 
0.20 
0.07 
4hr 0.49 
(no significant difference between 8 experiments) 0.17 
0.13 
0.15 
0.16 
0.16 
0.41 
0.25 
' Kruskal-Wallis test on individual tail moment values of S9 controls within each treatment time 
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4.3.2 Bacterial mutations induced by food mutagens: modulation by 
flavonoids 
A preliminary Ames test (Table 4-25) with a single plate per concentration determined 
the concentrations to be used in the principal studies. At 1 pg/plate, both Trp-P-2 and IQ 
induced high number of revertant colonies. It was decided not to use a higher 
concentration in the main studies in case that flavonoids (silymarin and myricetin) 
would only have weak modulating effects, and higher concentrations of food mutagens 
would compromise such modulating effects. Silymarin was non-mutagenic but 
myricetin, at the higher concentrations, displayed a clear positive response which was, 
however, orders of magnitude lower than that elicited by the food mutagens. Values of 
1 µg/plate Trp-P-2 and IQ and 10,100 and 1000 µg silymarin and myricetin were 
chosen for the main studies. 
Table 4-25: Preliminary analysis of the mutagenic potential of food mutagens (Trp- 
P-2 and IQ) andflavonoids (silymarin and myricetin) in the Ames test °' b 
Treatment Revertant colonies Treatment Revertant colonies 
Negative control 1 50 1 µg Trp-P-2 3643 
Negative control 2 49 5 µg Trp-P-2 1561 
25 µg Trp-P-2 1647 
1 µg Silymarin 43 125 µg Trp-P-2 3017 
10µg Silymarin 50 1 µg PhIP 1023 
100 µg Silymarin 59 5µg PhIP 2157 
500 µg Silymarin 48 25 µg PhIP 2984 
1000 µg Silymarin 78 125 µg PhIP 3755 
1000 µg Silymarin 54 625 µg PhIP 3324 
1 µg Myricetin 56 1 µg IQ 3728 
10 µg Myricetin 91 5µg IQ 3001 
100 µg Myricetin 166 25 µg IQ 3076 
500 µg Myricetin 232 125 µg IQ 1087 
1000 µg Myricetin 278 625 µg IQ 794 
a S. typhimurium strain TA98 + S9 mix (18% v/v), from rats treated with Aroclor 1254,72 hr 
incubation at 37°C; b Single plate per observation 
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Table 4-26: The effect offlavonoids silymarin and myricetin on the mutagenicity of the 
food mutagens Trp-P-2 and IQ in the Ames test' 
Revertant colonies per plate (mean ± SD) 
Treatment Study 1 Study 2 
Negative control 54 ±8 45: h 2 
1 µg Trp-P-2 3606 ±260** 3647±15O** 
1 µg IQ 3674 ± 52*** 3702± 109*** 
Trp-P-2 + 10 µg Silymarin 3762 ± 106***(15) 3774 ± 50***() 
Trp-P-2 + 100 µg Silymarin 3654 f 456*("s) 3628 ± 77***() 
Trp-P-2 + 1000 pg Silymarin 1188 ± 63**(***) 1210 t 164*(***) 
Trp-P-2 + 10 pg Myricetin 3400 f 138**() 3427±47***(' ) 
Trp-P-2 + 100 µg Myricetin 527 ± 9***(**) 527 ± 36**(***) 
Trp-P-2 + 1000 µg Myricetin 378 ± 8***(**) 378 ± 20**(***) 
IQ + 10 µg Silymarin 3433 ± 55***(*) 3419± 117**() 
IQ + 100 jig Silymarin 3505 ± 21***(*) 3496 ± 62***(***) 
IQ+ 1000 pg Silymarin 2650± 104**(***) 2642± 12***(***) 
IQ + 10 pg Myricetin 3387 f 356*( 3370 ± 119**() 
IQ + 100 µg Myricetin 1738 ± 71**(***) 1744 ± 549*) 
IQ+1000µgMyricetin 389±17**(***) 389±6***(**) 
10µg Silymarin 60 ± 4°' 
100 pg Silymarin 61 ± 2' 
1000 µg Silymarin 76 ± 1" 
10µg Myricetin 90± 6* 
100 µg Myricetin 15816** 
1000 pg Myricetin 315 ± 30* 
OS not significant; *p<0.05; ** p<0.01; ***p<0.001 by comparison with the negative control or in 
parenthesis by comparison with food mutagen alone. Since there are only three plates per observation the 
t-test tends to be insensitive. The statistical results of ANOVA are given below: 
Analysis of variance : F-statistic (F3,5) 
Treatment factors Trp-P-2 IQ 
Silymarin Study 1 21.29 49.06 
Study 2 106.02 29.03 
Myricetin Study 1 143.11 69.66 
Study 2 480.86 28.80 
All values statistically significant: p<0.001 
S. typhimurium strain TA98 + S9 mix (18% v/v), from rats treated with Aroclor 1254; b From 
triplicate plates; ° Analysis by Student t-test. 
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The effects of silymarin and myricetin on the mutagenicity of Trp-P-2 and IQ are 
shown in Table 4-26. Responses in the preliminary test (Table 4-25) and the first of 
the main studies (Table 4-26) showed that myricetin was mutagenic, whereas at the 
treatment levels used silymarin was devoid of mutagenicity. Both silymarin and 
myricetin statistically significantly reduced the mutagenicity of Trp-P-2 and IQ, as 
shown with the two-sample t-test and analysis of variance. This occurred in the 
absence of any toxicity as measured by a survival assay for Salmonella typhimurium 
(strain TA98) on complete medium (Table 4-27). 
Table 4-27: Salmonella typhimurium survival assay on complete medium'' b, 
Treatment Colony counts 
Control 1 687 
Control2 886 
1 mg Myricetin 888 
1 mg Myricetin +1 gg Trp-P-2 854 
1 mg Myricetin +1 µg IQ 843 
1 mg Silymarin 982 
1 mg Silymarin +1 µg Trp-P-2 620 
I mg Silymarin + 1µg IQ 799 
' BHI medium = brain heart infusion medium 
b Cell suspension was diluted to 10-3 
Single plate per observation 
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4.3.3 Chromosomal aberrations induced by doxorubicin 
4.3.3.1 Results with Giemsa staining method 
The effects of Dox on chromosomal aberrations 
A preliminary study (data not shown) revealed a concentration-related increase of 
chromosomal aberrations in human lymphocytes treated with Dox (0 -8 µM) before 
the PHA stimulation. It was also observed that Dox concentration levels greater than 
0.4 µM had an inhibitory effect on cell cycling. Table 4-28 shows that statistically 
significant concentration-related responses were observed in the study with Dox 
treatment before initiation of cycling followed by 48 hr incubation (as in the 
preliminary study) and with a 20 hr treatment, 48 hr after initiation of cycling. 
Table 4-28: Chromosomal aberrations induced by doxorubicin in human lymphocytes 
Doxorubicin 
concentration 
Metaphases 
scored 
Aberrant 
cells 
Gg cfm c/c CFM DR X CAs per 
metaphase 
Stud y 
negative control 100 4 4 0 0 0 0 0 0.04 
0.2 µM 100 53*** 42 32 0 0 0 0 0.74 
0.4 µM 100 55*** 43 49 7 7 0 0 1.06 
0.8 µM 12 b 7*** 7 7 0 0 0 0 1.17 
Stud y2c 
negative control 150 4 4 0 0 0 0 0 0.03 
0.1 µM 150 80*** 82 37 4 8 2 0 0.89 
0.2 µM 150 86*** 94 63 6 4 0 2 1.15 
0.4 µM 150 78*** 62 76 9 9 1 1 1.05 
'3 hr treatment before initiating cycling - 48 hr incubation; 
b Small number of metaphases available 
for scoring; ` 20 hr treatment after 48 hr initiating cycling - 68 hr incubation 
aberrant cells metaphases with at least 1 chromosomal aberration 
Gg chromatid and chromosome gaps 
cfm chromatid breaks and fragments 
c/c interchanges 
CFM chromosome breaks and fragments 
DR dicentrics and rings 
X> 10 aberrations in one metaphase 
CAs chromosomal aberrations 
*+* =p<0.001 (Fisher's Exact Test) 
127 
The effects of silymarin on doxorubicin-induced chromosomal aberrations 
Table 4-29 shows the effects of silymarin on Dox-induced chromosomal aberrations 
in human lymphocytes. Silymarin afforded no protection against the Dox-induced 
chromosomal aberrations. At the highest concentration of Dox, the presence of 
silymarin caused a modest increase (p = 0.08) of the damage induced by Dox. 
Silymarin alone induced a statistically significant increase (p < 0.01) in chromosomal 
aberrations. 
Table 4-29: Chromosomal aberrations induced by doxorubicin and their modulation by 
silymarin in peripheral human lymphocytes' 
Doxorubicin 
concentration 
Metaphases 
scored 
Aberrant 
cells 
Gg cfm c/c CFM DR X 
CAs per 
metaphase 
negative control 150 4 4 0 0 0 0 0 0.027 
0.1 µM 150 80*** 82 37 2 8 2 0 0.887 
0.2 µM 150 86*** 94 63 6 10 0 2 1.153 
0.4 µM 150 78*** 62 71 9 9 1 1 1.047 
SIL b 150 16** 13 3000 0 0.107 
0.1 µM+SIL 150 73***( 54 41 480 0 0.713 
0.2 pM+SIL 150 70***() 70 50 5 10 0 0 0.90 
0.4 µM+SIL 150 91***(-) 104 80 28 20 0 3 1.547 
' 20 hr treatment after initiating 48 hr cycling - 68 hr incubation; 
b SIL =10 pM silymarin 
Aberrant cells metaphases with at least 1 chromosomal aberration 
Gg chromatid and chromosome gaps 
cfm chromatid breaks and fragments 
c/c interchanges 
CFM chromosome breaks and fragments 
DR dicentrics and rings 
X > 10 aberrations in one metaphase 
CAs chromosomal aberrations 
°' = p; -> 
0.05; ** =p < 0.01; *** =p <0.001; compared with negative control or in parenthesis 
compared with corresponding doxorubicin concentration without silymarin (Fisher's Exact Test) 
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4.3.3.2 Results with FISH method 
The results of the FISH assay are shown in Table 4-30. Statistically significant 
concentration-related responses were observed, as in the conventional Giemsa staining 
method. Using the PAINT nomenclature (Tucker et al, 1995), various abnormalities 
were identified in Figure 4-5a, b, c and d. 
Table 4-30: Chromosomal aberrations induced by doxorubicin in human lymphocytes 
determined using the fluorescence in situ hybridisation (FISH) method a, b 
Aberrations/total scored metaphases 
Doxorubicin concentration 0 µM 0.1 . tM 0.2 µM 0.4 µM 
slide I 1/327 2/163 0/12 3/62 
slide II 2/536 2/406 7/148 3/34 
slide III 1/296 5/242 3/373 2/64 
Sum 4/1159 9/811* 10/534** 8/160*** 
Abnormal frequency 0.35% 1.11% 1.87% 5.00% 
Whole genome adjustment' 4.09% 12.97% 20.54% 58.41% 
' 20 hr treatment after 48 hr initiating cycling - 68 hr incubation; 
b Study using probe for 
chromosome 1; `Assuming random distribution of aberrations throughout the genome, FISH data 
are multiplied since only 8.56% of genome was visualised 
*=p<0.05; ** =p<0.01; *** =p<0.001 (Fisher's Exact Test) 
A comparison of results from the FISH (Table 4-30) and the conventional 
chromosomal aberration assay (Study 2, Table 4-28) using the same treatment 
regimen is shown in Table 4-31. 
Table 4-31: A comparison of the percentage of abnormal frequencies of chromosomal 
damage in the FISH and conventional chromosomal aberration assays' 
Doxorubicin concentration 0 µM 0.1 µM 0.2 µM 0.4 µM 
FISH assayb 4.09 12.97 20.84 58.41 
Conventional study 2.67 53.33 57.33 52.00 
' 20 hr treatment 48 hr after initiating cycling - 68 hr incubation; 
b Adjusted values for whole genome 
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Figure 4-5: Various types of chromosomal aberrations identified by FISH 
ab 
cd 
a: A pair of normal chromosome 1 which is painted by fluoresceinated chromosome 1-specific DNA 
probe (x 63 objective - oil immersion) 
b: Two translocations between the pair of chromosome 1 and other chromosomes [t-t(bAb)] (x 63 
objective -oil immersion) - after Tucker et al, (1995) 
c: An interchange between the pair of chromosome 1 is shown (x 63 objective -oil immersion) 
d: An acentric fragment is identified [ace (b)] (x 63 objective - oil immersion) - after Tucker et al, (1995) 
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4.3.4p21' as oncoprotein levels in cultured human peripheral lymphocytes 
and in Hela cells 
The p2lras levels in cultured cells were measured by scanning ras protein bands on 
ECL-film using a light densitometer (see Section 2.2.6), the area under the ras peak 
being used as the p21"s level in corresponding cultured cells. It proved difficult to 
determine the precise ras level in the cells as many variables, e. g. the binding 
efficiency of the antibodies, in the experiments could not be controlled. For their 
presentation, the ras levels in treated cells have been adjusted to their concurrent 
controls by assuming that the ras level in the controls is 1. 
p2i levels in human lymphocytes treated with ROS-generating agents 
Figure 4-6. Relative p21'°' levels in cultured human peripheral Ivinphocvtes 
treated with ROS-generating agents and sodium ascorbate e' n 
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Figure 4-6 shows the p21`ß levels relative to the control in cultured human peripheral 
lymphocytes treated with ROS-generating agents. Generally, ras levels in treated cells 
were lower than in the control cells with the exception of cells treated with 0.015 
U/ml of BLM, of which, the ras level was slightly above that of the control. 
p21'°" levels in Held cells treated with ROS-generating agents and modulating 
agents 
Figure 4-7 shows the p21"ß$ levels relative to the respective controls in experiments I 
and II in cultured Hela cells. All ROS-generating agents (benzene, Dox and BLM) 
alone induced some increases of ras levels in Hela cells. The increases of ras levels 
by 200 µM of benzene (from 1 to 5.1) and by 0.3 µM of Dox (from 1 to 2.3) were 
substantial in experiment I and experiment II respectively. The combination of 
deferoxamine or silymarin with ROS-generating agents generally diminished the ras 
increases induced by ROS-generating agents alone. For example, a combination of 
Dox (0.3 µM) and deferoxamine (100 µM) elicited a decrease in ras levels in both 
experiments (being substantial in experiment II from 1 to 0.3). No general effects 
were seen for sodium ascorbate when combined with ROS-generating agents. The 
quantitative inconsistency between the two experiments must be further addressed 
(see discussion section). 
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Figure 4-7: Relative p2]" levels in cultured Hela cells treated with ROS- 
generating agents and/or modulating agents "' 1' 
A: Expenmi 
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Experiments I and II are two independent experiments; Dox - doxoruhicin; UI. M - hleomycin; 
t DFO - supplemented with 100 pM deferoxamine; + Sl1, - supplemented with 100 11M 
silymarin; + Vit C- supplemented with 100 IM sodium ascorhate 
Cells treated for 24 hr at 37°C; 
t' Assuming that the rus level in control is I 
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4.4 Discussion 
As already described in Chapter 1 and demonstrated in Chapter 3, ROS can induce 
various types of DNA damage. In a cellular environment, DNA damage can lead to 
morphological/functional changes in the genome (e. g. chromosomal aberrations, 
micronuclei and electrophoretic behaviour of the nuclei); changes in cellular 
metabolism (e. g. auxotrophic bacteria become prototrophic, overexpression of certain 
genes by the cells). The comet assay, chromosomal aberration assay, Ames test and 
p2lras detection are designed to measure one of these changes. 
4.4.1 Comet assays using human peripheral lymphocytes and HT29 cells 
4.4.1.1 DNA damage in human lymphocytes induced by ROS-generators and its 
modulation by various agents 
All treatments in the assays were carried out in the absence of serum. It has been 
shown previously (Proctor et al, 1986), as in the present study (Table 4-1), that 
components in foetal calf serum can affect responses, usually being protective, due to 
chemical treatment. Many components of serum, e. g. transferrin and thiol-bearing 
proteins, may directly affect Fenton/Haber-Weiss type reactions (see Reactions 1-4 
tot-6 and Table 4-1 for comet assay data on apo-transferrin). 
Both H202 and BLM produced the anticipated concentration-response relationships in 
the comet assay using human lymphocytes (Figures 4-1 and 4-2). The responses 
produced by BLM were not as consistent between donors as those produced by H202 
(Table 4-10). H202, being a potentially harmful and common product of cellular 
metabolism, is removed by constitutively expressed catalase in most cells, whereas 
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BLM, being an exogenous compound, unsurprisingly elicited different response in 
cells with different genotypes or even in cells having same genotype but in different 
physiological states. It is known that transient physiological parameters may affect the 
extent to which responses are manifested in a human donor (Oliven and Bosi, 1992). 
When whole blood was utilised, there was no response with H202 even at a very high 
concentration (480 µM, Table 4-1). Factors in whole blood e. g. catalase and serum 
constituents could have been responsible. The endogenous antioxidants behaved 
differently with the two compounds. Catalase on its own totally abolished the effects 
due to H202 but this was not the case for BLM (Tables 4-1 and 4-2). Superoxide 
dismutase had little effect on both compounds. This suggests that extracellular SOD is 
not involved in the DNA-damaging effects of H202 or BLM within the cells. It is 
unlikely that SOD will penetrate the cellular membrane and the nucleus where the 
critical reactions are thought to occur. H202 can freely diffuse through cellular 
membranes, while 02' " is unable to do so. The permeability of cellular membrane to 
the two types of ROS also made a great difference for the protective effects of the two 
enzymes against ROS or ROS-generating agents. 
The exogenous antioxidant vitamin C is known to exert a genotoxic effect in several 
mutagenicity testing systems and an anti-mutagenic effect in others (Rosin et al, 1980; 
Shamberger et al, 1984; Weitberg and Weitzman, 1985). In the present system, 
vitamin C itself produced clear concentration-related responses and caused DNA 
damage (Figure 4-3). It is also known that in the presence of trace metal ions, vitamin 
C can easily undergo autooxidation generating ROS (see 3.4.1.2). In the present study, 
when H202 was used, vitamin C produced a protective effect at low concentrations 
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and exacerbating effects at high concentrations (Table 4-3). Weitberg and Weitzman 
(1985) have shown both protective and exacerbating effects of vitamin C on oxygen 
radical-induced SCEs. The interactions of vitamin C and H202 are known to be very 
complex (Shamberger, 1984; Aruoma, 1993a). When BLM was used as a ROS- 
generator, vitamin C only elicited exacerbating effects on BLM-induced damage 
(Table 4-4). It has been shown in the chemical study (Chapter 3), that a reducing 
environment is extremely detrimental if transition metals are present. BLM is 
reactivated via the reduction of [Fe(III)-BLM] (Povirk, 1996), and moreover, the 
BLM used in the study had a high content of copper ions. 
Vitamin E or trolox exhibited no protective or exacerbating effects with either H202 
or BLM over a wide concentration range (Table 4-5) or alone. Vitamin E exerts its 
antioxidant effect primarily in the lipophilic regions of the cell. Although trolox is 
more water-soluble, its solvent partition still favours the non-water region (e. g. to 
prepare the mM concentration aqueous solution of trolox required prolonged heating). 
The treatment time with trolox may have been insufficient to elicit a response, or the 
scale of damage was too extensive to be affected by the presence of trolox. Aruoma 
(1993b) has shown a pro-oxidant action of vitamin E in an assay for DNA damage 
with bleomycin and iron. The results of the chemical study in Chapter 3 (Section 3.3) 
also showed a dual-property of vitamin E, as an antioxidant as well as a pro-oxidant. 
Silymarin, a commercially available mixture of plant flavonoids, produced a 
protective effect (Table 4-6), in accordance with the results from the chemical study 
for most ROS-generating compounds (Section 3.3), and other genetic end-point 
studies (vide infra). Its protective effect could be due to its role as a direct radical 
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scavenger, as a chelating agent of metal ions, as a DNA structure stabiliser, or as an 
inhibitor of some enzymes which might be important in the expression of DNA 
damage (Formica and Regelson, 1995). 
It is generally thought that H202 induces damage via the generation of the hydroxyl 
radical in the presence of transition metals (see Section 1.4.4). Iron is the most 
abundant transition metal in biological systems, but in general it is complexed with 
proteins, as in haemoglobin, transferrin, ferritin and cytochromes (Meneghini, 1988). 
Transferrin is a poor Fenton reactant (Halliwell and Gutteridge, 1989) and 
deferoxamine mesylate, a metal chelator is presumed to render iron catalytically 
inactive (Knecht et al, 1993). Both deferoxamine and apo-transferrin were seen to 
have a protective effect with H202 and BLM presumably through the 
chelation/binding of iron (Tables 4-1,1-2 and 4-7). Ferrous chloride, however, 
exacerbated the effect of BLM, which was in contrast to the equivocal result in the 
chemical study (Figure 4-2, Section 3.3). The comet assay study, as well as the 
chemical study, showed that iron itself (Fe3+) does not induce DNA damage (Table 4- 
7 and Section 3.3); however, its interaction with other compounds, generally those of 
reducing power, can be extremely detrimental to DNA due to the OH' produced by 
the Fenton mechanism (Reaction 1-4). 
In contrast, mannitol and ß-carotene which are believed to act as an hydroxyl radical 
scavenger and an antioxidant respectively, had no effect on H202- or BLM-mediated 
responses (Table 4-8). Similarly, cellular reductants GSH and NADH were also 
ineffective. These observations suggest that these compounds were not involved in 
suppressing the genotoxic effect of ROS, or had no antioxidant activity at the 
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concentration -levels investigated. This may be because the hydroxyl radical is 
generated so close to DNA that those compounds have no opportunity to prevent the 
formation of ROS or the interaction of ROS with cellular DNA. 
In the Dox study, treatments were carried out in non-cycling and cycling cells over the 
same concentration range, because cells in different stages of cell cycle are known to 
respond differently to chemical treatment (Scott et al, 1983). In the comet assay, non- 
cycling lymphocyte cells were scored in a conventional manner immediately after 1 hr 
treatment, and no significant effects were observed (data not shown). Whole blood 
cells were also scored after a3 hr pre-cycling treatment (treatment followed by a 65 hr 
incubation after initiation of cycling, Table 4-9). It has been suggested that Dox can 
be retained in a non-exchangeable intracellular pool (Dordal et al, 1994), but even if 
this is the case, no increased response was observed in the comet assay. Only when 
cycling cells were examined after a 20 hr treatment, following 48 hr cycling, was 
damage observed. Any strand breaks or alkali-labile sites could have been repaired 
and/or decreased in magnitude due to cell division. It is known that Dox binds to 
DNA by intercalation, and its antitumour activity has been associated with the 
production of protein-concealed DNA strand breaks as a result of DNA 
topoisomerase II poisoning. It is thought that interference of the DNA-topoisomerase 
complex with replication or transcription may induce the lethal event (Wassermann, 
1994). In view of the similar sensitivity of the comet assay and other endpoints 
(Slamenovä et al, 1997; Plewa et al, 1997; Monteith and Vanstone, 1995; Siim, 
1996), a difference in kinetics of induction of DNA damage versus chromosomal 
aberrations (Section 4.3.3) might contribute to the different response observed in the 
comet assay for cycling and non-cycling cells. 
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4.4.1.2 DNA damage induced by some aromatic amines and food mutagens: 
modulation by various agents 
DNA damage induced by arylamines 
A review of the literature surprisingly did not reveal any previous analysis of 
genotoxicity of arylamines using the comet assay. When m-PDA or 2-AF were 
directly tested in human lymphocytes positive, concentration-dependent responses 
were observed with both compounds, 2-AF being the more potent (Figure 4-4a, b). 
These data suggest that human lymphocytes have the capacity to metabolize 
arylamine promutagens into products that induce DNA breaks or alkali-labile lesions. 
In human lymphocytes, DNA damage was not detected at the low concentrations that 
induced reversion in S. typhimurium. In S. typhimurium a concentration of 50 µM, 
TX1MX-activated m-PDA induced a significant mutagenic response (Plewa et al, 
1995), whereas at least a 200-fold higher concentration (10 mM) was required to 
induce a significant increase in lymphocyte DNA damage with or without TX1MX 
activation after 4 hr incubation (Figure 4-4). The same 10 mM concentration of m- 
PDA did not elicit a significant genotoxic effect in lymphocytes after 1 hr incubation 
(Table 4-11), even in the presence of S9. A similar response was observed with 2-AF. 
With TX1MX activation, 250 nM of 2-AF induced a positive response in S. 
typhimurium (Plewa et al, 1995); however, a 1000-fold increase in concentration was 
required to induce a direct, significant positive response in human lymphocytes. 
The plant-activated products of m-PDA and 2-AF by cultured tobacco cells or 
TX1MX are associated with the formation of high molecular weight components 
exceeding 100,000 Da. The formation of these high molecular weight mutagenic 
products for S. typhimurium by TX1 cells is dependent upon the activity of the plant 
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cell peroxidases (Plewa et al, ' 1993). The addition of TX1MX significantly reduced 
the DNA-damaging potency of m-PDA and 2-AF to human lymphocytes (Figure 4-4). 
At the 25 mM level of m-PDA, the direct-acting genotoxic response in the treated 
lymphocytes without TX1MX was 10 times higher than that of the treated 
lymphocytes incubated with TX1MX (median tail moment 46.3 vs 4.7, Figure 4-4). 
With 400 µM 2AF, cells treated directly were 3 times more responsive than those 
incubated with TX1MX (median tail moment 57.0 vs 18.2, Figure 4-4). TX1MX is 
necessary to activate m-PDA and 2-AF in S. typhimurium (Plewa et al, 1995) but it 
impedes the DNA strand breakage capacity in human lymphocytes. Incubating human 
cells with TX1MX did not, however, reduce the mean tail moment values. TX1MX, 
when assayed with direct-acting agents, did not demonstrate antimutagenic properties 
(Plewa et al, 1995). One possible mechanism that may account for the reduction of the 
genotoxic response of the arylamines in the presence of TX1MX is that a fraction of 
the arylamines is sequestered in a high molecular weight proximal mutagen which is 
unable to enter the human cells. This suggestion agrees with the 2-AF survival data in 
that at 500 µM 2AF the cell viability was reduced to 30% while no toxic effect was 
observed with 500 µM 2-AF plus TX1MX (Table 4-11). 
Human lymphocytes react differently to m-PDA and 2-AF. Both of these promutagens 
require mammalian microsomal activation or plant cell activation to become 
mutagenic in S. typhimurium (Plewa et al, 1995). Oxidative metabolites of these 
agents (the N-hydroxylated metabolites) serve as substrates for acetyl-CoA: N- 
hydroxyarylamine O-acetyltransferase. NAT] and NAT2 are the two isozymes of 
human cytosolic CoASAc: arylamine N-acetyltransferase (Dupret and Grant 1992) 
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which exist in lymphocytes (McQueen and Weber, 1980). Rat hepatic S9 activation of 
2-aminofluorene and benzidine were positive in S. typhimurium strains containing 
human NAT] and NAT2 (Grant et al, 1992). Plant-activated products of 2-aminofluor- 
ene, benzidine and 4-aminobiphenyl also are substrates for human NAT] and NAT2 
(Ju and Plewa, 1993). Deacetylated N-hydroxyarylamine products can lead to highly 
reactive nitrenium ions. These radicals and the ROS produced by oxidases and 
peroxidases may be the agents that induce DNA strand breaks and lesions that are 
detected in the comet assay. From the presented data, it is clear that human 
lymphocytes have the capacity to metabolize these arylamines into their electrophilic 
forms and that these reactive products induce DNA strand breaks. 
DNA damage induced by food mutagens 
Food mutagens, in the presence of appropriate activation system, are mutagenic to 
bacteria in the Ames test system (see Section 4.4.2), however, they also cause DNA 
damage in mammalian cells. Pearson et al (1992) proposed a mechanism for free 
radical formation by food mutagens, while Sato et al (1992) demonstrated that the 
metabolism of food mutagens by NADPH/cytochrome P-450 could generate ROS in 
vitro. Some plant phenolics, which have antioxidant properties, showed an 
antimutagenic effect towards IQ in Salmonella typhimurium TA98 and TA100 (Wang 
and Lee, 1996). It was also demonstrated that the antioxidant activity of tea extracts is 
correlated to their antimutagenicity, although the relationship varied with the mutagen 
and antioxidative properties (Yen and Chen, 1995). 
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In the present study, PhIP, IQ and Trp-P-2 were able to show directly DNA-damaging 
ability in human cells (Tables 4-16,4-17 and 4-18) at various concentration levels 
with or without S9 activation. In Experiment II in Table 4-17, the greater response of 
HT29 cell to PhIP, compared to the similar treatments in other experiments, was 
probably the result of over-trypsinisation, which is able to change the susceptibility of 
the cell as the consequence of the loss of membrane proteins. The DNA-damaging 
ability of PhIP seems to be about 5- 10 times more potent than that of IQ in human 
lymphocytes measured by the comet assay (Table 4-14). The results (Tables 4-16 and 
4-17) also indicated that the S9 activation of PhIP is not proportionate to the 
concentration, rather, is more effective at relatively lower concentrations, e. g. in Table 
4-16, the increases of damage cells were mainly in the concentration range of 0- 25 
pg/ml, while there were no increases between 25 and 100 pg/ml. It is likely due to the 
saturation of enzymes by PhIP/PhIP metabolites, or the rate-limiting state of PhIP 
activation had been reached. Some other food mutagens, like DiMeIQx, MeIQ, 
MeIQx and Tip-P-1, failed to produce positive responses in human lymphocytes and 
HT29 cells in the comet assay (data not shown). Although food mutagens are all 
activated/deactivated by similar microsomal enzymes (Rowland and Anderson, 1989; 
Goeptar et al, 1995), the reactivity of these food mutagens towards cellular DNA 
varies enormously. Various reasons may explain such differences, for example, they 
might originate from the differences of the DNA-damage ability between the active 
metabolites of the food mutagens; they might originate from differences of cellular 
deactivation of the active metabolites of food mutagens. 
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The effects of S9, catalase, silymarin and DFO on food mutagen activity 
The reduction of the potency of PhIP on human lymphocytes by catalase (Tables 4- 
15) and on HT29 cells by S9 or by silymarin, but not by deferoxamine (Table 4-18) 
indicates that there is a ROS component in the induction of DNA damage by PhIP, 
whereas free iron probably is not directly involved in the ROS production. It was 
likely that ROS produced by the xenobiotic metabolism of food mutagens were 
implicated, and it is known that silymarin can interfere with cellular metabolism 
(Formica and Regelson, 1995). The decreased toxicity of PhIP in the presence of S9 
was probably because S9 contains detoxifying enzymes, e. g. catalase and SOD 
(McGregor et al, 1991). The presence of proteinase K in the lysing solution, which 
was not related to the treatment, enhanced the expression of DNA damage in the 
comet assay system (Tables 4-15) as the phenomenon was observed in the other 
experiments (data not shown). proteinase K has been used for increasing the 
sensitivity of the comet assay (e. g. Singh et al, 1989). Increasing the sensitivity of the 
assay system also can be achieved by other means, such as co-incubating cells with a 
DNA repair inhibitor or using lesion-specific DNase to magnify the lesions (Collins et 
al, 1995). 
4.4.1.3 DNA damage in human lymphocytes induced by benzene and its metabolites 
Benzene, after a 0.5 hr treatment, elicited a very weak effect in the comet assay (in 
Table 4-19 not in Table 4-18) in the absence of metabolic activation, but this was 
markedly increased when a longer treatment (1 hr) was adopted, both in the presence 
and absence of S-9 mix. However, the concentrations were also increased by 5-fold. It 
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could be argued that there may have been some evaporation of benzene from the 
system. However, Randall et al (1993) showed that in a closed system in vitro, where 
evaporation was prevented, benzene was an active clastogen in the absence of 
exogenous metabolic activation. A closed system was also used in the present study, 
but the concentration used (in 0.5 hr treatment) may have been too low. The low 
concentration as opposed to evaporation may explain the ephemeral nature of the 
response. Such responses also highlight the need to repeat studies on several 
occasions to determine a weak response in a sensitive assay. Following 0.5 hr 
treatment a positive response was displayed by benzenetriol (Tables 4-18 to 4-20) 
and, to a smaller degree, by catechol (Tables 4-18). These responses were more 
pronounced with longer treatment times and increased concentrations. In fact, all 
metabolites were positive with longer treatment times and at high concentrations 
(Table 4-23). Benzenetriol has also been shown to produce micronuclei in both human 
lymphocytes and HL60 cells (Zhang et al, 1993). These authors reported that 
benzenetriol, and to a lesser extent catechol, readily oxidise to their corresponding 
quinones via semiquinone radicals. During this process, active oxygen species are 
formed that may damage DNA and other cellular macromolecules. When S-9 mix was 
added to the lymphocytes in the present study, the effect of benzenetriol and H202 
was diminished. Catalase also rendered benzenetriol much less active, suggesting that 
H202 formed during its autooxidation may be responsible for the observed DNA 
damage. Since S-9 mix contains a substantial amount of catalase (McGregor et al, 
1991), this could explain why benzenetriol was inactivated. The abolition of the effect 
of benzenetriol by catalase was demonstrated in the experiment whose results are 
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shown in Table 4-20. The reason for the morphological changes observed with 
p-benzoquinone at all treatment times is not clear, but could possibly be due to 
chemically generated cross-linking and/or DNA condensation. 
The differences observed between the same treatments of 20 µM H202 and 
40 µM H202 in Tables 4-18 and 4-20 was because studies were conducted at different 
times. Duthie et al (1996) and Green (1996) reported that resistance of lymphocytes to 
the in vitro challenge of H202 was influenced by donor's diet, and this may help 
explain the small differences between the same treatment in different experiments. 
Even within one experiment the higher concentration can sometimes produce less 
apparent damage than actual damage because after electrophoresis DNA is dispersed 
and diffused into the background, which is only barely distinguishable by eye through 
microscope and not at all by the image analysis system. Similarly, for cells which 
have very low levels of damage (less than around 5%) analysis by microscopic 
examination by eye is superior to analysis by computer, since the latter cannot 
discriminate such cells. 
There was a small difference in response between cycling and non-cycling cells at the 
0.5 hr treatment (Table 4-20). It was assumed that cells were cycling after PHA 
stimulation, since the same procedure was used as that which is used to prepare cells 
for measuring chromosomal aberrations, and many experiments carried out previously 
in this laboratory have shown that most cells are cycling at 44 hr in chromosomal 
aberration studies. This is the time recommended by UKEMS (Scott et al, 1983) to 
add S-9 mix to an asynchronous population which means that cells would have had to 
have progressed from Go to all different cell stages. The shift towards less damage in 
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cycling cells is somewhat surprising, as other genetic end-points, such as mutations, 
are more easily detected in cycling cells (UKEMS, 1990). However, the repair 
processes may be operating more efficiently in cycling cells (Collins et al, 1995). 
Hoeijmakers (1993), in a review on DNA repair, suggested the preferential (i. e. more 
rapid and complete) repair of transcribed sequences in mammalian cells undergoing 
active transcription by a special nucleotide repair pathway, which is also found in E. 
coli and yeast. Cycling cells would be expected to be transcribing more genes than 
non-cycling cells because they have to reproduce all the cellular structures. 
Alternatively, the cycling cells constitute T lymphocytes since they have been 
stimulated to divide by PHA. T lymphocytes, as opposed to B lymphocytes, respond 
to this mitogen, and the T lymphocyte sub-population may be slightly less sensitive 
than the whole population. It is known that sub-populations of lymphocytes exist 
(Goldstein et al, 1982) with different susceptibilities to genetic damage (Carrano and 
Natarajan, 1988). 
The results of this study show that DNA damage can be detected in the comet assay 
for benzene and its metabolites under certain conditions. They are in agreement with 
those obtained previously with benzene metabolites in other tests for DNA damage 
(Lewis et al, 1988; Zhang et al, 1993; Kawanishi et al, 1989), particularly with 
reference to the oxidative DNA damage caused by benzenetriol. 
4.4.2 Bacterial mutations induced by food mutagens in the Ames test: 
modulation byflavonoids 
The processing of proteinaceous food at high temperatures generates a wide variety of 
chemical substances not present in the unheated material. Many of them are 
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mutagenic in the Ames test system, hence are called food mutagens (Rowland and 
Anderson, 1989). These compounds are chemically heterocyclic aromatic amines 
(HAs, HCAs or HAAs), and cytochrome P450-mediated mixed-function oxidases 
(MFOs) are known to be important in the activation of these compounds (Rowland 
and Anderson, 1989). They are substrates of human cytochrome CYP1A2 (Goeptar et 
al, 1995), and it has been demonstrated that heterocyclic aromatic amines can be 
activated by human cytochrome CYP1A2 expressed in Ames tester strain bacteria 
(Josephy et al, 1995). Sato et al (1992), using in vitro techniques, demonstrated that 
ROS could be generated by the metabolism of food mutagens which is mediated by 
cytochrome P-450 and its reductase. Silymarin and myricetin are flavonoids which 
generally are known to have antioxidant properties (Formica and Regelson, 1995; 
Manach et al, 1996), but myricetin in the present study has been shown to have 
mutagenic activity in its own right (Tables 4-25 and 4-26). The mutagenic activity of 
myricetin also had been observed by others (Brown, 1980; Formica and Regelson, 
1995). In combination with the food mutagens, however, they have been shown to 
reduce reversion, at the highest concentrations, in the Ames test (Table 4-25). A 
similar response with these food mutagens has been shown in combination with 
paraoxon in Salmonella typhimurium strain YG1024 and in the comet assay in human 
lymphocytes (Plewa et al, in press, 1997a). Data from other experiments (Stavric et 
al, 1996; Bu-Abbas et al, 1994) showed that some tea extracts, which are rich in 
flavonoids, plant polyphenols and other antioxidants, have potent antimutagenic 
effects on HAs in the Ames test, partly due to their direct ROS-scavenging 
mechanism. It also has been shown that in cultured myocytes and in rats N- 
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acetylcysteine, an antioxidant, had a protective effect of against HAs-induced 
cardiotoxicity (Davis and Snyderwine, 1995). 
In the Ames test, S9 mix was present in all studies. In the comet assay, the damage 
induced by PhIP was significantly reduced by the presence of catalase (Tables 4-15) 
and S9 or silymarin, but not deferoxamine (Table 4-18). S9 mix is known to contain 
catalase (McGregor, 1991) and other constituents which have antioxidant properties, 
as well as some ROS-generating enzymes, e. g. microsomal oxidoreductase. From the 
combination of these facts and the findings in the comet assay experiments (see 
4.3.1.2 and 4.4.1.2), it seems that HAs-induced DNA damage may have a ROS 
component. 
In this study and in the comet assay study (see 4.3.1.2), in the absence of toxicity to 
the cell systems involved, the presence of the flavonoids at the higher concentration 
have shown a decrease in reversion and DNA damage induced by the food mutagens. 
The results of this study may have implications for humans in terms of modulating the 
genotoxic effects of isolated food constituents and drugs. 
4.4.3 Chromosomal aberrations induced by doxorubiein 
Chromosomal aberrations induced by doxorubicin 
Doxorubicin (adriamycin) is a benzanthroquinone drug which is useful in the 
treatment of several types of human malignancies. It is cytotoxic and mutagenic both 
in bacterial and mammalian systems. One type of interaction with DNA is associated 
with the production of reactive free radicals (Doroshow, 1986; Sinha et al, 1987; 
Akman et al, 1992; Malisza and Hasinoff, 1995), but others believe that there is no 
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evidence for Dox generating ROS in vivo (Butler and Hoey, 1987), and controversial 
views concerning its mechanism of action in vivo still exist. Its cytotoxic activity is 
mostly thought to be related to its interaction with nuclear topoisomerase II (Butler 
and Hoey, 1987; Wassermann, 1994). 
Dox has been shown to be mutagenic in the Ames test in various Salmonella 
typhimurium strains (Andrivon et al, 1995) and clastogenic in human lymphocytes in 
vitro and in vivo (Migliore et al, 1987; Hsu et al, 1982; Nevstead, 1978). It also 
induced DNA damage in the comet assay in rat embryonic cells (Barber and Fantel, 
1993). No responses using the FISH technique or using modulating agents in 
cytogenetic endpoints have yet been reported apart from this study, although other 
biomarkers have been measured in order to evaluate the modulation of Dox toxicity 
by some antioxidants, e. g. using microsomal lipid peroxidation as an index, in a study 
to attenuate the doxorubicin-dependent toxicity by glutathione and N-acetylcysteine in 
rat (Powell and McCay, 1995), and in an investigation of the cardioprotective effect of 
flavonoids against doxorubicin-induced cardiotoxicity in mice (Vanacker et al, 1996). 
In the present study, positive responses of the clastogenicity of Dox in human 
lymphocyte chromosomes have been observed both in the conventional CA studies 
and in the FISH chromosome analysis (Tables 4-28,4-29 and 4-30), which is in 
accordance with the previous experiments (Migliore et al, 1987; Hsu et al, 1982; 
Nevstead, 1978). Some pharmacological studies suggested that flavonoids may have a 
protective effect against Dox-induced cardiomyopathy mediated by ROS (Husken et 
al, 1995). However, in the present study, silymarin at a concentration of 10 µM did 
not show any protective effect with the lymphocytes against the clastogenicity of Dox 
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(Table 4-29). The concentration of 10 µM silymarin may have been too low to reduce 
the clastogenic response, in comparison with concentrations used in the comet assay. 
Higher concentrations of silymarin could not be used in this assay since they produced 
cell cycle inhibition (e. g. at 400 µM, data not shown). Silymarin (10 µM) itself 
produced a significant level of CAs in the cells (p < 0.01). A recent CA study (Silva et 
a11996) has shown that the genotoxicity of myricetin, as assessed by the induction of 
chromosomal aberrations, is not different in V79 cells lines genetically engineered for 
the expression of rat cytochromes CYP 1A1,1A2, and 2B1, compared to parental cell 
lines. It has also been shown that ROS resulting from the autooxidation of myricetin 
at pH values above neutrality have an important role in its mutagenicity. Therefore, 
the mechanism of CA induction by Dox and the possible modulating effect of 
flavonoids on the induction' are complicated by their interaction with other cellular 
components, and it may be too complex to be determined by genetic morphological 
studies. 
A comparison of the comet assay, Giemsa-stained CA assay, FISH assay and other 
genetic/biochemical endpoints in measuring DNA damage 
Chromosomal abnormalities are a leading cause of genetic disease including 
congenital disorders and acquired diseases such as cancer. According to Le Beau 
(1996), cytogenetic analysis by conventional banding techniques requires skilled 
personnel and is labour intensive, time consuming and expensive. Automated 
karyotyping is useful for some diagnostic applications, but it is ineffective for 
analysing the complex karyotypes characteristic of many human tumours. 
Investigators have sought alternative methods for identifying chromosomal 
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abnormalities, - and FISH is one such method. According to Tucker (1995), 
chromosome painting enables clinicians to obtain useful information from 
preparations of comparatively lesser quality than from a complete karyotype, with 
bands of moderately good quality. Despite limitations relating to cost and the optical 
resolution of FISH, the detection of translocations between painted and unpainted 
chromosomes is relatively straightforward and robust and identifies rearrangements 
too small or too numerous to be detected by banding techniques. Even newer methods 
are being pioneered, with painting probes for, each chromosome with a different 
assortment of fluorescent dyes (fluorochromes). However, the fluorochrome colours 
are not sufficiently distinct to distinguish by visual microscopic examination which 
combination a chromosome is painted with. Filters can be used which transmit only 
light of the wavelength range emitted by one fluorochrome. A computer then 
combines the data, displaying the chromosome as if it were stained with a distinct 
colour (Speicher, 1996). Alternatively, interferometers determine the full spectrum of 
light emitted by each stained chromosome, then a computer programme displays all 
the chromosomes, each with its own unique colour (Marx, 1996). However, such 
systems are very expensive. 
DNA damage in the comet assay was compared with other biochemical/genetic 
endpoints such as DNA alkaline elution,, chromosomal damage measured by laser 
flow cytometry, gpt gene forward-mutation in CHO AS52 cells, in vitro chromosomal 
aberrations and mutations in V79 Chinese hamster cells (Slamenovi et al, 1997; 
Plewa et al, 1997; Monteith and Vanstone, 1995; Siim, 1996). It has been concluded 
that comet assay is sensitive, and comparable to other biochemical, genetic and 
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cytotoxic endpoints. The mechanisms involved in the expression of the DNA damage 
in the comet assay have recently been considered by Klaude et al (1996). Using the 
comet assay as a comparison for chemical-induced genotoxicity in the FISH assay, the 
advantages and disadvantages of each of the methods in measuring genetic damage 
are self-evident. 
In the current comparative study, treatment with Dox was carried out in both non- 
cycling and cycling cells over the same concentration range. In the comet assay, non- 
cycling lymphocyte cells were scored in a conventional manner, immediately after 
1 hr treatment, but no positive response was observed. Whole blood cells were also 
scored after a3 hr treatment followed by a 65 hr incubation after initiation of cycling. 
It has been suggested that Dox can be retained in a non-exchangeable intracellular 
pool (Dordal et al, 1994), but even if this is the case, no increased response was 
observed in the comet assay. Only when cycling cells were examined after a 20 hr 
treatment, following 48 hr cycling, was damage observed. Any strand breaks or alkali- 
labile sites could have been repaired and/or decreased in magnitude due to cell 
division. In the case of the chromosome studies, chromosomal aberrations could have 
been induced during the first S phase post-treatment in non-cycling cells or during 
treatment in the cycling cells. In the FISH assay, only cycling cells were treated 
because the probe used was metaphase-specific. It cannot be ruled out that, since 
whole blood was used, leukocytes have been exposed in the various assays but only 
lymphocytes are stimulated to divide by PHA. Chromosomal damage, as measured in 
the conventional and FISH studies, appeared to be a more sensitive endpoint than 
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strand breakage in the comet assay, since positive responses were evident at lower 
concentrations. - 
Furthermore in the present study, when comparing the sensitivity of conventional 
chromosomal aberrations versus FISH aberrations using the same protocol involving a 
20 hr treatment, and after multiplying the FISH values to represent the whole genome 
(assuming that all aberrations occur randomly), it would appear that at the highest 
concentration of Dox (0.4 µM), sensitivity is similar for FISH and conventional 
aberrations. At the lower concentrations, values for FISH appeared lower, but gaps 
and breaks were detected by conventional chromosome analysis, and are unlikely to 
be readily detected by FISH. At higher concentrations a greater number of 
interchanges, chromosome breaks and fragments were seen (Tables 4-28 and 4-29) in 
the conventional method. Stable aberrations are more readily detected by FISH 
whereas some of these are not detected by conventional analyses. Similar sensitivity 
for FISH and conventional analyses have been reported (Ellard et al, 1995; Doherty et 
al, 1996) after treatment of human lymphocytes with cyclophosphamide, bleomycin 
and daunomycin. 
In contrast, it was observed that the linear-quadratic concentration-response curve for 
dicentrics, determined by FISH and conventional analysis, after exposure to y-rays 
were different, and the differences could not be ascribed to the methodologies. In this 
case, it was also assumed that aberrations were randomly distributed throughout the 
genome (Schmid et al, 1995). 
The different sensitivity for Dox observed in the two assays (Tables 4-9 and 4-28) 
may be agent-specific, that depend on the mode of action of Dox. Difference in 
153 
kinetics of induction of DNA damage versus chromosomal aberrations might also 
contribute to the different sensitivity. Consequently, it should be born in mind, that 
cells in various cycling stages may show different sensitivity towards the same 
compound. 
4.4.4 p21' oncoprotein levels in cultured human cells 
The concept that oncogenes could be responsible for the transformation of cells by 
retroviruses was introduced in the 1970s by H. Temin and D. Baltimore. It was later 
realised that oncogenes and oncoproteins are not only related to the malignancy of the 
animal tissues, but more importantly they control all cellular activities such as 
reproduction, proliferation, differentiation, growth and apoptosis. 
In the early 80s, several research groups discovered that the transforming genes of 
human bladder and lung carcinoma were homologous to the ras genes of Harvey and 
Kirsten murine sarcoma viruses (Lacal and Tronick, 1988). So far 3 types of proto- 
oncogene of ras (K-ras, H-ras and N-ras) have been identified in human cells. The 
protein products of these genes have more than 80% analogy in their amino acid 
sequence and a molecular weight of - 21 KDa, and are collectively called p21" or 
p21 (Grand and Owen, 1991). Most p21 molecules are located at the inner side of the 
plasma membrane, and one of the known important functions of p21 is as the inhibitor 
of cyclin-dependent kinase (Waga et al, 1994). Together with another oncoprotein 
p53, p21 controls the cellular entrance to the next stages of the cell cycle at crucial 
points (Jacks and Weinberg, 1996). 
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There are indications that these proto-oncogenes may be activated by ROS-related 
signals/mutations (Cerutti, 1994; El-Deiry et al, 1995; Agarwal et al, 1995; Page et al, 
1995). Studies showed the induction of p21 expression in cells exposed to DNA- 
damaging agents (Tanaka et al, 1996). Investigations have also indicated that some 
occupationally or environmentally exposed subjects might have elevated p21 levels, 
such as workers exposed to polycyclic aromatic hydrocarbons (Brandt-Rauf, 1991) 
and some of these exposures have a ROS component in them. A recent study showed 
that p21 expression can be accomplished in a p53-independent manner in these cells, 
and is mediated by an increase in the cellular steady-state concentration of oxygen 
radicals (Qiu et al, 1996). It is possible that p21 plays a role in the ROS-induced 
toxicity, especially in the possible induction of apoptosis or carcinogenesis. 
In the present investigation, p21 ras levels were measured in the lysates of human 
lymphocytes/Hela cells treated with various ROS-generating agents and antioxidants. 
Such an exploratory type of study is especially important to provide some preliminary 
indication whether ROS can induce a detectable ras increase in cells commonly used 
in toxicological studies, and further, whether the change in ras levels can be 
modulated by antioxidants. 
It was anticipated that ras levels in the treated lymphocytes would increase, and the 
modulation of sodium ascorbate would lead to a decrease, but no such trends were 
evident. Levels of ras in treated cells were generally lower than that in the control 
cells by an average of 25% (including treatments containing sodium ascorbate, Figure 
4-6). Therefore, it was decided to use Hela cells which are cycling cells and may have 
higher steady ras levels readily measurable. In the case of Hela cells, all ROS- 
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generating agents (benzene, Dox and BLM) alone elevated ras levels, substantially in 
some cases, e. g. in benzene-treated (200 µM) cells in experiment I and Dox-treated 
(0.3 µM) cells in experiment II. The modulating agents (deferoxamine and silymarin) 
generally diminished the ras increases induced by ROS-generating agents alone, with 
few exceptions. For example, a combination of Dox (0.3 µM) and deferoxamine (100 
µM) elicited a decrease in ras levels in both experiments. It was less clear, however, 
whether sodium ascorbate, being both an antioxidant and a pro-oxidant (see previous 
discussion and Section 3.4), had a modulating effect. When comparing the two 
identical experiments, there was a quantitative inconsistency between the two sets of 
data. This may be because the low levels of ras in the cell lysate samples did not 
allow more parallel samples to be processed, and therefore sophisticated data analysis 
was impossible; the assay involved many steps during operation procedures (see 
Section 2.2.6) and each step was potentially able to introduce variables, some of 
which were uncontrollable, e. g. the efficiency of the antibodies. However, the results 
from the Hela cell study suggested that it would be worthwhile to investigate further 
the modulation of p21 expression by ROS. At present, the results per se must be 
conservatively perceived, but with improved techniques for determining ras levels, 
and pursuing a deeper as opposed to a wider approach, a clearer conclusion might be 
possible in further studies. 
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CHAPTER 5 
ROS-INDUCED GENETIC DAMAGE IN VIVO 
IN ANIMALS 
5.1 Introduction 
It has been demonstrated in Chapters 3 and 4 that ROS and ROS-generating 
compounds can readily induce damage in DNA molecules or cellular genetic 
organelles in artificially controlled environments, i. e. in test tubes and in tissue- 
culture dishes. However, careful examination of data acquired from animal or human 
studies is essential to evaluate whether the knowledge obtained from in vitro studies 
can be extrapolated to higher biological organisation levels, i. e. to the tissue or 
individual animal levels, which are considered more relevant to toxicological studies. 
The integrity of germ cell DNA is vital for the accurate transmission of genetic 
information to future generations. DNA lesions in germ cells can lead to abortion, 
malformations, heritable diseases and cancer (Bloom, 1981) and similar lesions in 
somatic cells could also lead to cancer (Hagmar et al, 1994). Bone marrow is the 
target organ for many toxic compounds or the metabolites of those compounds, e. g. 
benzene (Dean, 1985) and 1,3-butadiene or BD (Recio and Meyer, 1995). 
Rodents are the most commonly used animal models for toxicological studies. A 
previous study (van Buul and Goudzwaard, 1980) showed that bleomycin (BLM), 
administrated intraperitoneally, induced structural chromosomal aberrations in 
spermatogonia and bone-marrow cells of mice, and there was no significant difference 
between the responses of the two cell types. However, in another study (Anderson et 
al, 1995c), using the micronucleus assay in CD-1 mice, blood and bone marrow cells 
showed different dose responses with BLM. 
In the current study, somatic bone marrow cells and testicular germ cells in rats were 
used to determine whether the comet assay, a very sensitive method under in vitro 
157 
conditions, was also reliable in animal studies in vivo. In this study generally 3 
animals per treatment group were investigated, after consultation with a statistician to 
determine if such an approach was feasible. The well known toxins cyclophosphamide 
(CP), ethyl methanesulphonate (EMS) and ethylene glycol monomethyl ether 
(EGME) were used as well as BLM, a ROS-generating agent that can induce explicit 
DNA damage in cells in vitro in the comet assay (see Chapter 4). 
Another rodent study on the industrial toxin 1,3-butadiene and its metabolite [1,2,3,4- 
diepoxybutane (DEB)] has also been carried out. BD is produced in large quantities for 
use in the manufacture of synthetic rubber. It is also an environmental pollutant, as it is 
present in car exhaust fumes. There is concern about exposure to BD since it has been 
shown to produce tumours in mice (Melnick et al, 1990) and rats (IARC, 1992) in 
animal studies and in men environmentally exposed (Macaluso et al, 1996). Moreover, 
BD and its metabolites have been shown to be genotoxic in the germ cells of mice 
(Morrissey et al, 1990; Adler et al, 1995). Species differences have been reported in 
dominant lethal and other toxic effects in rats and mice, possibly due to different 
metabolic capabilities (Adler et al, 1995; Anderson et al, 1997a, d). Although there has 
been extensive research in regard to the genotoxic effect of BD and its primary 
metabolites 1,2-epoxybutene (EB) and DEB, no consensus has been reached as to 
whether BD is a human carcinogen. In a recent epidemiological study, an association 
has been found between the exposure to BD in working environment and an increased 
risk for leukaemia in workers who, however, were also exposed to styrene and a number 
of other process chemicals (Macaluso et al, 1996). Some believe that the more 
susceptible mouse species would be a better model than rats to predict human effects of 
BD (Melnick and Kohn, 1995) although contrasting views have also been expressed 
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(Bond et al, 1995). The objectives of the study were to a) investigate whether BD could 
induce DNA damage in germ cells and somatic cells in mice, and b) establish whether 
DEB could cause DNA damage in germ cells in rat as measured in the comet assay. In 
these studies, mice were exposed to BD through inhalation whereas rats received DEB 
intraperitoneally. 
5.2 Materials and methods 
The comet assay was used for the evaluation of DNA damage in the two studies, and 
the general materials and methods have been detailed in Chapter 2. 
Software `Comet 2.4' was used for the comet assay slide scoring for the BLM study. 
Software `Comet 3.0' was used for the comet assay slide scoring for the BD study. 
5.2.1 Study using BLM, CP, EMS and EGME 
Animals and husbandry 
Male Sprague-Dawley rats (7 -8 weeks of age) were obtained from Olac Ltd, 
Bicester, Oxon. Animal husbandry has been described in Section 2.2.3.3. 
Animal treatments 
Chemicals dissolved in physiological saline were administered to animals by gavage in 
a single dose, at volumes not exceeding 5 ml/kg. Sub-lethal dosages were determined 
from previous experience in this laboratory and from the information acquired through 
literature search. Doses administered were 50,100 and 150 mg/kg body weight (bw) 
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CP; 100,200 and 300 mg/kg bw EMS; 500,1000 and 1500 mg/kg bw EGME; 50,100 
and 150 mg/kg bw of BLM. Control animals were given physiological saline only. 
After treatment, animals were killed by cervical dislocation, the femur and testes 
removed, and bone marrow and testicular cells prepared (see below). In the case of 
CP, EMS and BLM animals were killed at 2 weeks after treatment, In the case of 
weeks 
EGME animals were killed at 2,5 and 6Aafter treatment in order to determine the 
persistence of DNA damage as measured in the comet assay. It is recognised that 
different chemicals produce peak responses at different times (RR Tice, personal 
communication). 
Cell preparation 
The methods for cell preparation were detailed in Section 2.2.3.3. Germ cells were 
prepared according to Germ cell preparation I. 
Slide scoring 
Slide scoring has been described in Section 2.2.3.3. When testicular cells were scored, 
those nuclei with a diameter of about 17 µm (range: 14-20 µm) were considered 
haploid, while those with a diameter of about 27 µm (range: 24-30 µm) were 
considered diploid or polyploid. 
Statistical analysis 
Various methods of analysis were used: A nested analysis of variance (ANOVA) was 
performed where the mean square error between rats within dose groups was used to 
estimate differences between doses. Replicate slides were included in the model for 
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completeness but had no effect upon the measuring of dose response, since the 
residual error was not used to estimate the dose effect. 
Analysis of variance using the median value of each slide - The median was used as a 
representative value per slide since the distribution of data was skewed and extreme 
high values greatly influence the mean. The median value thus gives less weight to 
those high values. Analysis of variance using log transformed values - Logs were 
taken to normalise the data so that a parametric test could be performed. - One sided, 
least significant difference test (LSD) - This is a multiple comparison test. Liner and 
quadratic contrasts using analysis of variance - To measure for positive trends with 
increasing dose. 
5.2.2 Study using 1,3-butadiene and diepoxybutane 
Animals and Husbandry 
8-12 week old, male CD-1 mice were obtained from Charles River UK (Margate, 
Kent, UK), and 8-12 week old, male Sprague Dawley rats from Harlan Olac Ltd 
(Bicester, Oxon). Animal husbandry has been described in Section 2.2.3.3. 
Chemicals and treatment 
BD was stored at -20°C between exposures and kept on ice during dosing. BD gas 
was metred at a known and constant flow rate, using rotameters, into a diluting air 
stream of clean dry air in order to achieve the desired concentrations. The 
atmospheres were analysed by infra-red (IR) spectrophotometry at an 'appropriate 
wavelength (11.1 pm for butadiene) and pathlength and were recorded on continuous 
sheet recorders. The pathlengths were variable depending on the sensitivity 
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requirements and type of spectrophotometer used. They varied from 2.25-20.25 since 
MIRAN 104,1B and 1A IR gas analysers (Quantitech Ltd., Milton Keynes, UK) were 
used and a Fourier transformed IR analyser was fitted with a 100 mm gas flow cell. 
Adjustments were made immediately, when necessary, in order to maintain the correct 
concentrations. Contamination of the butadiene with the dimerized form was 
monitored by gas chromatography. As an additional precaution against a rise in dimer 
levels, BD cylinders were changed weekly. All exposures in a given experiment were 
performed in a closed whole-body incubation exposure system, simultaneously and in 
the same room with the control groups which were exposed similarly to ambient air. 
In the acute mouse inhalation study, animals were exposed to 0,12.5 and 125 ppm of 
BD for 6 hr before they were killed by cervical dislocation. In the 4-week subchronic 
inhalation study, mice were exposed to 0,12.5,65 and 130 ppm of BD. 
In the 10-week chronic inhalation study, mice were exposed to 0,12.5, and 125 ppm 
of BD. In the in vivo DEB study, rats were given single DEB doses of 0,12.5,25 and 
50 mg/kg by intraperitoneal injection and kept for 24 hr before they were sacrificed. 
(The exposure to BD and i. p. treatment with DEB were carried out, in my presence by 
other members of the Genetic and Reproductive Toxicology Department in BIBRA). 
Cell preparation 
The methods for cell preparation were detailed in Section 2.2.3.3. Germ cells were 
prepared according to Germ cell preparation H. Liver cells were obtained by mincing 
the liver and swirling in a tube, as for the tubules of the testes in the Germ cell 
preparation H. 
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Slide scoring 
Slide scoring has been described in Section 2.2.3.3. When testicular cells were scored, 
haploid, diploid or polyploid cells were differentiated as described in the Slide scoring 
part in Section 5.2.1. 
Statistical analysis 
Tail moment data were taken from each individual animal and the mean or median 
values were calculated for each treatment group. Tests for homogeneity of variance 
were carried out. Where data were normally distributed and homogeneous, analysis of 
variance was performed followed by a Least Significance Difference test. If data were 
normally distributed and not homogenous, a Student's t-test was performed. Where 
data were not normally distributed, a Kruskal-Wallis test was performed. If values 
were significant a Mann-Whitney test was carried out to compare individual treatment 
groups. 
5.3 Results 
5.3.1 DNA damage induced by CP and other genotoxins in rats 
The results of the induction of DNA damage by the different chemicals in somatic and 
testicular cells are presented in Tables 5-1 to 5-6. The chemicals induced varying levels 
of DNA damage in diploid somatic bone marrow cells and in spermatids (haploid) and 
and diploid 
spermatocytes (tetraploid) or other diploid (e. g. Sertoli or Leydig) cells. Slides were 
only scored for haploid 
/t(esticular 
cells, except after treatment with EGME (Table 5-5) 
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where diploid testicular cells were also scored. It is documented (Anderson et al, 1987) 
that CP and EMS affect spermatids whereas EGME also affects Sertoli cells. BLM was 
believed respond like CP and EMS, so it was also examined at week 2. 
The results 2 weeks after CP administration at doses of 50,100 and 150 mg/kg are 
presented in Table 5-1. In both bone marrow and testicular cells there were increases 
in DNA damage at 50 mg/kg and 100 mg/kg as measured by the mean tail moment. 
At the dose of 150 mg/kg there was mortality of the animals. The greatest extent of 
DNA damage was seen at 50 mg/kg while at 100 mg/kg there was obviously some 
toxicity and less apparent DNA damage. Toxicity was obvious due to the fact that 
there was 100% mortality of the animals at the highest dose. 
Table 5-1: The genotoxic effect of cyclophosphamide on bone marrow and 
testicular cells in rats' 
Dose level 
(mg/kg bw) 
No. of animals 
% Head DNA 
content b 
Tail length 
(µm) 
Mean tail 
moment b 
Median tail 
moment 
Control 
D 
3 
iploid bone mar 
95.8 10.9 
row cells 
16.0 ± 0.8 1.4±0.5 0.5 
50 3 88.3±4.0 19.2±1.5 5.2±2.4 1.1 
100 3 90.5±0.8 18.1 ± 1.1 3.8 ± 0.7 1.2 
150 3 100% Mortality in animals was observed 
Haploid testicular cells 
Control 3 96.7 ± 0.9 16.4 f 3.7 1.1 ± 0.4 0.2 
50 3 86.5±3.2 17.0± 1.0 5.0± 1.0 0.9 
100 3 90.7±0.6 13.5±0.6 2.3±0.4 0.7 
150 3 100% Mortality in animals was observed 
' Assessed using the comet assay 2 weeks after treatment; b± Standard error of mean; 
Statistical analysis of comet tail moment values are presented in Table 5-7. 
Table 5-2 presents the effects of EMS on DNA damage, 2 weeks after administration 
of doses of 100,200 and 300 mg/kg. There was a very small increase in DNA damage 
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in bone marrow cells but responses were more marked in testicular cells, where there 
was also some toxicity at the highest dose. 
Table 5-2: The genotoxic effect of ethyl methanesulphonate on bone 
marrow and testicular cells in rats * 
Dose level 
(mg/kg bw) 
No. of animals 
% Head DNA 
content b 
Tail length ° 
(µm) 
Mean tail 
moment b 
Median tail 
moment ` 
Control 
D 
3 
iploid bone mar 
96.7 ± 0.2 
row cells 
18.311.2 1.1 ± 0.1 0.5 
100 2 96.8 ± 0.1 17.1 ± 2.1 0.9±0.1 0.5 
200 2 95.5 ± 0.5 18.4±0.5 1.4 ± 0.2 0.8 
300 3 95.7 ± 0.4 16.9 ± 1.9 1.3 ± 0.2 0.9 
Haploid testicular cells 
Control 3 96.4 ± 0.4 17.8±0.6 1.1 ± 0.1 0.7 
100 2 94.7±0.7 20.9±0.5 2.0±0.3 0.6 
200 3 93.8 ± 0.5 19.4 ± 0.4 2.1 ± 0.2 1.3 
300 3 94.8 ± 0.4 17.1 ± 2.1 1.6 ± 0.2 0.9 
' Assessed using the comet assay 2 weeks after treatment; b± Standard error of mean; 
` Statistical analysis of comet tail moment values are presented in Table 5-7. 
Table 5-3: The genotoxic effect of ethylene glycol monomethyl ether on 
bone marrow and testicular cells in rats 8 
Dose level 
(mg/kg bw) 
No. of animals 
% Head DNA 
content ° 
Tail length b 
(µm) 
Mean tail 
moment ° 
Median tail 
moment 
Control 
D 
3 
iploid bone mar 
96.8±0.3 
row cells 
13.5±0.4 0.8±0.1 0.4 
500 3 94.1±0.6 13.6±0.9 1.6±0.2 0.8 
1000 3 90.8 ± 1.2 14.1 ± 0.6 2.9 ± 0.5 0.9 
1500 3 94.5±0.8 13.6±0.8 1.6±0.4 0.5 
Control 3 
Haploid 
97.0± 
testicul 
0.3 
ar cells 
12.9 ± 0.8 0.7 ± 0.1 0.3 
500 3 92.1± 3.0 13.9± 1.0 2.3 ± 1.0 0.5 
1000 3 89.7± 3.9 13.7± 1.0 3.6 ±2.0 0.7 
1500 3 87.7± 4.2 14.6± 1.3 4.4 ±2.0 1.0 
' Assessed using the comet assay 2 weeks after treatment; bt Standard error of mean; 
Statistical analysis of comet tail moment values are presented in Table 5-7. 
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The induction of DNA damage induced by EGME, 2 weeks after administration of 
doses of 500,1000 and 1500 mg/kg is presented in Table 5-3. There were increases in 
DNA damage in both bone marrow and testicular cells, and a decrease in percentage 
head DNA content was observed in testicular cells. 
Effects were also examined in bone marrow and haploid testicular cells at 5 weeks 
after treatment with EGME, and in haploid and polyploid testicular cells at 6 weeks 
after treatment (Tables 5-4 and 5-5). However, there was no significant induction of 
DNA damage at these times either in bone marrow or testicular cells. 
Table 5-6 shows the effects of BLM at 2 weeks after administration of doses of 50, 
100 and 150 mg/kg. There were only very small increases in DNA damage at the 
lower doses, in both bone marrow and haploid testicular cells. 
Table 5-4: The genotoxic effect of ethylene glycol monomethyl ether on 
bone marrow and testicular cells in rats " 
Dose level 
(mg/kg bw) 
No. of animals 
% Head DNA 
content 
Tail length b 
(µm) 
Mean tail 
moment 
Median tail 
moment 
Control 
D 
2 
iploid bone mar 
96.7 ± 0.2 
row cells 
15.0 ± 1.8 0.9 ± 0.2 0.6 
500 2 96.9±0.3 13.9± 1.0 0.7± 0.1 0.4 
1000 2 97.0 ± 0.3 14.1 ± 0.8 0.7±0.1 0.4 
1500 2 97.3 ± 0.3 13.1 ± 0.8 0.6±0.0 0.4 
Control 3 
Haploid testicul 
93.3 12.3 
ar cells 
14.6 ± 0.7 2.4. +1.2 0.7 
500 3 94.5± 1.1 16.2±0.8 2.0±0.6 0.4 
1000 3 89.3 ± 4.7 15.8 ± 0.7 4.5±2.4 0.4 
1500 3 93.4 ± 1.0 15.7 ± 1.5 2.5±0.3 0.4 
' Assessed using the comet assay 5 weeks after treatment; b± Standard error of mean; 
`There were no statistical differences between the treated and control animals 
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Table 5-5: The genotoxic effect of ethylene glycol monomethyl ether on 
bone marrow and testicular cells in rats' 
Dose level 
(mg/kg bw) 
No. of animals 
% Head DNA 
content' 
Tail lengthb 
(µm) 
Mean tail 
moment" 
Median tail 
moment` 
Control 4 
Haploid testicul 
90.2 ± 2.1 
ar cells 
14.810.7 4.21 1.1 0.6 
500 3 90.1 ± 1.3 15.9±0.8 4.2±0.4 0.5 
1000 4 90.1±1.2 14.9 ± 0.6 4.3 ± 0.6 0.6 
1500 4 90.7±0.5 14.410.7 3.8±0.4 0.6 
Diploid t esticul ar cells 
Control 3 87.9 ± 1.2 17.21 0.5 5.7 ± 0.8 0.8 
500 4 90.2 ± 1.0 16.8 ± 0.7 4.3 ± 0.6 0.7 
1000 4 90.9± 1.2 16.4± 0.5 3.8 ± 0.7 0.8 
1500 4 90.1± 3.0 17.0± 1.1 4.4± 1.6 0.7 
Assessed using the comet assay 6 weeks after treatment; bf Standard error of mean; `There 
were no statistical differences between the treated and control animals 
Table 5-6: The genotoxic effect of bleomycin on bone marrow and testicular cells in rats 
Dose level No. of animals % Head DNA Tail length" Mean tail Median tail 
(mg/kg bw) content b (µm) moment b moment 
Control 9° 
Diploid bone ma 
96.7 t 0.3 
rrow cells 
15.9 ± 0.8 1.110.2 0.5 
50 2 93.5 t 2.9 13.5 ± 2.0 2.0: b 1.1 0.6 
100 2 96.3 ± 0.01 12.1-11.0 0.9 ± 0.1 0.4 
150 le 96.2 14.3 0.9 0.6 
Control 8° 
Haploid 
96.5 ± 
testic 
0.3 
ular cells 
15.4 ± 1.5 0.9 ± 0.2 0.4 
50 2 91.9± 0.8 11.1± 1.2 2.0± 0.8 0.6 
100 2 92.2 ± 2.8 12.1 ± 1.0 1.9 ± 0.5 0.7 
150 2 94.2± 0.8 11.7± 0.0 1.3± 0.1 0.4 
' Assessed using comet assay 2 weeks after treatment; bf Standard error of mean; ' Statistical 
analysis of comet tail moment values are presented in Table 5-7; d Controls from CPS EMS and 
EGME were used as historical controls for this treatment group since a control group was not 
available for the BLM study; ` One animal died 
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The results of the various statistical analyses of the data for the 2-week studies are 
presented in Table 5-7. 
Table 5-7: Summarised results of statistical analysis for the genotoxic effect in rats a 
Data form Type of 
cells 
One-sided LSD test results 
control vs control vs control vs 
low medium high 
Trend test results 
Linear Quadratic 
Cyclophosphamide treated rats 
Median values B. M. C. **- * ns 
T. G. C. ns ns - ns ns 
Log transformed B. M. C. **- * ns 
T. G. C. * ns - ns ns 
---------- ----- ------------------------- Ethyl methanesulphonate treated rats 
------ ------- 
Median values B. M. C. ns ns ns ns ns 
T. G. C. ns * ns ns ns 
Log transformed B. M. C. ns ns ns ns ns 
T. G. C. ns ** ns ns 
---- ------------------------- Ethylene glycol monomethyl treated rats 
------ ------- 
Median values B. M. C. ns * ns ns ns 
a. v. li. uJ aao uý 
Log transformed B. M. C. * * ns ns 
T. G. C. * * ** ** ns 
---------- ------ ---- -------------- Bleomycin treated rats 
------ -- ---- ------- 
median values B. M. C. ns ns ns ns ns 
T. G. C. ns * ns ns ns 
log transformed B. M. C. ns ns ns ns ns 
T. G. C. ns ns ns ns ns 
` Experiments carried out at 2 weeks after various chemical treatments 
B. M. C. = bone marrow cells; T. G. C. = haploid testicular germ cells 
ns = not significant; *=p<0.05; ** =p<0.01 
In addition to the tables, the distribution of percentage tail moment values in bone 
marrow and testicular cells have been illustrated to show the dose response effects of 
the various chemicals, 2 weeks after the dose administration (Figures 5-la, b and 5- 
2a, b). 
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Figure 5-1. Distribution of percentage tail moments in hone marrow (B. M. ) 
and testicular cells from each group of anünals * 
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Figure 5-2: Distribution of percentage tail moments in bone marrow (B. M. ) 
and testicular cells from each group of animals * 
a 
v 
U 
w 
`v 
z 
J 
ýJ 
:C 
C 
L 
J 
y 
R. 
70 
60 
50 
40 
3( 
21 
1 eslis 15011 
is 1000 
500 
nlrol 
se (mg/kg Mal 
00 o 
rn 
b 
J. 
'J 
H 
L 
v 
L 
7 
z 
L 
'J 
L 
a 
70 
60 
--"ftw Tcsl1 ISO 
lestis Illll 
fcstisur 50 
Testis control 
6. M. 15)) 
Z *w II. M. 100 
B. M. 50 Dose (ntg/Iýg b%% ) 
R. M. control 
*2 weeks after treatment 
Ethylene glycol monomethyl ether-treated cells 
170 
Bleomycin-treated cells 
5.3.2 DNA damage induced by butadiene in mice and by diepoxybutane 
in rats 
Tables 5-8 and 5-9 show the mean and median tail moment values in the comet assay 
for 50 testicular cells per animal, in the 6 hr acute butadiene inhalation study 
conducted in mice. The results of statistical analysis are summarised in Table 5-15. 
Table 5-8: The acute genotoxic effect of butadiene on mouse haploid testicular cells °'b 
Control 12.5 ppm 125 ppm 
Mouse No. Mean' Median Mean ` Median Mean ` Median 
1 11.7±2.5 3.3 6.8±1.8 1.3 15.8±3.5 4.9 
2 10.1±1.9 5.0 7.9±1.7 2.9 15.1±3.2 2.5 
3 9.8±2.4 2.1 12.8±3.9 1.0 12.1±2.5 2.4 
4 7.6±1.8 2.4 11.6±2.3 3.0 10.5±2.4 1.6 
5 7.6±1.9 1.9 12.5±2.7 3.2 
' Animals exposed to butadiene through inhalation for 6 hr; b Assessed using comet assay, 
showing mean and median comet tail moment values for every 50 haploid testicular cells from 
each mouse; `±Standard error of the mean 
Table 5-9: The acute genotoxic effect of butadiene on mouse polyploid testicular cells a'b 
Control 12.5 ppm 125 ppm 
Mouse No. Mean ` Median Mean ` Median Mean ` Median 
1 9.7±1.6 3.4 7.8±1.4 3.6 33.2±3.7 34.3 
2 5.1±0.8 2.9 4.6±0.8 2.5 18.9±2.9 13.3 
3 11.3±1.4 9.1 23.9±3.5 11.3 13.8±1.6 11.5 
4 6.8±0.9 5.5 9.9±1.5 5.2 9.4±1.2 6.4 
5 5.6±0.9 3.8 12.0±1.4 10.8 
' Animals exposed to butadiene through inhalation for 6 hr; b Assessed using comet assay, 
showing mean and median comet tail moment values for every 50 polyploid testicular cells from 
each mouse; `±Standard error of the mean 
Table 5-10 shows body weights, and the weights of testis and epididymides of mice in 
the 4-week BD inhalation study. There were no significant differences between each 
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treatment group for their net weight gain and epididymal weight. However, the weight 
of testis for the 130 ppm group was significantly lower than that of the other groups 
(ANOVA, p=0.002). 
Table 5-10: The subchronic effect of butadiene inhalation exposure on body 
and sexual organ weights in male mice a'b 
Dose (No. of 
animals) 
Starting Final Net body Testis wt d 
body wt. ` body wt. wt. gain 
Epididymides 
wt. 
control (10) 27.2010.42 35.75±0.61 8.55 ± 0.56 0.2610.01 0.04±0.001 
12.5 ppm (5) 27.80± 0.58 35.20: k 1.15 7.40± 1.28 0.25±0.01 0.04: k 0.001 
65 ppm (5) 27.40 ± 0.40 37.3010.62 9.90: k 0.68 0.2710.02 0.04 ± 0.003 
130 ppm (5) 26.80±0.37 34.70± 1.18 7.90± 1.50 0.18±0.02 0.03 ± 0.001 
Animals exposed to butadiene through inhalation for 6 hr per day, 5 days per week, over 
4 weeks; b All values showing mean ± standard error of the mean; ° wt. = weight in 
grammes; d 130 ppm group significantly lower than other groups (ANOVA, p=0.002) 
Table 5-11 shows the response in the comet assay of cells from liver, bone marrow 
and testes of male CD-1 mice exposed by inhalation to BD 6 hr daily, 5 days per week 
over 4 weeks. There were no effects compared with the control animals exposed to air 
alone. Statistical analysis of the results are summarised in Table 5-15. 
Table 5-11: The subchronic genotoxic effects of butadiene on various murine cells a ,b 
Bone marrow cells Liver cells Haploid testicular cells 
Dose (No. of animals) Mean of Mean of Mean of Mean of Mean of Mean of 
means Medians Means Medians Means Medians 
control (5) 8.8 ± 0.7 6.3 ± 0.6 6.1±0.6 4.6±0.6 5.7±0.4 4.5±0.6 
12.5ppm(5) 8.8 ± 0.7 6.9±0.4 72±0.3 5.8 ± 0.2 5.6±0.7 4.7±0.5 
65ppm(5) 7.6±0.2 5.8±0.5 6.8 ± 0.7 5.4 ± 0.6 5.8 ± 0.3 4.3±0.3 
130ppm(5) 8.0±1.0 6.1±0.8 6.5±0.4 5.5±0.5 5.3±0.3 4.1±0.4 
' Animals exposed to butadiene through inhalation for 6 hr per day, 5 days per week, over 4 
weeks; b Assessed using comet assay, showing mean of means and medians of comet tail 
moment values for every 50 various cells from each mouse, all values presented as mean f 
standard error of the mean 
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Table 5-12 shows the response in the comet assay of haploid cells from testes of male 
CD-1 mice exposed to BD for 6 hr daily, 5 days per week over 10 weeks. The inter- 
animal differences within a treatment group were larger than expected. There were no 
effects by comparison with the control animals exposed to air alone. Statistical results 
are summarised in Table 5-15. 
Table 5-12: The chronic genotoxic effect of butadiene on mouse haploid testicular cells °'b 
Control 12.5 ppm 125 ppm 
Mouse No. Mean ` Median Mean' Median Mean' Median 
1 7.4±1.8 1.3 4.8±0.8 1.8 8.1±1.9 2.2 
2 13.9±2.4 5.5 6.2±1.2 2.6 9.2±1.8 3.3 
3 6.7±1.3 3.1 11.1±2.0 3.4 7.0±1.4 3.4 
4 9.7±1.5 4.8 14.4±2.0 8.9 5.8±1.2 2.2 
5 7.2±1.5 2.5 7.2±1.1 3.7 7.9±1.6 2.6 
' Ani mals exposed to butadiene through inhalation for 6 hr per day, 5 days per week, over 
10 weeks; b Assessed using comet assay; ` Presented as mean ± standard error of the mean 
for 50 cells from each mouse 
Table 5-13: The chronic genotoxic effect of butadiene on mouse 
diploid/polyploid testicular cells in vivo °'b 
Mouse No. 
Control 
Mean ` Median 
12.5 ppm 
Mean` Median 
125 ppm 
Mean` Median 
1 4.5±0.7 3.0 2.6±0.6 1.3 8.211.5 3.9 
2 13.2±1.4 11.1 6.8±0.9 4.5 7.4±1.2 3.9 
3 4.9±0.7 3.0 6.3±0.7 5.5 5.3±0.8 3.8 
4 7.4±1.1 4.6 8.0±1.0 6.1 2.9±0.4 2.2 
5 3.8±0.9 1.9 4.2±0.5 3.7 3.3±0.4 2.8 
Animals exposed to butadiene through inhalation for 6 hr per day, 5 days per week, over 
10 weeks; b Assessed using comet assay; ° Presented as mean f standard error of the mean 
for 50 cells from each mouse 
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Table 5-13 shows the response in the comet assay of diploid/polyploid cells from 
testes of male CD-1 mice exposed to BD for 6 hr per day, 5 days per week over 
10 weeks. There were no effects compared with the control, animals exposed to air 
alone. Statistical results are summarised in Table 5-15. 
Table 5-14 shows the response in the comet assay of haploid cells from testes of rats 
treated intraperitoneally with DEB after 24 hr. There were no effects compared with 
the control animals exposed to physiological saline. Statistical results are summarised 
in Table 5-15. 
Table 5-14: The acute genotoxic effect of 1,2,3,4-diepoxybutane on rat 
haploid testicular cells in vivo "b 
Control 12.5 mg/kg 25 mg/kg 50 mg/kg 
Mice No. Mean' Median Mean ` Median Mean ° Median Mean ° Median 
1 11.7±2.0 6.4 13.9±2.4 5.7 7.5±1.2 3.2 21.5±2.6 15.1 
2 22.8±3.5 8.8 15.6±2.3 7.9 15.7±2.4 7.0 10.1±1.6 5.4 
3 13.4±2.5 6.7 21.9±2.8 12.6 13.2±2.2 6.6 19.4±3.1 9.1 
4 13.1±2.1 7.5 15.0±2.2 6.9 15.2±2.7 4.3 16.3±2.5 7.1 
5 18.8±3.2 5.9 9.6±2.1 2 15.5±2.8 2.3 12.6±2.2 5.8 
' Animals treated with a single dose of diepoxybutane intraperitoneally and killed 24 hr 
after receiving treatment; b Assessed using come t assay; ` Presented as mean ± standard 
error of the mean for 50 cells from each rat 
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Table 5-15: Summary of statistical analysis of results of animal studies with 
butadiene (BD) and 1,2,3,4-diepoxybutane (DEB) using the comet assay 
Dose level Mean tail moment Median tail moment 
Mouse acute BD treatment. haploid testicular cells 
Control -- 
12.5 ppm ns ns 
125 ppm " ns 
Mouse acute BD treatment. diploi /polyploid testicular cells 
1Q week BD treatment testicular haploid cells and diploid bone marrow cells 
Control -- 
12.5 ppm ns ns 
125 ppm ns ns 
Mouse 4 -week BD treatment. bone marrow. 
liver and haploid testicular cells 
Control -- 
12.5 ppm ns ns 
65 ppm ns ns 
130 ppm ns ns 
Control -- 
12.5 mg/kg bw ns ns 
25 mg/kg bw ns ns 
50 mg/kg bw ns ns 
ns = not significant; *=p<0.05 
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5.4 Discussion 
5.4.1 DNA damage induced by CP and other genotoxins in rats 
In the present study, which aimed to transfer a sensitive in vitro technique for use in in 
vivo studies, the effect of CP, EMS, EGME and BLM on DNA in rat somatic and 
germ cells was investigated. In order to obtain a better overview of the data, a variety 
of statistical analyses were used to evaluate the best method to aid the interpretation of 
the data set since there appear to be no `ideal' way for analysis. The use of the non- 
parametric Kruskal-Wallis test to analyse the comet tail moment values was 
considered but this approach uses the cell as opposed to the animal as the unit of 
measurement, and consequently it does not take account of the inter-animal variation. 
The use of a non-parametric test was necessary because comet tail moment values 
violate normality and homogeneity requirements of parametric tests, such as an 
analysis of variance. However, using the Kruskal-Wallis approach on all the cells 
within a dose level could lead to an overestimation of significance, if differences exist 
between individual rats, as appeared to be the case. Thus the log-transformed method 
transformed data to obtain normality. An analysis of variance was also conducted on 
the median value of the tail moment for each slide. For each treatment group the 
median values were normally distributed and the skewing effect was reduced. 
Using the cell as the unit of measure provides the highest number of degrees of 
freedom but it ignores the animal variation and could lead to a high level of Type 1 
(false positive) errors. Using the animal as the unit of measure when limited to only 3 
animals per treatment group limits the degrees of freedom such that the occurrence of 
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Type 2 (false negative) errors may be enhanced. Log transformation of the data 
renders them more normally distributed, allowing for the use of a parametric analysis 
of variance; however, it does not resolve the problems regarding sample size. The use 
of a balanced design in which the median tail moment values are used appears to be a 
reasonable compromise for this short-term in vivo comet assay. The average values 
are normally distributed, and the balanced design makes the slide the unit of measure 
(2 slides per animal). A conclusion from this study is that in future experiments it 
would seem advisable to have larger numbers of animals per group which might 
increase accuracy and reduce false negatives. 
CP is an anticancer drug, a well-studied mutagen and is used as a positive control in 
many genetic toxicology studies (Anderson et al, 1995b). It is an alkylating agent, as 
is EMS, which has also been used as a positive control in many studies. However, CP 
is a bifunctional agent and primarily induces DNA cross-links, in contrast to EMS 
which is a monofunctional alkylating agent. CP showed persistent effects in an in vivo 
investigation on human blood cell using the comet assay, but varied greatly form 
subject to subject (Hartmann et al, 1995). It also elicited positive effects on blood 
lymphocytes and bone marrow cells in vivo in mice in comet assays (Vaghef et al, 
1996; Hellman et al, 1997). EMS showed positive effects in fish (Belpaeme et al, 
1996) and in mouse leucocytes and ovarian cells in vivo (Croom et al, 1991) in the 
comet assay. EGME is generally considered to be a reproductive toxin but not a 
genotoxin (ECETOC, 1995). However, Chiewchanwit and Au (1994) have shown that 
EGME, at high doses, and 'methoxyacetaldehyde, a metabolite of EGME, induced 
chromosomal aberrations in mammalian cells in vitro. The same metabolite also 
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induced gpt gene mutations (deletion mutations) in CHO-A552 cells (Chiewchanwit 
et al, 1995) indicating that EGME may be a somatic cell mutagen, in addition to being 
a reproductive (i. e. germ cell) toxin. Bleomycin is an anticancer drug (Umezawa et al, 
1966) and is thought to act through oxygen radical mechanisms (Povirk, 1996). 
Furthermore, it induced DNA damage in the comet assay in human lymphocytes 
(Anderson et al, 1994). 
In the present study the chemicals to which the animals appeared to be most 
responsive were CP and EGME, both for somatic and testicular cells. With EMS there 
was little effect on bone marrow cells and only small increases in germ cell effects. 
Similarly, only modest effects were observed with BLM in haploid testicular germ 
cells, which is in contrast to the response in the in vitro study (Chapter 4; Anderson et 
al, 1994). Possible reasons for the poor effect of BLM in this rat study may be due to: 
the high activity of BLM hydrolase in the rat in vivo, as it is known that rat BLM 
hydrolase can deactivate BLM (Povirk and Austin, 1991; Takeda et al, 1996); or 
DNA repair in the bone marrow and testicular cells might have eliminated the early 
damage so that it was not detectable by the comet assay; and possibly, the bone 
marrow and testis of the rats are poor target organs for BLM. 
The present study shows that the comet assay is able to detect persistent damage in 
somatic bone marrow and testicular cells. After treatment with the chemicals, comets 
were produced in haploid, diploid and polyploid testicular cells. Haploid cells 
(probably round spermatids) were studied after treatment with CP, EMS and BLM 
because the spermatids are known to be the germ cell stage most sensitive to these 
chemicals (Dean et al, 1982). Haploid and polyploid cells were investigated after 
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treatment with EGME, because diploid cells are also known to be affected by EGME 
in other studies (Anderson et al, 1987). However, the dose-related decline in 
percentage head DNA content after EGME treatment might relate to a change in ratio 
of polyploid to haploid cells. A clear dose-related decrease in percentage head DNA 
content did not happen with the other chemicals, which were not observed at 5 and 6 
weeks after treatment. Such a change may be caused by the different kinetics of 
chemical in vivo, i. e. the action of the chemical in the body over the treatment period, 
including its absorption, distribution and metabolism. 
5.4.2 DNA damage induced by butadiene in mice and by diepoxybutane 
in rats 
Based on the findings of the previous study, at least 5 animals per group were used in 
this investigation. 
It is known that the bio-transformation of BD is mediated by CYP2E1 and other 
cytochrome P450 proteins (Elfarra et al, 1996), and the enzymatic reactions can lead 
to ROS generation (Goeptar et al, 1995). So far, there is no experimental evidence of 
the relevance of ROS in the genotoxic effects of BD. 
Extensive experimental evidence has accumulated concerning the genotoxic effects of 
BD and its metabolites (Sorsa et al, 1993; Löser and Tordoir, 1996; Himmelstein et 
al, 1997; ECETOC, 1997). It is generally believed that EB and DEB are the two 
active BD metabolites, and both can directly react with cellular DNA, with DEB 
being several times more active than EB (Adler et al, 1995). In the present 
investigation mice, which were thought to be more susceptible than rats to the toxicity 
of BD (Adler et al, 1995; Himmelstein et al, 1997), were used in the BD inhalation 
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studies to try to determine any possible genotoxic effects in male mice. The less 
susceptible rats were used to assess whether DEB, 24 hr after its administration, could 
cause DNA damage as determined in the comet assay. 
In all the comet experiments in the present investigation all groups of mice, except 
one did not respond to BD inhalation exposure. Only the haploid cells from the testes 
in mice after acute inhalation to BD (6 hr) at 125 ppm, showed an increase in DNA 
damage. The weight of testis for the 130 ppm group was significantly lower than that 
of the other groups in the 4-week study (body and organ weights were not examined 
in the other studies). Compared with the data acquired in other experiments (Anderson 
et al, 1997b), where dominant lethal effects were observed, the damage assessed by 
the comet assay endpoint was ephemeral. The reason for the significant effect after 6 
hr acute inhalation exposure and the lack of significance for chronic and subchronic 
exposure might be due to a metabolic/kinetic mechanism of the comet-detectable 
DNA damage. The extent of DNA damage might have increased with the increased 
level of reactive BD metabolites soon after inhalation commenced, and at the same 
time the expression of inducible components (such as detoxifying enzymes, DNA 
repair and maintenance elements, stress proteins, etc. ) in the cells also gradually was 
increased. In a relatively short time, the DNA damage level (i. e. comet-detectable 
breaks and alkali-labile sites rather than other types of lesions) reached a maximum 
peak. As time progressed the DNA damage level was reduced and limited by the 
inducible components, until it reached a dynamic equilibrium state which was 
indistinguishable between control animals and treated animals. The above hypothesis 
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does not exclude the accumulation of other DNA lesions (e. g. point mutations and 
other stable changes) in the treated animals. 
DEB, known to be the most active among BD metabolites, failed to show positive 
responses in the comet assay of haploid cells from testes of rats. However, the results 
were not surprising for two reasons: rats are insensitive to BD treatment (Himmelstein 
et al, 1997), and are therefore likely to be resistant to BD metabolites; moreover, the 
comet assay used in this study was designed to detect DNA strand breakage and 
alkali-labile sites in DNA, and the method requires a minimum number of such 
lesions to be present when the assay is conducted, which possibly was not the case. 
Both of the above hypothetical reasons can easily be tested in future experiments, i. e. 
through an in vitro metabolic rate study or a time course in an in vivo comet assay 
using rats. In contrast, rat bone marrow cells showed a positive response in the comet 
assay at 50 mg/kg bw DEB given intraperitoneally (Anderson et al, 1997b). Another 
genetic endpoint, micronuclei in rat bone marrow cells, showed highly significant 
responses at a dose level of DEB of 25 and 50 mg/kg bw administrated 
intraperitoneally (Anderson et al, 1997b). It seems that cells from different organs in 
rats have different susceptibilities to DEB in the comet assay. Again, as discussed 
previously, the chemical kinetics might be an important factor in the genotoxicity of 
DEB in male rats. 
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CHAPTER 6 
ROS-INDUCED GENETIC DAMAGE IN HUMANS 
6.1 Introduction 
Two human studies are presented in this chapter, the first concerned with the benefit 
of an exogenous antioxidant, vitamin C in healthy human volunteers, whereas the 
second is concerned with the detection of oxidative stress in diabetic patients. 
Vitamin C Study 
Human tissues are protected from oxidative damage by a variety of mechanisms 
(Anderson, 1996), including small molecular weight antioxidants, ROS-detoxifying 
enzymes and DNA-repair enzymes (see Chapter 1). Among the simpler antioxidants, 
vitamin C is one of the most well-known and possibly the most important. 
Epidemiological evidence suggests that antioxidant vitamins can inhibit heart disease 
(Kardinaal et al, 1993) and cancer (Flagg et al, 1995). Since humans cannot 
synthesise ascorbate, their main source of the vitamin C is intake from fruit and 
vegetables. However, there is considerable uncertainty about the optimal level of 
intake. It is widely believed among the general population, that the greater the amount 
consumed the greater the beneficial effect in terms of preventing oxidative damage 
and the diseases thought to result from it. This concept has been challenged by 
Diplock (1987,1996). 
The Vitamin C Study was undertaken to address the question of whether any benefit 
can be demonstrated from the intake of large quantities of vitamin C by a population 
of healthy, well-nourished individuals. A number of biomarkers which include the 
comet assay, antioxidant capacity, plasma lipoperoxidation and plasma p21 levels 
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were used to investigate the effect of vitamin C supplementation on antioxidant status 
and oxidative damage. 
Diabetes Study 
There are generally two forms of diabetes: type I, insulin-dependent diabetes mellitus 
(IDDM) and type II, non-insulin-dependent diabetes mellitus (NIDDM). Both are 
characterised by a systemic defect in insulin-dependent metabolism but differ in their 
mechanisms of pathogenesis, insulin deficiency versus insulin resistance, respectively. 
There is evidence to suggest that ROS are involved in the pathogenesis and . 
complications arising from IDDM, whether resulting from autoimmune mechanisms 
or from chemical induction. Indeed, the two most commonly employed diabetogens 
namely alloxan and streptozotocin, act at least partly through the production of 
reactive oxygen species (Baynes, 1991). However, there is little experimental 
evidence to suggest a role of oxidative stress in the pathogenesis of NIDDM (Baynes, 
1991; 1995). 
In order to investigate the hypothesis of ROS involvement further, in the present 
study, peripheral blood samples were taken from healthy volunteers and IDDM and 
NIDDM patients. Samples were examined in the comet assay to determine whether a 
difference in DNA damage might be discerned, which could result from oxidative 
stress produced by reactive oxygen species. In addition, the antioxidant status of the 
individuals was investigated to determine if there were any differences in the three 
groups. Creatinine levels and glycosylated haemoglobin (HbAIc) values, well known 
chemical markers for diabetic patients, have also been measured to evaluate kidney 
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function and diabetic control by insulin administration respectively. Finally, various 
life-style factors have been taken into account in a questionnaire for each individual, 
since these may have a confounding influence in human monitoring studies (Anderson 
et al, 1988). 
6.2 Materials and methods 
General materials and methods have been detailed in Chapter 2. 
6.2.1 The Vitamin C Study 
Study design 
Cholesterol status was considered to be an important factor in the design of the study, 
since a correlation has been established between serum cholesterol level and risk of 
coronary heart disease, as well as the severity of atherosclerosis (Stamler et al, 1986). 
The following serum cholesterol values have been recommended for the recognition 
of hypercholesterolaemia: suspected if serum cholesterol is above 5.7 mmol/l, and 
elevated if above 6.7 mmol/l (Schettler and Nüssel, 1975). For analysis of the data 
from this study, volunteers with serum cholesterol levels below 6.0 mmol/l were 
classified as `low' cholesterol and those with levels higher than 6.0 mmol/l were 
classified as `high' cholesterol. 
From a panel of over 100 non-smoking volunteers, 48 were selected to have as wide a 
range of serum cholesterol levels as possible. These individuals were allocated to 3 
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groups of 16, each consisting of 4 males with low cholesterol levels, matched for age 
and build with 4 males with high cholesterol levels, and 8 females matched in the 
same way. The ages of the volunteers ranged from 20 to 68 years with a mean of 45.7 
years. None of the volunteers was taking medication to control cholesterol levels and 
they were allowed to maintain their normal dietary habits so as not to compromise 
their cholesterol status. For the main study, a three way cross-over design (three- 
treatment x three-treatment-period) was adopted (shown in Table 6-1) to take account 
of temporal differences in response which have been demonstrated for certain 
parameters (Dewdney et al 1986; Anderson et al, 1991). In each treatment period, 
volunteers were given either a placebo, 60 mg vitamin C or 6g vitamin C per day for 
14 days. A period of 6 weeks was allowed between treatment periods. Blood samples 
were taken at the end of the treatment period, approximately 8 hr after the last dose. 
Prior to the main study a preliminary study was conducted to test the suitability of the 
parameters to be examined and the methods to be used. 
Table 6-1: Design of the main vitamin C supplementation study 
Time course (week) Placebo 
Vitamin C treatment 
60 mg per day 6g per day 
1 and 2 Group A Group B Group C 
Blood sample 1 
3-8 WASHOUT PERIOD 
9 and 10 Group B Group C Group A 
Blood sample 2 
11-16 WASHOUT PERIOD 
17 and 18 Group C Group A Group B 
Blood sample 3 
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Vitamin C administration 
The lower dose of vitamin C was administered in the form of 2x 30 mg Sanatogen 
Chewable Vitamin C tablets taken once daily. The high dose was administered as 6x 
1000 mg Redoxon effervescent tablets dissolved in water; 2 tablets were taken 
approximately every 8 hours. The placebo consisted of Horlicks tablets. These 
materials were purchased from a local retailer. 
Blood sampling 
All the assays were conducted on each sample of peripheral blood obtained by 
venepuncture, the post sampling treatment of blood for each assay has been detailed in 
Chapter 2. 
Lipid peroxidation breakdown products 
This has been described in Section 2.2.7. 
Total antioxidant capacity 
This has been described in Section 2.2.8. 
Comet assay 
The separated lymphocytes from blood were washed once with PBS and either 
incubated with or without H202 for 30 min at 37°C, followed by a standard comet 
assay procedure (Section 2.2.3). Software `Comet 2.4' was used for the slide scoring 
in this study. 
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p2I ra protein estimation 
This has been detailed in Section 2.2.6. 
Statistical analysis 
For continuous variables, the data were tested for normality and homogeneity. If 
either of these assumptions was violated, transformations were performed. 
The data were subjected to an analysis of variance testing for treatment, treatment 
period, cholesterol and gender effects. Pair-wise comparisons between groups were 
made using a least significant difference test (LSD). A level of probability of less than 
0.05 was taken as indicating statistical significance. 
6.2.2 The Diabetes Study 
Study design 
The individuals answered a questionnaire to provide information relating to lifestyle 
factors that might have a confounding effect. There were 20 controls, 22 IDDM patients 
and 23 NIDDM patients. Information relating to each individual is shown in Table 6-2, 
including disease status and various types of possible confounding factors such as age, 
sex, contraceptive pill use, cups'of tea/coffee intake per day, smoking, alcohol intake, 
illness (virus, e. g. cold) and vitamin intake. Peripheral blood samples (10 ml) were 
collected by venepuncture into heparinised tubes from patients and as well-matched as 
possible to control individuals. They were obtained by Dr John Wright from The Royal 
Surrey County Hospital over a5 week period and were examined `blind', i. e. without 
knowledge of their origin. The measurement of creatinine levels and HbAIc levels was 
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carried out by the Clinical Biochemistry Department in The Royal Surrey County 
Hospital. The coefficient of variation for both assays is less than 5%. The comet assay 
and the antioxidant capacity assay were carried out at BIBRA. 
Table 6-2: Information of individual patient relating to the subject of the study 
Individual 
No Age Sex 
2 Diagnosis2 Patient Contraceptive 
use 
Tea 
intake` Smoking Alcohols ll` 
Vitamins 
intake 
1 65 M III B no 10 no ii yes yes 
2 54 F II C no 8 no ii yes no 
3 64 F II C no 9 no ii no yes 
4 63 F III B no 10 no ii no no 
5 42 M III B no 9 no ii no no 
6 51 M II B no 6 no i no no 
7 54 M III C no 13 yes ii yes no 
8 49 F II B no 5 no ii yes no 
9 33 M III B no 6 no i yes no 
10 66 F II C no 5 yes i no yes 
11 31 F III B yes 5 no ii no no 
12 50 F III C no 7 no i yes no 
13 78 M III B no 8 no ii no yes 
14 58 F III B no * * ii 
15 55 M III C no 4 yes ii no yes 
16 63 M III B no 8 no i yes no 
17 66 M II C no 7 no ii no no 
18 73 M III B no 8 no ii no yes 
19 43 M III B no 6 yes i no no 
20 30 M III B no 6 yes i no no 
21 60 M III C no 10 no ii yes no 
22 50 F II C no 3 no i no no 
23 69 F III B no 14 no ii yes yes 
24 57 M III C no 5 no i yes no 
25 46 F III B no 3 no i no yes 
26 48 M III C no 10 no i no no 
27 65 F II C no 2 no ii no no 
28 67 M III B no 8 no ii no no 
29 68 F III B no 4 no ii no no 
30 63 F 11 B no 2 no ii yes no 
31 84 F III B no 8 no ii no no 
32 75 M III C no 5 no ii yes yes 
33 66 F II C no 6 no ii no no 
34 74 M III C no 6 no ii yes no 
35 70 M III C no 6 no ii no no 
36 55 M I A no 4 no i no no 
37 45 F I A no 8 no i no no 
38 50 F I A no 8 yes ii no yes 
continued..... . 
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?9 F III B yes 8 no ii yes no 
40 24 M I A no 8 yes i no no 
41 68 F I A no 10 no ii no no 
42 47 M I A no 3 no i no no 
43 31 F I A no 7 yes i no yes 
44 52 M I A no 7 yes i no no 
45 35 F III B no 7 no ii yes no 
46 40 M I A no 3 no ii no yes 
47 64 F I A no 4 no ii no no 
48 16 M III B no 3 no ii no no 
49 70 F III C no 4 no ii no 
50 55 M II C no 0 yes ii no no 
51 67 M 11 C no 8 no ii yes no 
52 60 M * C no 11 no ii yes yes 
53 60 M I A no 8 no i no yes 
54 59 M I A no 3 no ii no no 
55 51 M II C no 6 no ii no no 
56 55 M II C no 8 no ii no no 
57 60 M III C no 4 no ii yes no 
58 40 F I A no 8 no ii no no 
59 64 F I A no 5 no i yes no 
60 61 F I A no 6 no i no no 
61 67 F I A no 8 no i yes yes 
62 40 F I A no 5 yes i no yes 
63 37 M I A no 10 yes ii no no 
64 62 F I A no 6 no i yes yes 
65 36 M * A no 9 no i no no 
' Years since disease had been diagnosed, I= control, II= <5 yr from diagnosis, III= >5 yr from diagnosis; 
b Patient Group, A= control, B= insulin-dependent diabetes mellitus, C= non-insulin-dependent diabetes 
mellitus; ` Cups of teaicoffee consumed daily; d Units of alcohol consumed weekly, i= >5, ii= <5; ` Illness, 
yes= there had been infections or a disease state in the last six months, e. g. a cold; *= Missing value 
Creatinine levels 
Plasma creatinine was measured by a kinetic Joffe reaction on an IL Monarch® 
automated analyser. Creatinine can be increased in individuals with diabetes due to 
kidney complications. 
Glycosylated haemoglobin (HbAId measurement 
HbAJ(. comprises 5% of adult haemoglobin. This glycosylated Hb is increased in 
patients with diabetes. This was measured by an HPLC method on a Biomen® analyser. 
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Total antioxidant capacity 
This has been described in Section 2.2.8. 
Comet assay 
The general procedures have been detailed in Section 2.2.3. Peripheral cells from 
whole blood from donors were used instead of purified cells. A microscopic scoring 
method was used for this study. 100 cells were examined per slide and 200 cells were 
examined per individual. Cells were classified into 4 categories: no damage, low 
damage, high damage and complete damage; less than - 10%, less than - 90% and 
greater than - 90% damage, respectively. 
Statistical methods 
The Anderson-Darling method was used to test the normal distribution of data for all 
parameters examined (p > 0.05 was considered to be normally distributed). A pair-wise 
comparison of data for the control and patient groups was performed using the Mann- 
Whitney test (non-normally distributed data) or t-test (normally distributed data). 
6.3 Experimental results 
6.3.1 The Vitamin C Study 
Prior to the main study, a preliminary investigation was conducted to test the 
suitability of the chosen parameters and of the methodology. In this trial, volunteers 
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received either 60 mg vitamin C per day or 6g vitamin C per day for 14 days; no 
placebo group was included. Blood samples were examined for total antioxidant 
capacity and DNA damage in lymphocytes (comet assay). A statistically significant 
increase in total antioxidant capacity of plasma was found in the volunteers receiving 
6g vitamin C per day compared with 60 mg per day but there was no overall 
significant effect on DNA damage measured by the comet assay (Anderson et al, 
1995d). The main study was based on the result of this preliminary investigation. 
Blood cholesterol and vitamin C levels 
In both the preliminary and the main studies, cholesterol and vitamin C levels in the 
blood samples were measured by the Biochemistry Department in BIBRA (Anderson 
et al, 1997b). These two parameters are not shown, but discussed in this thesis for the 
completeness of the whole study. 
There was no evidence of an effect of vitamin C supplementation on serum 
cholesterol levels during the study (Anderson et al, 1997b). 
Both levels of vitamin C supplementation caused a statistically significant increase in 
mean plasma vitamin C levels (Anderson et al, 1997b). The value for the top 
supplementation dose was also statistically significantly higher than that for the low 
supplementation level. There was no statistically significant difference between vitamin C 
levels in volunteers with `low' and `high' cholesterol levels but there was a statistically 
significant difference between male and female volunteers (Anderson et al, 1997b). 
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Lipid peroxidation in blood plasma 
The level of lipid peroxidation breakdown products found in plasma varied very little 
between volunteers and between treatments (Table 6-3). No statistically significant 
differences were found between `low' and `high' cholesterol groups, males and 
females or the three treatment groups. However, there was a small dose-related 
reduction in lipid peroxidation breakdown products with vitamin C supplementation. 
Table 6-3: Plasma lipid peroxidation levels in volunteers on vitamin C supplementation °'b 
Overall ` Placebo Low Vit C High Vit C 
ns ns 
Overall ` 0.84±0.02 0.840.04 0.83±0.03 0.860.02 
n=142 n=48 n=48 n=46 
ns 
Low Cholesterol 0.85±0.02 0.87±0.05 0.86±0.03 0.81±0.02 
n=96 n=32 n=32 n=32 
ns 
High Cholesterol 0.83±0.03 0.93±0.08 0.78±0.04 0.77±0.03 
n=46 n=16 n=16 n=14 
Males 0.86±0.02 0.91±0.05 0.81±0.03 0.85±0.02 
n=72 n=24 n=24 n=24 
ns 
0.83±0.03 0.87±0.07 0.85±0.04 0.74±0.03 
Females n=70 n=24 n=24 n=22 
' Concentration of malondialdehyde plus 4-hydroxyalkenals in µM; b Presented as mean ± standard 
error and levels of significance resulting from data that were subjected to an analysis of variance and 
pair-wise comparisons made using an LSD test; ` Overall means for all and each group of subjects 
ns = not significantly different (>0.05) 
Total antioxidant capacity in blood plasma 
The overall mean values for all treatment groups (Table 6-4) showed a statistically 
significant difference between the `low' and `high' cholesterol groups, the antioxidant 
capacity being greater in the high cholesterol group. Male volunteers had a higher 
mean antioxidant capacity than the females. Vitamin C supplementation significantly 
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increased antioxidant capacity but there was no statistically significant difference 
between the low and high levels of vitamin C supplementation. 
Table 6-4: Plasma antioxidant capacity in volunteers on vitamin C supplementation ''b 
Overall ` Placebo Low Vit C High Vit C 
** 
Overall 
Low cholesterol 
High cholesterol 
Males 
258.9±7.0 
n=141 
242.0±7.9 
n=95 
293.7±12.9 
n=46 
292.0±11.1 
n=72 s* 
ns 
241.519.5 269.9±13.5 265.0±12.8 
n-47 n=48 n=46 
229.7±11.0 252.4±17.0 243.5±11.6 
n=31 n=32 n=32 
264.4117.1 
n=16 
305.0±20.1 
n=16 
314.3±29.2 
n=14 
268.9±15.2 
n=24 
305.8±22.5 
n=24 
301.4±19.2 
n=24 
Females 224.3±6.2 J 213.0±7.9 234.1±11.5 225.3±12.2 
n=69 n=23 n=24 n=22 
' Measured as lag time in seconds; b Presented as mean f standard error and levels of significance 
resulting from data that were subjected to an analysis of variance and pair-wise comparisons made 
using an LSD test; ` Overall means for all and each group of subjects 
as = not significantly different (>0.05); ** = p<0.01 
DNA integrity in lymphocytes and resistance of lymphocytes to H202 challenge 
DNA integrity in lymphocytes and the resistance of lymphocytes to H202 challenge 
were measured using the comet assay. Tables 6-5 and 6-6 show the results of comet 
assays in lymphocytes, without challenge and with hydrogen peroxide challenge, and 
reflect the DNA integrity in cells and the resistance of cells to H202 challenge 
respectively. There were no statistically significant differences in the extent of DNA 
damage measured by this assay due to cholesterol status, gender or treatment with 
vitamin C. 
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Table 6-5: The effect of vitamin C supplementation on DNA integrity in human lymphocytes a'b 
Overall ` Placebo Low Vit C High Vit C 
ns ns 
Overall ` 0.61±0.03 0.6310.07 0.56±0.06 0.6310.05 
n=139 n=45 n=48 n=46 
ns 
Low Cholesterol 0.62±0.04 l 0.65±0.08 0.60±0.07 0.62±0.06 
n--94 I n=30 n=32 n=32 tns 
High Cholesterol 0.58±0.06 0.59±0.13 0.48±0.09 0.67±0.11 
n=45 n=15 n=16 n=14 
Males 0.61±0.04 0.60±0.08 0.47±0.06 0.75±0.08 
n=70 n=22 n=24 n=24 
ns 
Females 0.61±0.05 0.66±0.11 0.65±0.09 0.50±0.07 
n=69 n=23 n=24 n=22 
' Cells from peripheral blood were assessed using comet assay; b Presented as mean (of median tail moments) 
f standard error and levels of significance resulting from data that were subjected to an analysis of variance 
and pair-wise comparisons made using an LSD test; ` Overall means for all and each group of subjects 
ns = not significantly different (>0.05) 
Table 6-6: The responses of human lymphocytes to hydrogen peroxide challenge *, b 
Overall` Placebo Low Vit C High Vit C 
ns ns 
Overall` 37.44±1.40 38.65±2.01 33.73±2.68 40.19±2.42 
n=138 n=45 n=48 n=45 
ns 
Low cholesterol 39.10±1.69 41.06±2.49 34.08±3.31 42.39±2.75 
n=93 n=30 n=32 n=31 
ns 
High cholesterol 34.01±2.41 33.83±3.15 33.03±4.74 35.33±4.70 
n=45 n=15 n=16 n=14 
Males 36.74±1.92 37.53±2.63 34.36±3.52 38.41±3.70 
n=70 n=22 n=24 n=24 
ns 
38.16±2.04 39.72±3.07 33.09±4.11 42.23±3.02 
Females n=68 n=23 n=24 n=21 
' Lymphocytes from vitamin C-supplemented volunteers were challenged with 10 pM of hydrogen 
peroxide in the comet assay; b Presented as mean (of median tail moments), ± standard error and levels of 
significance resulting from data that were subjected to an analysis of variance and pair-wise comparisons 
made using an LSD test; ` Overall means for all and each group of subjects 
ns = not significantly different 
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Plasma levels of p21 ' protein 
The plasma levels of ras protein were measured only aller treatment period 3 (see 
study design in Section 6.2.1). The data are shown in Table 6-7 as the observed area 
of the p21 kD protein band. An increased expression of this protein is defined as a 
peak area greater than the mean for normal controls (the placebo group) plus 2 
standard deviations of the mean (as suggested by Perera ct a/, 1992). Only one sample 
fulfilled this criterion and that was in the placebo group. Thus there was no detectable 
difference in ras protein levels between the treatment groups and the controls. 
Table 6-7: The effect of vitamin C supplementation on ras le've'ls in blood plasma " 
Volunteer No. Placebo Low Vitamin CI ligh Vitamin C 
1 0.05 0.0 0.33 
2 0.42 0.0 1.51 
3 0.03 0.99 0.13 
4 0.0 0.53 0.07 
5 0.03 0.47 0.0 
6 0.02 0.0 0.0 
7 0.0 0.14 0.0 
8 0.0 0.04 0.0 
9 0.0 0.17 1.14 
10 0.13 0.0 0.0 
11 0.34 0.0 0.55 
12 0.58 0.21 0.54 
13 1.31 0.0 0.42 
14 1.16 0.32 0.75 
15 1.771' 0.60 0.55 
16 1.07 0.42 1.29 
Mean 0.43 0.24 0.46 
SD 0.58 0.29 0.50 
Mean±2SD 0- 1.59 0-0.82 0- 1.45 
Measured after treatment period three in a 3-way cross-over study (three- 
treatment x three-treatm ent-period); h One value which exceeds the mean 12 SD 
of the placebo control 
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6.3.2 The Diabetes Study 
Antioxidant capacity, creatinine and HbA, c levels in blood plasma 
Mean values for controls and for IDDM and NIDDM groups for antioxidant lag time, 
creatinine and HbAIc values are shown in Table 6-8. There were no differences in 
creatinine values or antioxidant capacity among the three groups. However, there were 
differences in HbA1C values (p < 0.001) between the 2 diabetic groups and the 
controls. 
Table 6-8: Creatinine, glycosylated haemoglobin (HbAId and antioxidant capacity 
levels in the blood plasma of diabetic patients' 
Antioxidant capacity 
Patient group Creatinine HbA1c Lag time Equivalent 
(seconds) vitamin C (µM) 
Control 88.16 ± 3.46 4.35 t 0.08 124.10: L 6.07 552.5 ± 27.0 
(n = 19) (n = 19) (n = 20) 
Insulin-dependent 89.62 ± 4.06 7.61 f 0.31*** 124.68 ± 11.3 555.0 f 50.0 
diabetes mellitus (n = 21)' (n = 22) (n = 22)' 
Non-insulin-dependent 93.72 ± 5.73 7.12 ± 0.47*** 135.59: 6 7.73 603.5 f 34.5 
diabetes mellitus (n =18)' (n = 19) (n - 23)0° 
* Results presented as means :L standard error of mean; 
°s = not statistically significant; ***=p<0.001 
DNA integrity in lymphocytes of diabetic patients 
DNA integrity in lymphocytes of diabetic patients was measured using the comet 
assay. Table 6-9 shows mean and median values of various categories of damage of 
comets for control and diabetic groups in the comet assay. There were no significant 
differences between the three groups for high and complete comet damage categories. 
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However, there were differences for the low and no damage categories in the IDDM 
group, and for the no damage category in the NIDDM group by comparison with the 
negative control group. Since these differences were contrary to the hypothesis of 
`diabetes would have more damaged cells and less undamaged cells', they were 
considered not to be biologically significant (a one-sided statistical analysis gave non 
significant results and the hypothesis was rejected). 
Table 6-9: Mean and median numbers of cells in no, low, high or complete damage 
categories as measured in the comet assay in various of group ofpatients 
200 cells examined per individual 
Type of individual Damage category Mean number :h SE Median values 
Control (n = 20) No damage 39.35: h 6.42 33.0 
Low damage 152.25 ± 6.58 158.5 
High damage 4.55 ± 1.27 2.5 
Complete damage 3.88: b 1.08 1.5 
IDDM (n = 22) No damage 115.00f 9.13 129.0*** 
Low damage 81.09: b 8.51 66.5*** 
High damage 1.68f 0.41 1.0" 
Complete damage 2.18: h 0.72 . on, 
NIDDM (n = 23) No damage 74.43: h 9.86 65.0* 
Low damage 119.57: k 9.26 134.0" 
High damage 3.00: h 0.84 2.0' 
Complete damage 2.96: h 0.81 . On 
SE = standard error of mean; IDDM - insulin-dependent diabetes mellitus; NIDDM - non- 
insulin-dependent diabetes mellitus 
There was no statistically significant responses by comparison with controls; 
*=p<0.05; ***=p<0.001 by comparison with controls 
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6.4 Discussion 
6.4.1 Vitamin C study 
The purpose of this study was to investigate whether vitamin C supplementation has a 
measurable protective effect against oxidative damage in healthy people consuming 
their normal diet. Underlying this objective was the premise that a number of 
degenerative conditions and chronic diseases related to ageing, e. g. atherosclerosis 
and cancer, are caused in part by an accumulation of oxidative damage to 
macromolecules and that such damage can be ameliorated by antioxidants such as 
vitamin C. 
The volunteers in this study had plasma vitamin C concentrations of 4.73-23.54 
mg/ml after placebo treatment and none could therefore be regarded as deficient in 
vitamin C. Supplementation with 60 mg per day of vitamin C increased the mean 
plasma level from 11.19 to 13.84 mg/ml, a modest increase which was largely due to 
substantial increases in those individuals with a low value (less than about 10 mg/ml) 
after placebo treatment. Supplementation with 6g vitamin C per day increased the 
mean value further to 20.12 mg/ml but this was again a modest increase relative to the 
100-fold increase in vitamin C dose. It can be concluded that most of a high dose 
vitamin C supplement is either not absorbed (Rivers, 1987) due to the saturation of its 
absorption or rapidly excreted. A substantial increase in plasma vitamin C only 
occurred in a subset of volunteers with relatively low dietary intakes. For this reason, 
large effects of supplementation on biomarkers of oxidative damage were not to be 
expected. Higher plasma levels of 800 to 900 mg/ml after chronic intake of vitamin C 
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have been observed in other individuals (Rivers, 1987). A longer supplementation 
time might have produced higher plasma levels. 
Vitamin C supplementation produced a dose-related, but statistically non-significant, 
reduction in the level of lipid peroxide breakdown products in plasma, suggesting that 
within the range of concentrations seen in this study, vitamin C had some small effect 
in controlling plasma lipid peroxidation. Vitamin C is known to protect lipids and low 
density lipoprotein (LDL) in human plasma against oxidation (Retsky et al, 1993). 
Vitamin C supplementation was not given to deliberately oxidatively stressed 
individuals. This approach is in contrast to the approach used for measurement of 
DNA damage [comet assay and assay for chromosome aberrations (Anderson et al, 
1997b)], where cells were challenged with H202 or bleomycin in vitro. A study 
involving in vitro induction of lipid peroxidation in plasma obtained after dietary 
supplementation might have yielded different results. Although vitamin C has a role 
in the regeneration of tocopheryl radicals, it is unlikely that the small changes in 
plasma vitamin C observed in this study would have influenced the effectiveness of 
protection of lipids by vitamin E. If supplementation with vitamin C was prolonged, a 
more pronounced effect on lipid peroxidation might have been visible. Unfortunately, 
LDL and HDL were not measured in this study since the emphasis was on the 
measurement of genetic end-points. 
The total antioxidant capacity of plasma was increased significantly by vitamin C 
supplementation. However, the increase was small (as was the increase in plasma 
levels of the vitamin itself), and there was no difference between the 60 mg per day 
and the 6g per day supplementation levels. Miller et al (1993) cite calculations from 
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The fact that the antioxidant capacity in volunteers with high cholesterol levels is greater 
than that of volunteers with low cholesterol may be because cholesterol itself has some 
antioxidant capacity (Smith, 1991). 
The gender differences in antioxidant capacity is in keeping with the differences already 
observed for males and females in chromosomal aberrations after challenge with 
bleomycin in this same study (Anderson et al, 1997b). Females with lower antioxidant 
capacity have higher chromosomal damage. 
:j 
their own results and those of others, using different methods, showing that vitamin C 
contributes only about 10 % of the total antioxidant capacity in most human plasma 
samples. -Thus, large increases in this parameter would not be expected from 
increasing the plasma level of vitamin C. 
Previous studies in this laboratory (Anderson et al, 1994) have shown that in vitro, 
vitamin C can protect human lymphocytes against DNA damage induced by oxidative 
agents such as hydrogen peroxide, although at high concentrations it can exacerbate 
such damage., In this study, the results of comet assays on lymphocytes showed no 
evidence of an effect of vitamin C supplementation on either basal levels of DNA 
damage or on DNA damage induced by hydrogen peroxide. 
In both comet and chromosome assays (Anderson et al, 1997b) the blood and its 
constituent cells were exposed to vitamin C for a total of 339 hours (336 in vivo and 3 
in vitro). Any effect of dilution of vitamin C in vitro was thus considered practically 
non-existent. 
Similarly, there was no effect on ras p21 proteins. These proteins were measured 
because it has been shown that in workers exposed to occupational factors such as oil 
containing polycyclic aromatic hydrocarbons and other carcinogens, there was an 
increase in ras oncoprotein levels (Brandt-Rauf, 1991). Such increases have been used 
as biomarkers of exposure to genotoxic agents. By analogy, oxidative stress is known 
to cause chromosomal damage (Phillips et al, 1984) and increased ras oncoproteins 
have been shown to accompany such damage (Anderson et al, 1997c). It was thus 
considered possible that an increase in ras oncoproteins might be a biomarker of 
oxidative stress. The determination of ras oncoprotein levels was derived from a 
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single treatment period only. It is appreciated that this might have reduced the 
sensitivity of these measurements. 
There was no evidence that cholesterol status affected any of the parameters measured 
in this study, except for the total antioxidant capacity of plasma which was 
significantly increased in the `high' cholesterol subjects. Significant differences 
between males and females for plasma vitamin C levels, the antioxidant capacity of 
the plasma and for chromosomal aberrations after bleomycin challenge have been 
found (Anderson et al, 1997b). Gender differences have been shown on previous 
occasions for alternative endpoints, such as chromosomal damage, sister chromatid 
exchanges, proliferative rate index and mitogen-induced blastogenesis (Margolin and 
Shelby, 1988; Dewdney et al, 1986; Anderson et al, 1988). 
The results of this study, using these biomarkers, provide no evidence for any benefit 
to be gained from short-term vitamin C supplementation if an adequate diet is 
consumed. The volunteers participating in the study were all healthy and able to 
provide themselves with a good diet. The observed plasma vitamin C levels were all 
within the normal range. Some effect of supplementation on plasma concentration was 
seen in individuals with relatively low starting levels, but for most there was very 
little effect. It is possible, however, that tissue levels were increased more than plasma 
levels. The higher supplementation dose was 100 times the RDA but, had no 
measurably greater effect on most endpoints than the low dose apart from raising 
plasma concentration by a small amount. 
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No differences could be detected in control and diabetic patient groups in terms of 
creatinine levels and antioxidant capacity. However, in the comet assay in the low and no 
damage categories there were lower levels in the IDDM patients, and there was also a 
slight shift in the NIDDM patients. A possible explanation may be that unstimulated 
lymphocytes are not repair proficient and may accumulate a small amount of DNA 
damage. Perhaps damage must exceed a certain level to trigger repair. The decrease in 
background DNA damage in IDDM patients could indicate that these cells are handling 
more oxidative damage on a regular basis and at the same time as they repair oxidative 
damage they also repair other background damage. The result is a lower level of DNA 
damage in stressed cells. Results supporting this hypothesis have been reported by James 
et al (1991), who showed that cumulative DNA damage and associated DNA repair 
activity in unstimulated cells are both reduced after very low-level oxidant stress from low 
dose radiation exposure. That the antioxidant capacity was not altered may be due to the 
chronic low levels of oxidative stress encountered by the patients. 
t 
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6.4.2 Diabetes study 
* 
Collins et al (1993), using endonuclease III specific for oxidised pyrimidines, 
were able to detect significant oxidative damage in untreated lymphocytes from 
normal, healthy individuals. Anderson et al (1995d, 1997b) challenged in vitro 
lymphocytes from normal, healthy volunteers with H202 in an attempt to determine if 
individuals supplemented with vitamin C were more resistant to the challenge. Both 
these approaches can increase the ability of the assay to detect oxygen radical- 
mediated damage. However, in the present study it was felt that differences in 
individuals should be detected by a direct comparison of groups. Smokers in which 
oxidised bases are increased (Ames, 1989) are characterised by a higher degree of 
damage in the comet assay when measured directly, without endonuclease or 
challenge, both in lymphocytes (Betti et al, 1994) and in buccal mucosal cells (Rojas 
et al, 1996). 
Glycosylated haemoglobin (HbAIc) is presented in human blood with a normal range 
of 4.3 - 6.3%, and it is usually higher in diabetic patients (Peters et al, 1996). As 
expected, there were differences in HbA1c levels between the control and the two 
patient groups. In view of the negative findings, differences in life-style factors which 
might confound a study (e. g. contraceptive pill usage, smoking, drinking, vitamin 
intakes etc. ) appeared to have no effect and were therefore not statistically analysed. 
In previous studies (Anderson et al, 1995d, 1997b) healthy volunteers on vitamin C 
supplementation were shown to have altered antioxidant status by comparison with 
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controls. Vitamin E has been shown to prevent the glycosylation of haemoglobin and 
glycosylation of proteins is a major complication of hyperglycaemia in diabetics (Jain 
and Palmer, 1997). 
According to Baynes (1995), various studies in the literature suggest that oxidative 
stress in diabetics, as exemplified by the status of lipid peroxidation, is not increased 
in diabetics except in patients with vascular complications. However, there is no 
evidence from clinical or animal model studies that antioxidant supplementation 
inhibits the development of vascular disease or other long-term complications of 
diabetes (Baynes, 1995). Since beta cells contain low amounts of the superoxide 
radical scavenger enzyme MnSOD, and genetic variation in the MnSOD locus could 
reflect differences in scavenger potential, Pociot et al (1993) tried to link the possible 
restriction fragment length polymorphisms (RFLPs) of manganese superoxide 
dismutase (MnSOD) in IDDM patients and control individuals. However, no overall 
difference in allelic or genotype frequencies were observed between IDDM patients 
and control individuals (p = 0.11) and no significant association of any particular 
RFLP pattern with IDDM was found. In contrast, in a study by Griesmacher et al 
(1995) serum levels of lipid peroxides, measured as thiobarbituric acid reactive 
substances (TBARS), were significantly increased in all patients suffering from 
Diabetes mellitus and type II (NIDDM) patients had significantly higher levels than 
type I (IDDM) patients. This would suggest that enhanced lipid peroxidation 
contributes to an increased formation of free radicals in Diabetes mellitus. But, from 
the results of this study, it appears that the ROS generated in diabetic cells were below 
a critical threshold, above which induced DNA damage could be detected by the 
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comet assay. The similar antioxidant capacity levels among the different groups 
probably also reflect a low level oxidative stress in the diabetic patients, since 
oxidative stress frequently has a link with low antioxidant capacity. It also has been 
suggested (C. Ioannides, personal communication) that ROS may be important in the 
aetiology but not progression of IDDM, which also may partly contribute to the 
negative findings. 
In conclusion, in the present study the comet assay in peripheral lymphocytes did not 
detect any increases in DNA damage in IDDM or NIDDM patients. Furthermore, 
there were no differences in antioxidant capacity or creatinine levels. However, as 
expected, there were differences in glycosylated haemoglobin in patients with 
diabetes. 
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CHAPTER 7 
GENERAL DISCUSSION 
The importance ROS-induced genotoxicity 
The omnipresence of free oxygen provides living organisms with both a useful 
resource and a potential hazard. The oxidation of dietary polysaccharides, lipids, 
proteins, etc. in the food by oxygen is the main energy source of most auxotrophic 
cells, whilst at the same time the partially reduced oxygen species in the biological 
processes can be highly deleterious to the components of a living cell. 
Genetic information stored in the nucleotide sequence of DNA can be altered by 
mutation caused by interaction between ROS and cellular DNA. Ample evidence has 
shown that dysfunction of living organisms can originate from the mutations caused 
directly by physical, chemical and biological factors including ROS. 
Recent studies suggest that ROS may play an important role in human degenerative 
diseases, which include ageing, cancer and many others (Ames, 1983; Martin et al, 
1996) as well as being involved in many pathological conditions (Section 1.6.1). 
Indeed ROS seems very suitable candidates for the cause of these degenerative 
diseases (Kehrer, 1993; Janssen et al, 1993; Kaul et al, 1993; Jenner, 1994; Martin et 
al, 1996). However, to construct a unified theory or to find the common features of 
ROS involvement, a deeper and better understanding of ROS-DNA interaction at the 
in vivo subcellular level is essential. 
To ascertain the nature of the genotypic change in these diseases, in which genetic 
toxicology is one of the most important tools, is the key to understanding the 
mechanism of pathogenesis of these conditions. From a toxicological point of view, 
the investigation of ROS-induced genotoxicity usually begins with the determination 
of whether ROS are involved in the genotoxic effects of a compound. A further goal is 
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to investigate the mechanism of the genotoxicity induced by ROS and how the 
genotoxic effects can be avoided or minimised. As the genotoxic effects are manifest 
at different levels of biological structure/organisation and have different degrees of 
severity, there is a need to investigate the effect of a compound at these different 
levels, especially subcellularly. Such investigations will lead to clarification of the 
toxicological nature of each individual compound, and hence find a better solution to 
control or to minimise the toxic effects of those compounds to humans and to the 
various living organisms in the eco-system. 
The chemical approach to the ROS-induced genotoxicity 
The significance of ROS in mutagenesis, carcinogenesis and pathogenesis has been 
addressed for many years and a great deal of data has been accumulated on the subject 
of ROS toxicity. However, our knowledge on ROS-DNA interaction, especially the 
modulation of such interaction in vivo by antioxidants, is still limited and it is mainly 
due to the lack of knowledge on this subject at subcelluler levels. For example, the 
benefit of the antioxidant vitamins E and C has been known since their discovery and 
some of their functions in vivo have been carefully investigated; however, their 
detailed antioxidant mechanisms remain largely unresolved (Liebler, 1993). The 
history of natural science demonstrates that to understand the mechanism of biological 
processes, the study of relevant chemical reactions is indispensable. Chemical studies 
not only can provide direct evidence of possible ROS involvement in the toxicity of a 
compound, but also can provide a basis for the chemical mechanism of such an 
involvement. 
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In the present `ROS-induced Genotoxicity' studies, a chemical investigation was 
conducted to examine the induction of DNA DSBs by the direct contact of DNA 
molecules and various ROS-generating agents. If the chemical nature of these ROS- 
generating agents is to be considered, a common feature will emerge, Le. the very 
reactive OH' radical or an H abstracting species is always required to induce DNA 
breaks. 
H202 itself is the most important ROS in biological systems and it has great potential 
to be reduced to H2O. However, it cannot induce large numbers of DNA breaks 
directly without the presence of a catalyst to overcome the kinetic barrier. In the 
presence of iron; the very reactive OH' radical can be formed through Fenton or 
Haber-Weiss reactions (Reactions 1-3 to 1-5). 
Figure 7-1: The redox cycle of quinone compounds leading to ROS generation 
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Hydroquinone, BQ and BT are the metabolites of benzene, and in the presence of 
electron donors and acceptors, all three compounds can undergo redox cycling which 
can produce ROS and ultimately OH* radicals via various pathways (Figure 7-1). 
Among the three benzene metabolites, HQ and BT have reducing power, i. e. they can 
serve as electron donors. However, the kinetics of such redox cycling are the 
determining factors of the extent of DNA damage which they can induce, and the 
kinetics are influenced by the constituents in the medium. In a cellular environment, 
NADP quinone oxidoreductase (DT diaphorase) can reduce the quinones to the 
hydroquinones (phenols) via a two-electron reaction, which bypasses the 
autooxidasible semiquinone forms, thus minimising ROS production (Figure 7-1). 
The genotoxic mechanisms of Dox and BLM are less clear than those of simple 
quinones. Dox is an anthracycline compound which contains a quinone structure. 
Many in vitro studies have demonstrated that Dox can cause oxidative damage to 
biomolecules through the generation of ROS (Halliwell and Gutteridge, 1989); 
however, direct evidence for showing ROS involvement in the in vivo situation is yet 
to be substantiated. BLM appears to have a different genotoxic mechanism. It is a 
strong chelator of transition metal ions, e. g. Cue+, Fe 2+, Fe 3+ or Co 2+ by donation of 
electrons from nitrogen atoms and from a carbonyl group to the metal ion (Halliwell 
and Gutteridge, 1989). The degradation of DNA by BLM requires that a reduced 
transition metal ion is present within the DNA-BLM complex, and 02 is also needed. 
A recent review proposed that the toxicity of BLM is mediated by the formation of a 
hydrogen-abstracting ROS (Povirk, 1996). 
That Vit C or ascorbic acid (AH2), the most important antioxidant in the human diet, 
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can be a pro-oxidant seems paradoxical. However, a close examination of its 
chemistry provides an unequivocal answer. In a chemical system containing transition 
metals [M"+ and its partially reduced form M("'l)+], the following reactions can take 
place: 
AH2 - AH'+H+ (7-1) 
2AHf + 02 + 2M(n-1)+ -* 2AA' + H202 + 2M"+ (7-2) 
H202 + AH2, AH', A2-, etc. -4 various free radicals and other products (7-3) 
These reactions are affected by the pH of the cellular environment, the concentrations 
of transition metals and the availability of 02, and the final products of the reactions 
which include various ROS can be of great diversity (Shamberger, 1984). 
In conclusion, it was clearly demonstrated in the chemical study that the ROS- 
generating agents Dox, BLM, HQ, BQ, BT and H202 all induced large numbers of 
DNA DSBs. The induction of DNA DSBs was modulated by various factors including 
antioxidants. The results also provide some indication of how to minimise ROS 
generation, and perhaps to reduce the toxicity of ROS in vivo. 
The in vitro approach to investigating ROS-induced genotoxicity 
Chemical and biochemical approaches may help elucidate the basic mechanisms of 
toxic effects induced by an agent. However, the in vivo situation can be very complex 
and is impossible to simulate in a chemical or biochemical model. Animal and human 
studies are often costly in terms of time and resources, and involve ethical and other 
technical problems. The complexity due to the existence of confounding factors also 
prevents the wide use of in vivo techniques in toxicological studies. A compromise 
approach is to employ in vitro techniques to assess the possible toxic effects which 
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might occur in vivo. The widely used bacterial mutation assay (the Ames test), the 
chromosome aberration assay and the increasingly popular comet assay are such 
techniques. 
In the present study, a wide range of chemicals, including ROS-generating agents, 
antioxidants, food mutagens, HAs and some other miscellaneous agents, were 
investigated for their involvement in ROS-induced genotoxicity and/or the modulation 
of genotoxicity in bacterial cells using the Ames test, in HT29 cells and human 
lymphocytes using the chromosomal aberration and comet assays. The overall results 
showed a good correlation between the genotoxicity induced by ROS-generating 
compounds and the concentrations of those compounds, as well as a correlation 
between the reduced genotoxicity and the existence of antioxidants. 
In the comet assay studies, treatment of human lymphocytes with H202 provided a 
basic model for investigating the genotoxic effect of 'ROS and ROS-generating 
compounds. The genotoxic effect of H202 was unequivocally clear, and such an effect 
was often attenuated in the presence of various antioxidants e. g. catalase and 
silymarin and the transition metal chelators e. g. apo-transferrin and DFO. These 
observations are largely consistent with the chemical study in Chapter 3 with a few 
exceptions e. g. trolox did not protect lymphocytes in the comet assay (Section 4.3) but 
it protected X-DNA in the chemical study (Section 3.3). All the other chemicals whose 
metabolism involved ROS generation, e. g. BLM and benzene, also manifested a clear 
genotoxic effect under certain experimental conditions. However, the modulating 
effect of various antioxidants and other modifying compounds was more complex in 
the comet assay than the effect on ROS-DNA interactions in a simple chemical 
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system, e. g. in the chemical study, SOD when compared with BSA/control showed a 
strong protective effect when DNA was treated with H202, whereas the protection 
from SOD was weak in the comet assay. In the chemical environment, SOD was able 
to dismutate 02 " into H202 and 02, which reduced the generation of OH* via the 
Haber-Weiss reaction (Reaction 1-5), and thus reduced the DNA DSBs induced by 
OH'. In the comet assay, both SOD and its substrate 02"' were unable to pass through 
the plasma membrane, therefore the effect of SOD was an indirect one and appeared 
not to be strong. 
When the comet assay was applied to determine the genotoxic effect of benzene and 
its metabolites, aromatic amines and food mutagens, a metabolic activation system, 
rat liver S9 was sometimes used. The presence of S-9 mix often changed the response 
of cells to the chemicals investigated, e. g. the responses of human lymphocytes to BT 
and BQ were decreased and increased respectively. How relevant was such an 
approach for determining the in vivo situations in humans is questionable. However, it 
is equally true that if an in vitro assay system, e. g. the comet assay, fails to show a 
positive response with the agents investigated in the absence of a mammalian/human 
activation system, a conclusion of a negative response will not be convincing. 
In the Ames test, the modulation of mutagenicity of food mutagens by flavonoids was 
investigated. Plant flavonoids exist in the human diet in large quantities and are 
biological antioxidants (Formica and Regelson, 1995; Manach et al, 1996). On the 
other hand, food mutagens are heterocyclic aromatic amines whose genotoxic effect 
may partly involve ROS (Sato et al, 1992), and are of great interest in human health. 
The results of the Ames test studies have provided useful information with regard to 
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the benefit of such bioflavonoids. The reduced mutagenicity of food mutagens in the 
presence of flavonoids demands future investigations in which the relationship 
between the genotoxicity of food mutagens and the production of ROS should be 
explored. 
In the chromosome aberration study, the effect of Dox and the modulating effects of 
silymarin were investigated. Structural abnormalities in the chromosomes reflect the 
DNA sequence changes which are the leading causes of genetic disorders and can also 
lead to carcinogenesis and other diseases. A comprehensive survey of over 950 
chemicals (Ishidate et al, 1988) found that many chemicals including radiomimetic 
compounds and bioreducible compounds (e. g. BLM and Dox, which both may act 
through ROS/free radical mechanism) are clastogenic. The clastogenicity of Dox has 
already been demonstrated (Nevstad, 1978; Hsu et al, 1982; Migliore et al, 1987). 
There is no concrete evidence that its toxicity in the cellular environment is directly 
caused by ROS, although many experiments suggested there is a ROS involvement in 
its general toxicity (Akman et al, 1992; Ollinger and Brunmark, 1994; Malisza and 
Hasinoff, 1995). The genotoxicity of Dox may derive from two of its 
physicochemical properties: first, its high affinity for DNA and iron; and second, its 
redox cycling ability. These two properties not only allow for the generation of ROS 
in DNA proximity, but also allow the DNA strand breaks induced by ROS to be 
concealed as long as no interference from other DNA activities occur (e. g. cell 
cycling - compare the tail moment values in the comet assay for cycling and non- 
cycling lymphocytes). The experiments were designed to determine whether 
silymarin, an antioxidant, could reduce the clastogenicity of Dox since previous 
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experiments have shown that some flavonoids had a protective effect against 
doxorubicin-induced cardiotoxicity (Vanacker et al, 1995; Husken et al, 1995). At the 
treatment dose level of 10 µM, silymarin appeared to have no significant effect on the 
clastogenicity of Dox. At higher dose levels, silymarin had a synergistic inhibitory 
effect with doxorubicin on cell cycling which was thought to act through Type II 
oestrogen binding sites (Scambia et al, 1996). Further investigations are needed to 
clarify the genotoxic mechanism of Dox and the feasibility 'Of using some flavonoids 
as protective agents against Dox-induced toxicity. 
It has been suggested that ROS are involved in carcinogenesis (Ames, 1983; Feig et 
al, 1994), and DNA-damaging agents (Tanaka et al, 1996) including oxygen radicals 
(Qiu et äl, 1996) may result in increased expression of p21". In the assays measuring 
p21', an effort was made to establish a link between the exposure of cells to some 
carcinogenic ROS-generating compounds and the cellular expression of p21", an 
important regulator of the cell cycle (Jacks and Weinberg, 1996). Although the results 
of the experiments were not conclusive, they suggested that further exploration in in 
vitro toxicological studies of this type would be worthwhile. 
In a cellular environment, the kinetics of each factor relevant to genotoxicity (e. g. the 
permeability of biomembranes for the toxic compounds and the timing of the DNA 
repair) as well as the thermodynamics (i. e. the possibility of the reaction taking place) 
need to be considered when studies are carried out and before a conclusion is drawn. 
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The in vivo approach to investigating ROS-induced genotoxicity 
In vivo experiments are indispensable for toxicological studies because only they can 
genuinely reflect the toxicity in living organisms resulting from the contact with 
toxins. Due to similarities in their physiology, it has been assumed that the adverse 
effects caused by chemicals in higher animals are generally the same as those induced 
by the same chemicals in man (Gad, 1995). Thus the data acquired from animal 
models may be used to predict effects in humans. However, many limitations of in 
vivo studies still exist, e. g. potential confounding of the system due to the prevalence 
of shorter-term local effects as opposed to the intended objectives, and large 
variability between experimental units (Gad, 1995). In many cases, the difference in 
toxic responses to a chemical varies greatly in different species, e. g. the response to 
1,3-butadiene in mice and in rats (Adler et al, 1995; Himmelstein et al, 1997). . 
In the present studies, the in vivo experiments were conducted in both animal models 
and humans. Four studies were carried out: a study on DNA damage induced by BLM 
and other genotoxins in rats, a study on DNA damage induced by BD in mice and by 
DEB in rats, a study on the benefit of vitamin C supplementation in humans, and a 
study on the DNA damage in humans diabetics. 
In the study of DNA damage induced by BLM and other genotoxins in rats, the effect 
of BLM and classic genotoxins CP, EMS and EGME on DNA in rat somatic bone 
marrow and germinal testicular cells was investigated using the comet assay. A 
previous study showed that BLM could induce chromosomal aberrations in 
spermatogonia and bone-marrow cells in rats in vivo (van Buul and Goudzwaard, 
1980). In the present study, the comet tail moment endpoint represents DNA strand 
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breaks and alkali-labile sites expressed in the nuclear DNA at the time of investigation 
(i. e. 2 weeks after the administration of BLM), which may not be the best time of 
choice to detect the effects of BLM. It is possible that the damage induced by BLM is 
short-lived and is rapidly repaired. However, in the parallel experiments, the same 
endpoint was able to detect the positive effects of CP and EGME which suggests that 
damage from these agents is more persistent. A modified regimen of treatment and a 
larger number of animals would be required for further investigations, especially for 
low-responding chemicals. A time course study to determine the peak response time 
of a genotoxin is also very important in toxicology as well as in clinical toxicology 
and pharmacology. 
In the study of DNA damage induced by BD in mice and by DEB in rats, the effects 
of BD and its reactive metabolite DEB in somatic bone marrow cells and germinal 
testicular cells in rodents were examined. There is no direct evidence to suggest that 
the toxic effect of BD and its metabolites is caused by ROS. However, sustained 
elevation of xenobiotic metabolism may lead to increased ROS-production by the 
cells since BD and its metabolites are the substrates of cytochrome CYP2E1 and other 
cytochrome P450 proteins (Elfarra et al, 1996). The toxic effect of BD to mice was 
significant in the comet assay in the acute inhalation study, and was significant in 
terms of reduced testicular weight in the sub-chronic inhalation study at higher doses. 
However, the comet tail moments of treated mice at the lower doses were not 
significantly different from those of the control animals partly due to a small sample 
size and a larger inter-animal variability. The comet endpoint tends to be more 
relevant immediately after acute exposure than in the long term (which also seemed to 
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be the case after BLM treatment in rats in vivo). If a delay occurs, cellular repair 
processes can take place and will diminish the response. In addition, longer exposure 
produces increased cell death in the target organs which perhaps also affects the comet 
response. The difference between the acute experiment and the subchronic/chronic 
experiment may be merely a kinetic mechanism of the cellular response in vivo (see 
Section 5.4.2) which should be taken into consideration in future studies. 
Vitamin C supplementation study 
In the vitamin C study in humans, the popular assumption `an increased intake of the 
external antioxidant vitamin C' has great benefits in healthy people consuming their 
normal diet was investigated. Earlier investigations involving lipo-peroxidation after 
vitamin C supplementation (Maxwell et al, 1993; Rifici and Khachadurian, 1993) or 
combined supplementation of vitamins (Abbey et al, 1993; Morcos and Tomita, 1996) 
were contradicting, but similar results were usually obtained in plasma vitamin levels 
and antioxidant capacities. In the present study, a significant increase of total 
antioxidant capacity in the blood plasma was observed with the vitamin C 
supplementation. Moreover, there was a slight, but not significant, difference between 
the lipid peroxidation levels of volunteers receiving placebo and vitamin C 
supplementation, being lower in the latter, and finally DNA damage in lymphocyte 
before and after exposure to H202 was similar in different treatment groups. However, 
a significant difference was evident between the groups in chromosomal aberration 
frequency in lymphocytes after BLM challenge in the same study (Anderson et al, 
1997b) in which higher sensitivity was observed -in the vitamin C supplemented 
groups. A similar detrimental effect of vitamin C also was seen in the in vitro comet 
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assay and could perhaps be explained by vitamin C providing a reducing environment 
which was favourable for the regeneration of `active BLM' (Povirk, 1996). Overall, 
the study provided no evidence for any of the biomarkers studied of any benefit to be 
gained from short-term vitamin C supplementation if an adequate diet was consumed. 
However, other biomarkers related to ROS effects as well as the long term effect of 
vitamin C supplementation need to be further investigated. 
Study in diabetic patients 
The alkaline comet assay is a sensitive method for detecting lesions in DNA and has 
been used for human biomonitoring studies with or without modification to the 
original protocol described by Singh et al in 1988 (Singh et al 1991; Collins et al 
1993; Betti et al 1994; Rojas et al 1996; Hellman et al 1997). In studies with 
streptozotocin-induced diabetic rats, increased oxidative DNA damage has been 
reported (Ha et al, 1994). In the present study in humans, the comet assay (pH > 13) 
and an antioxidant capacity assay were employed to detect oxidative lesions in 
lymphocyte DNA and altered antioxidant status in patients diagnosed with insulin- 
dependent diabetes. Blood creatinine levels and glycosylated haemoglobin (HbAIC) 
values, biochemical markers for diabetic patients, were also measured to evaluate 
kidney function and diabetic control by insulin administration respectively. No 
elevation of ROS-induced DNA damage or reduction in antioxidant capacity ' in 
patient groups was observed. However, there was a difference in HbAIc values 
between patient groups and the control group as expected. Several reasons might 
contribute to the negative findings concerning the role of ROS in the aetiology of 
diabetes in this study: firstly, the examined endpoint might not necessarily be relevant 
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as in the case of lipid peroxidation in diabetes (Baynes, 1995); secondly, the 
sensitivity of the methods used in the study might not be adequate; and thirdly, the 
hypothesis of ROS involvement is null which seems not to be fully supported by other 
experimenters (Ha et al, 1994). Further approaches are required to confirm whether 
ROS are involved in producing DNA damage in diabetic patients. 
Final conclusions 
THE VARIOUS GENOTOXIC ASSAYS USED IN ROS STUDIES 
The toxicological study of ROS commenced following the early observations of the 
toxicity of oxygen on living organisms and humans. The development of modem 
biomedical sciences enables ROS to be studied at various levels, i. e. from the 
subcellular to the population level. Several assays were employed in the present study 
and each has its advantages and disadvantages. Apart from the assay measuring DNA 
double strand breaks in the chemical study discussed in Chapter 3, all the other assays 
involve using living systems. 
The Ames test measures the frequency of reverse mutations in Salmonella bacteria, 
and it is sensitive to the detection of mutations caused by physicochemical agents in 
bacterial cells. Large numbers of chemical mutagens were identified using this assay. 
For some chemicals, there is a correlation between the mutagenicity in Ames test and 
carcinogenic potency (McCann et al, 1984). However, the genotoxic potency of an 
agent in mammalian cells could be substantially different from its potency in bacteria 
even when mammalian S9 activation system is used in the Ames test (Ishidate et al, 
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1988). Thus assays using mammalian systems are more relevant in predicting 
genotoxic hazards in humans. 
The chromosomal aberration assay using human lymphocytes is a well-established 
method in genetic toxicology, measuring the morphological changes in metaphase 
chromosomes which are characterised in and/or related to the pathogenesis of many 
kinds of diseases, e. g. cancer (Hagmar et al, 1994). Chromosomal aberrations in 
human cells are more relevant than bacterial mutations in predicting genotoxic 
hazards of a compound to human. However, the collection and processing of 
experimental data have proven difficult. Staff training and large man-power used in 
such an assay can be forbidding in some laboratories. 
The comet assay or single cell microgel electrophoresis assay detects DNA strand 
breaks and/or alkali-labile sites in individual cells. It can be applied to all eukaryotic 
cells using both in vitro and in vivo systems. In a recent survey (D. Anderson et al, 
personal communication), agreement with other genotoxic endpoints was established 
for most chemicals, and in many cases it was comparable with other assays in 
sensitivity. It is simple and only requires a small number of cells, thus it can be easily 
incorporated with other existing toxicological methods. Among the assays used in the 
present study to detect ROS-induced genotoxicity, it is the most efficient method. 
ANTIOXIDANTS IN RELATION TO HUMAN HEALTH 
Endogenous antioxidants, such as ROS-detoxifying enzymes, various plasma proteins, 
glutathione and urate, are the major contributors to body defences against ROS- 
induced cellular damage (Miller et al, 1993; Wayner et al, 1987). Thus the genotype 
and physiological status of a person may have great significance in the aetiology of 
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ROS related diseases, such as diabetes. However, due to the definitive nature of a 
person's genotype, the power of contemporary science is limited when the genotype is 
the main cause of ROS-related diseases. 
Exogenous antioxidants, such as vitamins C and E, have proven very important in 
disease prevention and treatment as evidenced in many epidemiological 
investigations, clinical practice and laboratory experiments. A review on 
epidemiological studies of antioxidants and human cancer (Flagg et al, 1995) suggests 
that dietary vitamin C may be inversely related to lung, upper aerodigestive tract and 
uterine cervical cancers, and vitamin E probably has the same effect. Similar 
suggestions have been made that exogenous antioxidants might reduce the risk of 
some other diseases, such as cardiovascular disease, but definitive proof is still 
lacking (Gaziano, 1996). Laboratory experiments, especially in vitro, such as those 
carried out in the present study, often provide strong support for the benefit of 
exogenous antioxidants within the non-toxic range. 
Vitamin C was the most extensively investigated antioxidant in the present study. The 
documented mean concentration of vitamin C in the blood of normal healthy humans 
is about 40 to 70 µM depending on the study (Hultqvist et al, 1997; Anderson et al, 
1997b). In subjects on chronic vitamin C supplementation, the plasma vitamin C 
concentration can reach a level as high as 4.5 -5 mM (Rivers, 1987). From the in 
vitro toxicological data acquired in the comet assays, it appears that when its level 
exceeds 100 µM, vitamin C is more a prooxidant rather than an antioxidant. Under in 
vivo conditions, taking into account body tolerance and the interactions among various 
antioxidants and other molecules, it is unlikely that vitamin C levels over 1 mM are 
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beneficial, and may be toxic. For other antioxidants, although sufficient data are not 
available to make further comment, a cautious approach is recommended when 
supplementation is considered, e. g. in the case of vitamin E (Aruoma, 1993b; Bowry 
and Stocker, 1993). 
Ultimately, the oxidative metabolism adopted by living organisms gives them both 
advantages and disadvantages, in which ROS generation appears to be one of the 
determining factors of life itself. However, the toxicity of ROS and ROS-generating 
compounds appears to involve a complex process in a cellular environment, and even 
more so in animals in vivo. The combination of interactions among 02, ROS- 
generating compounds, transition metals and various cellular components, including 
antioxidants, will determine the in vivo toxicity of ROS. The best solution to reduce 
ROS-induced toxicity is prevention, i. e. by minimising the contact of 02 and 
transition metals in a reducing environment. An alternative approach is to restrict the 
diffusion and proliferation of ROS, i. e. by increasing the levels of various antioxidants 
in the cellular matrix. 
With the aid of improved modem analytical techniques and molecular biology 
methods, such as GC-MS, HPLC, ESR, DNA-sequencing, cell culture, FISH and 
genetic engineering, in combination with `traditional' methods, such as electrophoresis 
and enzymatic reaction assays, there will be a better understanding of ROS-induced 
toxicity and ultimately it may be possible to find a way to ameliorate any detrimental 
effects induced by ROS. 
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